id	sid	tid	token	lemma	pos
cord-254852-qr5gdmbc	1	1	key	key	NN
cord-254852-qr5gdmbc	1	2	:	:	:
cord-254852-qr5gdmbc	1	3	cord-254852-qr5gdmbc	cord-254852-qr5gdmbc	CD
cord-254852-qr5gdmbc	1	4	authors	author	NNS
cord-254852-qr5gdmbc	1	5	:	:	:
cord-254852-qr5gdmbc	1	6	Grief	grief	NN
cord-254852-qr5gdmbc	1	7	,	,	,
cord-254852-qr5gdmbc	1	8	Samuel	Samuel	NNP
cord-254852-qr5gdmbc	1	9	N.	N.	NNP
cord-254852-qr5gdmbc	1	10	;	;	:
cord-254852-qr5gdmbc	1	11	Loza	Loza	NNP
cord-254852-qr5gdmbc	1	12	,	,	,
cord-254852-qr5gdmbc	1	13	Julie	Julie	NNP
cord-254852-qr5gdmbc	1	14	K.	K.	NNP
cord-254852-qr5gdmbc	1	15	title	title	NN
cord-254852-qr5gdmbc	1	16	:	:	:
cord-254852-qr5gdmbc	1	17	Guidelines	guideline	NNS
cord-254852-qr5gdmbc	1	18	for	for	IN
cord-254852-qr5gdmbc	1	19	the	the	DT
cord-254852-qr5gdmbc	1	20	Evaluation	Evaluation	NNP
cord-254852-qr5gdmbc	1	21	and	and	CC
cord-254852-qr5gdmbc	1	22	Treatment	Treatment	NNP
cord-254852-qr5gdmbc	1	23	of	of	IN
cord-254852-qr5gdmbc	1	24	Pneumonia	Pneumonia	NNP
cord-254852-qr5gdmbc	1	25	date	date	NN
cord-254852-qr5gdmbc	1	26	:	:	:
cord-254852-qr5gdmbc	1	27	2018	2018	CD
cord-254852-qr5gdmbc	1	28	-	-	HYPH
cord-254852-qr5gdmbc	1	29	08	08	CD
cord-254852-qr5gdmbc	1	30	-	-	SYM
cord-254852-qr5gdmbc	1	31	14	14	CD
cord-254852-qr5gdmbc	1	32	journal	journal	NN
cord-254852-qr5gdmbc	1	33	:	:	:
cord-254852-qr5gdmbc	2	1	Prim	Prim	NNP
cord-254852-qr5gdmbc	2	2	Care	Care	NNP
cord-254852-qr5gdmbc	2	3	DOI	DOI	NNP
cord-254852-qr5gdmbc	2	4	:	:	:
cord-254852-qr5gdmbc	2	5	10.1016	10.1016	CD
cord-254852-qr5gdmbc	3	1	/j.pop.2018.04.001	/j.pop.2018.04.001	NNP
cord-254852-qr5gdmbc	3	2	sha	sha	NNP
cord-254852-qr5gdmbc	3	3	:	:	:
cord-254852-qr5gdmbc	3	4	f892f5eed6131e0038666da671bdb51a04578918	f892f5eed6131e0038666da671bdb51a04578918	NNP
cord-254852-qr5gdmbc	3	5	doc_id	doc_id	CD
cord-254852-qr5gdmbc	3	6	:	:	:
cord-254852-qr5gdmbc	3	7	254852	254852	CD
cord-254852-qr5gdmbc	3	8	cord_uid	cord_uid	NNS
cord-254852-qr5gdmbc	3	9	:	:	:
cord-254852-qr5gdmbc	4	1	qr5gdmbc	qr5gdmbc	.
cord-254852-qr5gdmbc	5	1	Pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	5	2	is	be	VBZ
cord-254852-qr5gdmbc	5	3	a	a	DT
cord-254852-qr5gdmbc	5	4	common	common	JJ
cord-254852-qr5gdmbc	5	5	cause	cause	NN
cord-254852-qr5gdmbc	5	6	of	of	IN
cord-254852-qr5gdmbc	5	7	respiratory	respiratory	JJ
cord-254852-qr5gdmbc	5	8	infection	infection	NN
cord-254852-qr5gdmbc	5	9	,	,	,
cord-254852-qr5gdmbc	5	10	accounting	account	VBG
cord-254852-qr5gdmbc	5	11	for	for	IN
cord-254852-qr5gdmbc	5	12	more	more	JJR
cord-254852-qr5gdmbc	5	13	than	than	IN
cord-254852-qr5gdmbc	5	14	800,000	800,000	CD
cord-254852-qr5gdmbc	5	15	hospitalizations	hospitalization	NNS
cord-254852-qr5gdmbc	5	16	in	in	IN
cord-254852-qr5gdmbc	5	17	the	the	DT
cord-254852-qr5gdmbc	5	18	United	United	NNP
cord-254852-qr5gdmbc	5	19	States	States	NNP
cord-254852-qr5gdmbc	5	20	annually	annually	RB
cord-254852-qr5gdmbc	5	21	.	.	.
cord-254852-qr5gdmbc	6	1	Presenting	present	VBG
cord-254852-qr5gdmbc	6	2	symptoms	symptom	NNS
cord-254852-qr5gdmbc	6	3	of	of	IN
cord-254852-qr5gdmbc	6	4	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	6	5	are	be	VBP
cord-254852-qr5gdmbc	6	6	typically	typically	RB
cord-254852-qr5gdmbc	6	7	cough	cough	NN
cord-254852-qr5gdmbc	6	8	,	,	,
cord-254852-qr5gdmbc	6	9	pleuritic	pleuritic	JJ
cord-254852-qr5gdmbc	6	10	chest	chest	NN
cord-254852-qr5gdmbc	6	11	pain	pain	NN
cord-254852-qr5gdmbc	6	12	,	,	,
cord-254852-qr5gdmbc	6	13	fever	fever	NN
cord-254852-qr5gdmbc	6	14	,	,	,
cord-254852-qr5gdmbc	6	15	fatigue	fatigue	NN
cord-254852-qr5gdmbc	6	16	,	,	,
cord-254852-qr5gdmbc	6	17	and	and	CC
cord-254852-qr5gdmbc	6	18	loss	loss	NN
cord-254852-qr5gdmbc	6	19	of	of	IN
cord-254852-qr5gdmbc	6	20	appetite	appetite	NN
cord-254852-qr5gdmbc	6	21	.	.	.
cord-254852-qr5gdmbc	7	1	Children	child	NNS
cord-254852-qr5gdmbc	7	2	and	and	CC
cord-254852-qr5gdmbc	7	3	the	the	DT
cord-254852-qr5gdmbc	7	4	elderly	elderly	JJ
cord-254852-qr5gdmbc	7	5	have	have	VBP
cord-254852-qr5gdmbc	7	6	different	different	JJ
cord-254852-qr5gdmbc	7	7	presenting	present	VBG
cord-254852-qr5gdmbc	7	8	features	feature	NNS
cord-254852-qr5gdmbc	7	9	of	of	IN
cord-254852-qr5gdmbc	7	10	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	7	11	,	,	,
cord-254852-qr5gdmbc	7	12	which	which	WDT
cord-254852-qr5gdmbc	7	13	include	include	VBP
cord-254852-qr5gdmbc	7	14	headache	headache	NN
cord-254852-qr5gdmbc	7	15	,	,	,
cord-254852-qr5gdmbc	7	16	nausea	nausea	NN
cord-254852-qr5gdmbc	7	17	,	,	,
cord-254852-qr5gdmbc	7	18	abdominal	abdominal	JJ
cord-254852-qr5gdmbc	7	19	pain	pain	NN
cord-254852-qr5gdmbc	7	20	,	,	,
cord-254852-qr5gdmbc	7	21	and	and	CC
cord-254852-qr5gdmbc	7	22	absence	absence	NN
cord-254852-qr5gdmbc	7	23	of	of	IN
cord-254852-qr5gdmbc	7	24	one	one	CD
cord-254852-qr5gdmbc	7	25	or	or	CC
cord-254852-qr5gdmbc	7	26	more	more	JJR
cord-254852-qr5gdmbc	7	27	of	of	IN
cord-254852-qr5gdmbc	7	28	the	the	DT
cord-254852-qr5gdmbc	7	29	prototypical	prototypical	JJ
cord-254852-qr5gdmbc	7	30	symptoms	symptom	NNS
cord-254852-qr5gdmbc	7	31	.	.	.
cord-254852-qr5gdmbc	8	1	Knowledge	knowledge	NN
cord-254852-qr5gdmbc	8	2	of	of	IN
cord-254852-qr5gdmbc	8	3	local	local	JJ
cord-254852-qr5gdmbc	8	4	bacterial	bacterial	JJ
cord-254852-qr5gdmbc	8	5	pathogens	pathogen	NNS
cord-254852-qr5gdmbc	8	6	and	and	CC
cord-254852-qr5gdmbc	8	7	their	-PRON-	PRP$
cord-254852-qr5gdmbc	8	8	antibiotic	antibiotic	JJ
cord-254852-qr5gdmbc	8	9	susceptibility	susceptibility	NN
cord-254852-qr5gdmbc	8	10	and	and	CC
cord-254852-qr5gdmbc	8	11	resistance	resistance	NN
cord-254852-qr5gdmbc	8	12	profiles	profile	NNS
cord-254852-qr5gdmbc	8	13	is	be	VBZ
cord-254852-qr5gdmbc	8	14	the	the	DT
cord-254852-qr5gdmbc	8	15	key	key	NN
cord-254852-qr5gdmbc	8	16	for	for	IN
cord-254852-qr5gdmbc	8	17	effective	effective	JJ
cord-254852-qr5gdmbc	8	18	pharmacologic	pharmacologic	JJ
cord-254852-qr5gdmbc	8	19	selection	selection	NN
cord-254852-qr5gdmbc	8	20	and	and	CC
cord-254852-qr5gdmbc	8	21	treatment	treatment	NN
cord-254852-qr5gdmbc	8	22	of	of	IN
cord-254852-qr5gdmbc	8	23	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	8	24	.	.	.
cord-254852-qr5gdmbc	9	1	Pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	9	2	is	be	VBZ
cord-254852-qr5gdmbc	9	3	a	a	DT
cord-254852-qr5gdmbc	9	4	leading	leading	JJ
cord-254852-qr5gdmbc	9	5	cause	cause	NN
cord-254852-qr5gdmbc	9	6	of	of	IN
cord-254852-qr5gdmbc	9	7	hospitalization	hospitalization	NN
cord-254852-qr5gdmbc	9	8	among	among	IN
cord-254852-qr5gdmbc	9	9	both	both	DT
cord-254852-qr5gdmbc	9	10	adults	adult	NNS
cord-254852-qr5gdmbc	9	11	and	and	CC
cord-254852-qr5gdmbc	9	12	children	child	NNS
cord-254852-qr5gdmbc	9	13	in	in	IN
cord-254852-qr5gdmbc	9	14	the	the	DT
cord-254852-qr5gdmbc	9	15	United	United	NNP
cord-254852-qr5gdmbc	9	16	States	States	NNP
cord-254852-qr5gdmbc	9	17	,	,	,
cord-254852-qr5gdmbc	9	18	accounting	account	VBG
cord-254852-qr5gdmbc	9	19	for	for	IN
cord-254852-qr5gdmbc	9	20	more	more	JJR
cord-254852-qr5gdmbc	9	21	than	than	IN
cord-254852-qr5gdmbc	9	22	800,000	800,000	CD
cord-254852-qr5gdmbc	9	23	hospitalizations	hospitalization	NNS
cord-254852-qr5gdmbc	9	24	and	and	CC
cord-254852-qr5gdmbc	9	25	more	more	JJR
cord-254852-qr5gdmbc	9	26	than	than	IN
cord-254852-qr5gdmbc	9	27	400,000	400,000	CD
cord-254852-qr5gdmbc	9	28	emergency	emergency	NN
cord-254852-qr5gdmbc	9	29	department	department	NN
cord-254852-qr5gdmbc	9	30	visits	visit	VBZ
cord-254852-qr5gdmbc	9	31	in	in	IN
cord-254852-qr5gdmbc	9	32	2014	2014	CD
cord-254852-qr5gdmbc	9	33	.	.	.
cord-254852-qr5gdmbc	10	1	1	1	CD
cord-254852-qr5gdmbc	10	2	,	,	,
cord-254852-qr5gdmbc	10	3	2	2	CD
cord-254852-qr5gdmbc	11	1	It	-PRON-	PRP
cord-254852-qr5gdmbc	11	2	is	be	VBZ
cord-254852-qr5gdmbc	11	3	among	among	IN
cord-254852-qr5gdmbc	11	4	the	the	DT
cord-254852-qr5gdmbc	11	5	most	most	RBS
cord-254852-qr5gdmbc	11	6	expensive	expensive	JJ
cord-254852-qr5gdmbc	11	7	conditions	condition	NNS
cord-254852-qr5gdmbc	11	8	treated	treat	VBN
cord-254852-qr5gdmbc	11	9	in	in	IN
cord-254852-qr5gdmbc	11	10	US	US	NNP
cord-254852-qr5gdmbc	11	11	hospitals	hospital	NNS
cord-254852-qr5gdmbc	11	12	with	with	IN
cord-254852-qr5gdmbc	11	13	national	national	JJ
cord-254852-qr5gdmbc	11	14	aggregate	aggregate	JJ
cord-254852-qr5gdmbc	11	15	costs	cost	NNS
cord-254852-qr5gdmbc	11	16	of	of	IN
cord-254852-qr5gdmbc	11	17	$	$	$
cord-254852-qr5gdmbc	11	18	9.5	9.5	CD
cord-254852-qr5gdmbc	11	19	billion	billion	CD
cord-254852-qr5gdmbc	11	20	in	in	IN
cord-254852-qr5gdmbc	11	21	2013	2013	CD
cord-254852-qr5gdmbc	11	22	.	.	.
cord-254852-qr5gdmbc	12	1	3	3	LS
cord-254852-qr5gdmbc	13	1	A	a	DT
cord-254852-qr5gdmbc	13	2	causal	causal	JJ
cord-254852-qr5gdmbc	13	3	pathogen	pathogen	NN
cord-254852-qr5gdmbc	13	4	is	be	VBZ
cord-254852-qr5gdmbc	13	5	often	often	RB
cord-254852-qr5gdmbc	13	6	not	not	RB
cord-254852-qr5gdmbc	13	7	identified	identify	VBN
cord-254852-qr5gdmbc	13	8	.	.	.
cord-254852-qr5gdmbc	14	1	A	a	DT
cord-254852-qr5gdmbc	14	2	2015	2015	CD
cord-254852-qr5gdmbc	14	3	prospective	prospective	JJ
cord-254852-qr5gdmbc	14	4	,	,	,
cord-254852-qr5gdmbc	14	5	multi	multi	JJ
cord-254852-qr5gdmbc	14	6	-	-	JJ
cord-254852-qr5gdmbc	14	7	center	center	JJ
cord-254852-qr5gdmbc	14	8	study	study	NN
cord-254852-qr5gdmbc	14	9	by	by	IN
cord-254852-qr5gdmbc	14	10	the	the	DT
cord-254852-qr5gdmbc	14	11	Centers	Centers	NNPS
cord-254852-qr5gdmbc	14	12	for	for	IN
cord-254852-qr5gdmbc	14	13	Disease	Disease	NNP
cord-254852-qr5gdmbc	14	14	Control	Control	NNP
cord-254852-qr5gdmbc	14	15	and	and	CC
cord-254852-qr5gdmbc	14	16	Prevention	Prevention	NNP
cord-254852-qr5gdmbc	14	17	identified	identify	VBD
cord-254852-qr5gdmbc	14	18	a	a	DT
cord-254852-qr5gdmbc	14	19	responsible	responsible	JJ
cord-254852-qr5gdmbc	14	20	pathogen	pathogen	NN
cord-254852-qr5gdmbc	14	21	in	in	IN
cord-254852-qr5gdmbc	14	22	only	only	RB
cord-254852-qr5gdmbc	14	23	38	38	CD
cord-254852-qr5gdmbc	14	24	%	%	NN
cord-254852-qr5gdmbc	14	25	of	of	IN
cord-254852-qr5gdmbc	14	26	cases	case	NNS
cord-254852-qr5gdmbc	14	27	of	of	IN
cord-254852-qr5gdmbc	14	28	community	community	NN
cord-254852-qr5gdmbc	14	29	-	-	HYPH
cord-254852-qr5gdmbc	14	30	acquired	acquire	VBN
cord-254852-qr5gdmbc	14	31	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	14	32	(	(	-LRB-
cord-254852-qr5gdmbc	14	33	CAP	CAP	NNP
cord-254852-qr5gdmbc	14	34	)	)	-RRB-
cord-254852-qr5gdmbc	14	35	in	in	IN
cord-254852-qr5gdmbc	14	36	adults	adult	NNS
cord-254852-qr5gdmbc	14	37	requiring	require	VBG
cord-254852-qr5gdmbc	14	38	hospitalization	hospitalization	NN
cord-254852-qr5gdmbc	14	39	.	.	.
cord-254852-qr5gdmbc	15	1	4	4	CD
cord-254852-qr5gdmbc	15	2	CAP	CAP	NNP
cord-254852-qr5gdmbc	15	3	is	be	VBZ
cord-254852-qr5gdmbc	15	4	an	an	DT
cord-254852-qr5gdmbc	15	5	infection	infection	NN
cord-254852-qr5gdmbc	15	6	of	of	IN
cord-254852-qr5gdmbc	15	7	the	the	DT
cord-254852-qr5gdmbc	15	8	lung	lung	NN
cord-254852-qr5gdmbc	15	9	parenchyma	parenchyma	NNS
cord-254852-qr5gdmbc	15	10	that	that	WDT
cord-254852-qr5gdmbc	15	11	is	be	VBZ
cord-254852-qr5gdmbc	15	12	acquired	acquire	VBN
cord-254852-qr5gdmbc	15	13	outside	outside	IN
cord-254852-qr5gdmbc	15	14	of	of	IN
cord-254852-qr5gdmbc	15	15	hospitals	hospital	NNS
cord-254852-qr5gdmbc	15	16	or	or	CC
cord-254852-qr5gdmbc	15	17	extended	extend	VBN
cord-254852-qr5gdmbc	15	18	-	-	HYPH
cord-254852-qr5gdmbc	15	19	care	care	NN
cord-254852-qr5gdmbc	15	20	facilities	facility	NNS
cord-254852-qr5gdmbc	15	21	.	.	.
cord-254852-qr5gdmbc	16	1	5	5	CD
cord-254852-qr5gdmbc	16	2	Viral	viral	JJ
cord-254852-qr5gdmbc	16	3	pathogens	pathogen	NNS
cord-254852-qr5gdmbc	16	4	were	be	VBD
cord-254852-qr5gdmbc	16	5	identified	identify	VBN
cord-254852-qr5gdmbc	16	6	in	in	IN
cord-254852-qr5gdmbc	16	7	27	27	CD
cord-254852-qr5gdmbc	16	8	%	%	NN
cord-254852-qr5gdmbc	16	9	of	of	IN
cord-254852-qr5gdmbc	16	10	cases	case	NNS
cord-254852-qr5gdmbc	16	11	and	and	CC
cord-254852-qr5gdmbc	16	12	bacterial	bacterial	JJ
cord-254852-qr5gdmbc	16	13	pathogens	pathogen	NNS
cord-254852-qr5gdmbc	16	14	in	in	IN
cord-254852-qr5gdmbc	16	15	14	14	CD
cord-254852-qr5gdmbc	16	16	%	%	NN
cord-254852-qr5gdmbc	16	17	of	of	IN
cord-254852-qr5gdmbc	16	18	cases	case	NNS
cord-254852-qr5gdmbc	16	19	.	.	.
cord-254852-qr5gdmbc	17	1	5	5	LS
cord-254852-qr5gdmbc	18	1	In	in	IN
cord-254852-qr5gdmbc	18	2	adults	adult	NNS
cord-254852-qr5gdmbc	18	3	of	of	IN
cord-254852-qr5gdmbc	18	4	all	all	DT
cord-254852-qr5gdmbc	18	5	ages	age	NNS
cord-254852-qr5gdmbc	18	6	,	,	,
cord-254852-qr5gdmbc	18	7	human	human	JJ
cord-254852-qr5gdmbc	18	8	rhinovirus	rhinovirus	NN
cord-254852-qr5gdmbc	18	9	and	and	CC
cord-254852-qr5gdmbc	18	10	influenza	influenza	NN
cord-254852-qr5gdmbc	18	11	were	be	VBD
cord-254852-qr5gdmbc	18	12	the	the	DT
cord-254852-qr5gdmbc	18	13	most	most	RBS
cord-254852-qr5gdmbc	18	14	frequently	frequently	RB
cord-254852-qr5gdmbc	18	15	identified	identify	VBN
cord-254852-qr5gdmbc	18	16	viruses	virus	NNS
cord-254852-qr5gdmbc	18	17	.	.	.
cord-254852-qr5gdmbc	19	1	5	5	CD
cord-254852-qr5gdmbc	19	2	Streptococcus	streptococcus	NN
cord-254852-qr5gdmbc	19	3	pneumoniae	pneumoniae	NN
cord-254852-qr5gdmbc	19	4	is	be	VBZ
cord-254852-qr5gdmbc	19	5	the	the	DT
cord-254852-qr5gdmbc	19	6	most	most	RBS
cord-254852-qr5gdmbc	19	7	common	common	JJ
cord-254852-qr5gdmbc	19	8	causal	causal	JJ
cord-254852-qr5gdmbc	19	9	bacterium	bacterium	NN
cord-254852-qr5gdmbc	19	10	.	.	.
cord-254852-qr5gdmbc	20	1	Staphylococcus	staphylococcus	NN
cord-254852-qr5gdmbc	20	2	aureus	aureus	NN
cord-254852-qr5gdmbc	20	3	and	and	CC
cord-254852-qr5gdmbc	20	4	Enterobacteriaceae	Enterobacteriaceae	NNP
cord-254852-qr5gdmbc	20	5	were	be	VBD
cord-254852-qr5gdmbc	20	6	significantly	significantly	RB
cord-254852-qr5gdmbc	20	7	more	more	RBR
cord-254852-qr5gdmbc	20	8	common	common	JJ
cord-254852-qr5gdmbc	20	9	among	among	IN
cord-254852-qr5gdmbc	20	10	patients	patient	NNS
cord-254852-qr5gdmbc	20	11	requiring	require	VBG
cord-254852-qr5gdmbc	20	12	intensive	intensive	JJ
cord-254852-qr5gdmbc	20	13	care	care	NN
cord-254852-qr5gdmbc	20	14	unit	unit	NN
cord-254852-qr5gdmbc	20	15	(	(	-LRB-
cord-254852-qr5gdmbc	20	16	ICU	ICU	NNP
cord-254852-qr5gdmbc	20	17	)	)	-RRB-
cord-254852-qr5gdmbc	20	18	level	level	NN
cord-254852-qr5gdmbc	20	19	care	care	NN
cord-254852-qr5gdmbc	20	20	.	.	.
cord-254852-qr5gdmbc	21	1	4	4	LS
cord-254852-qr5gdmbc	22	1	Other	other	JJ
cord-254852-qr5gdmbc	22	2	bacteria	bacteria	NNS
cord-254852-qr5gdmbc	22	3	identified	identify	VBN
cord-254852-qr5gdmbc	22	4	in	in	IN
cord-254852-qr5gdmbc	22	5	CAP	CAP	NNP
cord-254852-qr5gdmbc	22	6	include	include	VBP
cord-254852-qr5gdmbc	22	7	Mycoplasma	mycoplasma	NN
cord-254852-qr5gdmbc	22	8	pneumoniae	pneumoniae	NNS
cord-254852-qr5gdmbc	22	9	,	,	,
cord-254852-qr5gdmbc	22	10	Chlamydophila	Chlamydophila	NNP
cord-254852-qr5gdmbc	22	11	pneumoniae	pneumoniae	NN
cord-254852-qr5gdmbc	22	12	,	,	,
cord-254852-qr5gdmbc	22	13	and	and	CC
cord-254852-qr5gdmbc	22	14	Haemophilus	haemophilus	JJ
cord-254852-qr5gdmbc	22	15	influenzae	influenzae	NN
cord-254852-qr5gdmbc	22	16	.	.	.
cord-254852-qr5gdmbc	23	1	5	5	LS
cord-254852-qr5gdmbc	24	1	Less	less	RBR
cord-254852-qr5gdmbc	24	2	common	common	JJ
cord-254852-qr5gdmbc	24	3	bacterial	bacterial	JJ
cord-254852-qr5gdmbc	24	4	causes	cause	NNS
cord-254852-qr5gdmbc	24	5	include	include	VBP
cord-254852-qr5gdmbc	24	6	Mycobacterium	Mycobacterium	NNP
cord-254852-qr5gdmbc	24	7	tuberculosis	tuberculosis	NN
cord-254852-qr5gdmbc	24	8	,	,	,
cord-254852-qr5gdmbc	24	9	Legionella	Legionella	NNP
cord-254852-qr5gdmbc	24	10	sp	sp	NN
cord-254852-qr5gdmbc	24	11	,	,	,
cord-254852-qr5gdmbc	24	12	and	and	CC
cord-254852-qr5gdmbc	24	13	Pseudomonas	Pseudomonas	NNP
cord-254852-qr5gdmbc	24	14	aeruginosa	aeruginosa	NN
cord-254852-qr5gdmbc	24	15	.	.	.
cord-254852-qr5gdmbc	25	1	These	these	DT
cord-254852-qr5gdmbc	25	2	and	and	CC
cord-254852-qr5gdmbc	25	3	other	other	JJ
cord-254852-qr5gdmbc	25	4	bacteria	bacteria	NNS
cord-254852-qr5gdmbc	25	5	may	may	MD
cord-254852-qr5gdmbc	25	6	be	be	VB
cord-254852-qr5gdmbc	25	7	considered	consider	VBN
cord-254852-qr5gdmbc	25	8	more	more	RBR
cord-254852-qr5gdmbc	25	9	likely	likely	JJ
cord-254852-qr5gdmbc	25	10	in	in	IN
cord-254852-qr5gdmbc	25	11	patients	patient	NNS
cord-254852-qr5gdmbc	25	12	with	with	IN
cord-254852-qr5gdmbc	25	13	certain	certain	JJ
cord-254852-qr5gdmbc	25	14	risk	risk	NN
cord-254852-qr5gdmbc	25	15	factors	factor	NNS
cord-254852-qr5gdmbc	25	16	(	(	-LRB-
cord-254852-qr5gdmbc	25	17	Table	table	NN
cord-254852-qr5gdmbc	25	18	1	1	CD
cord-254852-qr5gdmbc	25	19	)	)	-RRB-
cord-254852-qr5gdmbc	25	20	.	.	.
cord-254852-qr5gdmbc	26	1	6	6	CD
cord-254852-qr5gdmbc	26	2	DIAGNOSIS	diagnosis	NN
cord-254852-qr5gdmbc	27	1	A	a	DT
cord-254852-qr5gdmbc	27	2	diagnosis	diagnosis	NN
cord-254852-qr5gdmbc	27	3	of	of	IN
cord-254852-qr5gdmbc	27	4	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	27	5	should	should	MD
cord-254852-qr5gdmbc	27	6	be	be	VB
cord-254852-qr5gdmbc	27	7	considered	consider	VBN
cord-254852-qr5gdmbc	27	8	in	in	IN
cord-254852-qr5gdmbc	27	9	patients	patient	NNS
cord-254852-qr5gdmbc	27	10	presenting	present	VBG
cord-254852-qr5gdmbc	27	11	with	with	IN
cord-254852-qr5gdmbc	27	12	acute	acute	JJ
cord-254852-qr5gdmbc	27	13	onset	onset	NN
cord-254852-qr5gdmbc	27	14	fever	fever	NN
cord-254852-qr5gdmbc	27	15	or	or	CC
cord-254852-qr5gdmbc	27	16	chills	chill	NNS
cord-254852-qr5gdmbc	27	17	and	and	CC
cord-254852-qr5gdmbc	27	18	cough	cough	NN
cord-254852-qr5gdmbc	27	19	.	.	.
cord-254852-qr5gdmbc	28	1	The	the	DT
cord-254852-qr5gdmbc	28	2	cough	cough	NN
cord-254852-qr5gdmbc	28	3	may	may	MD
cord-254852-qr5gdmbc	28	4	be	be	VB
cord-254852-qr5gdmbc	28	5	described	describe	VBN
cord-254852-qr5gdmbc	28	6	as	as	IN
cord-254852-qr5gdmbc	28	7	productive	productive	JJ
cord-254852-qr5gdmbc	28	8	.	.	.
cord-254852-qr5gdmbc	29	1	Additional	additional	JJ
cord-254852-qr5gdmbc	29	2	symptoms	symptom	NNS
cord-254852-qr5gdmbc	29	3	frequently	frequently	RB
cord-254852-qr5gdmbc	29	4	seen	see	VBN
cord-254852-qr5gdmbc	29	5	include	include	VBP
cord-254852-qr5gdmbc	29	6	fatigue	fatigue	NN
cord-254852-qr5gdmbc	29	7	,	,	,
cord-254852-qr5gdmbc	29	8	anorexia	anorexia	NN
cord-254852-qr5gdmbc	29	9	,	,	,
cord-254852-qr5gdmbc	29	10	and	and	CC
cord-254852-qr5gdmbc	29	11	pleuritic	pleuritic	JJ
cord-254852-qr5gdmbc	29	12	chest	chest	NN
cord-254852-qr5gdmbc	29	13	pain	pain	NN
cord-254852-qr5gdmbc	29	14	.	.	.
cord-254852-qr5gdmbc	30	1	Important	important	JJ
cord-254852-qr5gdmbc	30	2	components	component	NNS
cord-254852-qr5gdmbc	30	3	of	of	IN
cord-254852-qr5gdmbc	30	4	a	a	DT
cord-254852-qr5gdmbc	30	5	history	history	NN
cord-254852-qr5gdmbc	30	6	include	include	VBP
cord-254852-qr5gdmbc	30	7	recent	recent	JJ
cord-254852-qr5gdmbc	30	8	travel	travel	NN
cord-254852-qr5gdmbc	30	9	,	,	,
cord-254852-qr5gdmbc	30	10	history	history	NN
cord-254852-qr5gdmbc	30	11	of	of	IN
cord-254852-qr5gdmbc	30	12	underlying	underlie	VBG
cord-254852-qr5gdmbc	30	13	lung	lung	NN
cord-254852-qr5gdmbc	30	14	disease	disease	NN
cord-254852-qr5gdmbc	30	15	,	,	,
cord-254852-qr5gdmbc	30	16	and	and	CC
cord-254852-qr5gdmbc	30	17	smoking	smoke	VBG
cord-254852-qr5gdmbc	30	18	history	history	NN
cord-254852-qr5gdmbc	30	19	.	.	.
cord-254852-qr5gdmbc	31	1	4,6	4,6	CD
cord-254852-qr5gdmbc	32	1	A	a	DT
cord-254852-qr5gdmbc	32	2	study	study	NN
cord-254852-qr5gdmbc	32	3	by	by	IN
cord-254852-qr5gdmbc	32	4	Diehr	Diehr	NNP
cord-254852-qr5gdmbc	32	5	and	and	CC
cord-254852-qr5gdmbc	32	6	colleagues	colleague	NNS
cord-254852-qr5gdmbc	32	7	7	7	CD
cord-254852-qr5gdmbc	32	8	found	find	VBD
cord-254852-qr5gdmbc	32	9	that	that	IN
cord-254852-qr5gdmbc	32	10	history	history	NN
cord-254852-qr5gdmbc	32	11	of	of	IN
cord-254852-qr5gdmbc	32	12	alcoholism	alcoholism	NN
cord-254852-qr5gdmbc	32	13	or	or	CC
cord-254852-qr5gdmbc	32	14	bloody	bloody	JJ
cord-254852-qr5gdmbc	32	15	sputum	sputum	NN
cord-254852-qr5gdmbc	32	16	have	have	VBP
cord-254852-qr5gdmbc	32	17	relative	relative	JJ
cord-254852-qr5gdmbc	32	18	risk	risk	NN
cord-254852-qr5gdmbc	32	19	of	of	IN
cord-254852-qr5gdmbc	32	20	1	1	CD
cord-254852-qr5gdmbc	32	21	,	,	,
cord-254852-qr5gdmbc	32	22	so	so	RB
cord-254852-qr5gdmbc	33	1	the	the	DT
cord-254852-qr5gdmbc	33	2	presence	presence	NN
cord-254852-qr5gdmbc	33	3	of	of	IN
cord-254852-qr5gdmbc	33	4	these	these	DT
cord-254852-qr5gdmbc	33	5	findings	finding	NNS
cord-254852-qr5gdmbc	33	6	is	be	VBZ
cord-254852-qr5gdmbc	33	7	not	not	RB
cord-254852-qr5gdmbc	33	8	predictive	predictive	JJ
cord-254852-qr5gdmbc	33	9	of	of	IN
cord-254852-qr5gdmbc	33	10	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	33	11	.	.	.
cord-254852-qr5gdmbc	34	1	Physical	physical	JJ
cord-254852-qr5gdmbc	34	2	examination	examination	NN
cord-254852-qr5gdmbc	34	3	findings	finding	NNS
cord-254852-qr5gdmbc	34	4	frequently	frequently	RB
cord-254852-qr5gdmbc	34	5	appreciated	appreciate	VBN
cord-254852-qr5gdmbc	34	6	in	in	IN
cord-254852-qr5gdmbc	34	7	patients	patient	NNS
cord-254852-qr5gdmbc	34	8	with	with	IN
cord-254852-qr5gdmbc	34	9	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	34	10	include	include	VBP
cord-254852-qr5gdmbc	34	11	decreased	decrease	VBN
cord-254852-qr5gdmbc	34	12	breath	breath	NN
cord-254852-qr5gdmbc	34	13	sounds	sound	NNS
cord-254852-qr5gdmbc	34	14	,	,	,
cord-254852-qr5gdmbc	34	15	rales	rale	NNS
cord-254852-qr5gdmbc	34	16	,	,	,
cord-254852-qr5gdmbc	34	17	tactile	tactile	JJ
cord-254852-qr5gdmbc	34	18	fremitus	fremitus	NN
cord-254852-qr5gdmbc	34	19	,	,	,
cord-254852-qr5gdmbc	34	20	and	and	CC
cord-254852-qr5gdmbc	34	21	crackles	crackle	NNS
cord-254852-qr5gdmbc	34	22	.	.	.
cord-254852-qr5gdmbc	35	1	4	4	LS
cord-254852-qr5gdmbc	35	2	,	,	,
cord-254852-qr5gdmbc	35	3	8	8	CD
cord-254852-qr5gdmbc	35	4	Tachypnea	Tachypnea	NNP
cord-254852-qr5gdmbc	35	5	and	and	CC
cord-254852-qr5gdmbc	35	6	hypotension	hypotension	NN
cord-254852-qr5gdmbc	35	7	are	be	VBP
cord-254852-qr5gdmbc	35	8	more	more	RBR
cord-254852-qr5gdmbc	35	9	worrisome	worrisome	JJ
cord-254852-qr5gdmbc	35	10	symptoms	symptom	NNS
cord-254852-qr5gdmbc	35	11	that	that	WDT
cord-254852-qr5gdmbc	35	12	may	may	MD
cord-254852-qr5gdmbc	35	13	also	also	RB
cord-254852-qr5gdmbc	35	14	be	be	VB
cord-254852-qr5gdmbc	35	15	seen	see	VBN
cord-254852-qr5gdmbc	35	16	and	and	CC
cord-254852-qr5gdmbc	35	17	require	require	VB
cord-254852-qr5gdmbc	35	18	urgent	urgent	JJ
cord-254852-qr5gdmbc	35	19	evaluation	evaluation	NN
cord-254852-qr5gdmbc	35	20	.	.	.
cord-254852-qr5gdmbc	36	1	4	4	LS
cord-254852-qr5gdmbc	37	1	It	-PRON-	PRP
cord-254852-qr5gdmbc	37	2	is	be	VBZ
cord-254852-qr5gdmbc	37	3	imperative	imperative	JJ
cord-254852-qr5gdmbc	37	4	to	to	TO
cord-254852-qr5gdmbc	37	5	maintain	maintain	VB
cord-254852-qr5gdmbc	37	6	a	a	DT
cord-254852-qr5gdmbc	37	7	high	high	JJ
cord-254852-qr5gdmbc	37	8	level	level	NN
cord-254852-qr5gdmbc	37	9	of	of	IN
cord-254852-qr5gdmbc	37	10	suspicion	suspicion	NN
cord-254852-qr5gdmbc	37	11	in	in	IN
cord-254852-qr5gdmbc	37	12	immunocompromised	immunocompromised	JJ
cord-254852-qr5gdmbc	37	13	or	or	CC
cord-254852-qr5gdmbc	37	14	elderly	elderly	JJ
cord-254852-qr5gdmbc	37	15	and	and	CC
cord-254852-qr5gdmbc	37	16	nursing	nursing	NN
cord-254852-qr5gdmbc	37	17	home	home	NN
cord-254852-qr5gdmbc	37	18	patients	patient	NNS
cord-254852-qr5gdmbc	37	19	,	,	,
cord-254852-qr5gdmbc	37	20	because	because	IN
cord-254852-qr5gdmbc	37	21	they	-PRON-	PRP
cord-254852-qr5gdmbc	37	22	frequently	frequently	RB
cord-254852-qr5gdmbc	37	23	display	display	VBP
cord-254852-qr5gdmbc	37	24	fewer	few	JJR
cord-254852-qr5gdmbc	37	25	overt	overt	JJ
cord-254852-qr5gdmbc	37	26	symptoms	symptom	NNS
cord-254852-qr5gdmbc	37	27	of	of	IN
cord-254852-qr5gdmbc	37	28	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	37	29	when	when	WRB
cord-254852-qr5gdmbc	37	30	compared	compare	VBN
cord-254852-qr5gdmbc	37	31	with	with	IN
cord-254852-qr5gdmbc	37	32	the	the	DT
cord-254852-qr5gdmbc	37	33	general	general	JJ
cord-254852-qr5gdmbc	37	34	population	population	NN
cord-254852-qr5gdmbc	37	35	.	.	.
cord-254852-qr5gdmbc	38	1	8	8	CD
cord-254852-qr5gdmbc	38	2	,	,	,
cord-254852-qr5gdmbc	38	3	9	9	CD
cord-254852-qr5gdmbc	38	4	No	no	DT
cord-254852-qr5gdmbc	38	5	individual	individual	JJ
cord-254852-qr5gdmbc	38	6	component	component	NN
cord-254852-qr5gdmbc	38	7	of	of	IN
cord-254852-qr5gdmbc	38	8	the	the	DT
cord-254852-qr5gdmbc	38	9	history	history	NN
cord-254852-qr5gdmbc	38	10	or	or	CC
cord-254852-qr5gdmbc	38	11	physical	physical	JJ
cord-254852-qr5gdmbc	38	12	examination	examination	NN
cord-254852-qr5gdmbc	38	13	is	be	VBZ
cord-254852-qr5gdmbc	38	14	useful	useful	JJ
cord-254852-qr5gdmbc	38	15	in	in	IN
cord-254852-qr5gdmbc	38	16	diagnosing	diagnose	VBG
cord-254852-qr5gdmbc	38	17	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	38	18	,	,	,
cord-254852-qr5gdmbc	38	19	but	but	CC
cord-254852-qr5gdmbc	38	20	the	the	DT
cord-254852-qr5gdmbc	38	21	presence	presence	NN
cord-254852-qr5gdmbc	38	22	of	of	IN
cord-254852-qr5gdmbc	38	23	multiple	multiple	JJ
cord-254852-qr5gdmbc	38	24	findings	finding	NNS
cord-254852-qr5gdmbc	38	25	is	be	VBZ
cord-254852-qr5gdmbc	38	26	required	require	VBN
cord-254852-qr5gdmbc	38	27	(	(	-LRB-
cord-254852-qr5gdmbc	38	28	Table	table	NN
cord-254852-qr5gdmbc	38	29	2	2	CD
cord-254852-qr5gdmbc	38	30	)	)	-RRB-
cord-254852-qr5gdmbc	38	31	.	.	.
cord-254852-qr5gdmbc	39	1	In	in	IN
cord-254852-qr5gdmbc	39	2	adults	adult	NNS
cord-254852-qr5gdmbc	39	3	presenting	present	VBG
cord-254852-qr5gdmbc	39	4	with	with	IN
cord-254852-qr5gdmbc	39	5	acute	acute	JJ
cord-254852-qr5gdmbc	39	6	cough	cough	NN
cord-254852-qr5gdmbc	39	7	,	,	,
cord-254852-qr5gdmbc	39	8	the	the	DT
cord-254852-qr5gdmbc	39	9	baseline	baseline	JJ
cord-254852-qr5gdmbc	39	10	probability	probability	NN
cord-254852-qr5gdmbc	39	11	of	of	IN
cord-254852-qr5gdmbc	39	12	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	39	13	is	be	VBZ
cord-254852-qr5gdmbc	39	14	only	only	RB
cord-254852-qr5gdmbc	39	15	5	5	CD
cord-254852-qr5gdmbc	39	16	%	%	NN
cord-254852-qr5gdmbc	39	17	.	.	.
cord-254852-qr5gdmbc	40	1	Absence	absence	NN
cord-254852-qr5gdmbc	40	2	of	of	IN
cord-254852-qr5gdmbc	40	3	any	any	DT
cord-254852-qr5gdmbc	40	4	vital	vital	JJ
cord-254852-qr5gdmbc	40	5	sign	sign	NN
cord-254852-qr5gdmbc	40	6	abnormality	abnormality	NN
cord-254852-qr5gdmbc	40	7	(	(	-LRB-
cord-254852-qr5gdmbc	40	8	blood	blood	NN
cord-254852-qr5gdmbc	40	9	pressure	pressure	NN
cord-254852-qr5gdmbc	40	10	,	,	,
cord-254852-qr5gdmbc	40	11	heart	heart	NN
cord-254852-qr5gdmbc	40	12	rate	rate	NN
cord-254852-qr5gdmbc	40	13	,	,	,
cord-254852-qr5gdmbc	40	14	respiratory	respiratory	JJ
cord-254852-qr5gdmbc	40	15	rate	rate	NN
cord-254852-qr5gdmbc	40	16	)	)	-RRB-
cord-254852-qr5gdmbc	40	17	reduces	reduce	VBZ
cord-254852-qr5gdmbc	40	18	the	the	DT
cord-254852-qr5gdmbc	40	19	predicted	predict	VBN
cord-254852-qr5gdmbc	40	20	probability	probability	NN
cord-254852-qr5gdmbc	40	21	of	of	IN
cord-254852-qr5gdmbc	40	22	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	40	23	to	to	IN
cord-254852-qr5gdmbc	40	24	1	1	CD
cord-254852-qr5gdmbc	40	25	%	%	NN
cord-254852-qr5gdmbc	40	26	.	.	.
cord-254852-qr5gdmbc	41	1	8	8	CD
cord-254852-qr5gdmbc	42	1	A	a	DT
cord-254852-qr5gdmbc	42	2	chest	chest	NN
cord-254852-qr5gdmbc	42	3	radiograph	radiograph	NN
cord-254852-qr5gdmbc	42	4	should	should	MD
cord-254852-qr5gdmbc	42	5	be	be	VB
cord-254852-qr5gdmbc	42	6	ordered	order	VBN
cord-254852-qr5gdmbc	42	7	for	for	IN
cord-254852-qr5gdmbc	42	8	any	any	DT
cord-254852-qr5gdmbc	42	9	patient	patient	NN
cord-254852-qr5gdmbc	42	10	with	with	IN
cord-254852-qr5gdmbc	42	11	abnormal	abnormal	JJ
cord-254852-qr5gdmbc	42	12	vital	vital	JJ
cord-254852-qr5gdmbc	42	13	signs	sign	NNS
cord-254852-qr5gdmbc	42	14	defined	define	VBN
cord-254852-qr5gdmbc	42	15	as	as	IN
cord-254852-qr5gdmbc	42	16	temperature	temperature	NN
cord-254852-qr5gdmbc	42	17	higher	high	JJR
cord-254852-qr5gdmbc	42	18	than	than	IN
cord-254852-qr5gdmbc	42	19	100	100	CD
cord-254852-qr5gdmbc	42	20	F	f	NN
cord-254852-qr5gdmbc	42	21	,	,	,
cord-254852-qr5gdmbc	42	22	heart	heart	NN
cord-254852-qr5gdmbc	42	23	rate	rate	NN
cord-254852-qr5gdmbc	42	24	higher	high	JJR
cord-254852-qr5gdmbc	42	25	than	than	IN
cord-254852-qr5gdmbc	42	26	100	100	CD
cord-254852-qr5gdmbc	42	27	bpm	bpm	NNS
cord-254852-qr5gdmbc	42	28	,	,	,
cord-254852-qr5gdmbc	42	29	or	or	CC
cord-254852-qr5gdmbc	42	30	respiratory	respiratory	JJ
cord-254852-qr5gdmbc	42	31	rate	rate	NN
cord-254852-qr5gdmbc	42	32	higher	high	JJR
cord-254852-qr5gdmbc	42	33	than	than	IN
cord-254852-qr5gdmbc	42	34	20	20	CD
cord-254852-qr5gdmbc	42	35	bpm	bpm	NNS
cord-254852-qr5gdmbc	42	36	.	.	.
cord-254852-qr5gdmbc	43	1	Imaging	imaging	NN
cord-254852-qr5gdmbc	43	2	should	should	MD
cord-254852-qr5gdmbc	43	3	also	also	RB
cord-254852-qr5gdmbc	43	4	be	be	VB
cord-254852-qr5gdmbc	43	5	obtained	obtain	VBN
cord-254852-qr5gdmbc	43	6	for	for	IN
cord-254852-qr5gdmbc	43	7	physical	physical	JJ
cord-254852-qr5gdmbc	43	8	examination	examination	NN
cord-254852-qr5gdmbc	43	9	abnormalities	abnormality	NNS
cord-254852-qr5gdmbc	43	10	of	of	IN
cord-254852-qr5gdmbc	43	11	crackles	crackle	NNS
cord-254852-qr5gdmbc	43	12	or	or	CC
cord-254852-qr5gdmbc	43	13	decreased	decrease	VBD
cord-254852-qr5gdmbc	43	14	breath	breath	NN
cord-254852-qr5gdmbc	43	15	sounds	sound	VBZ
cord-254852-qr5gdmbc	43	16	in	in	IN
cord-254852-qr5gdmbc	43	17	a	a	DT
cord-254852-qr5gdmbc	43	18	patient	patient	NN
cord-254852-qr5gdmbc	43	19	without	without	IN
cord-254852-qr5gdmbc	43	20	asthma	asthma	NN
cord-254852-qr5gdmbc	43	21	.	.	.
cord-254852-qr5gdmbc	44	1	10	10	CD
cord-254852-qr5gdmbc	44	2	Infectious	Infectious	NNP
cord-254852-qr5gdmbc	44	3	Disease	Disease	NNP
cord-254852-qr5gdmbc	44	4	Society	Society	NNP
cord-254852-qr5gdmbc	44	5	of	of	IN
cord-254852-qr5gdmbc	44	6	America	America	NNP
cord-254852-qr5gdmbc	44	7	2016	2016	CD
cord-254852-qr5gdmbc	44	8	Guidelines	Guidelines	NNPS
cord-254852-qr5gdmbc	44	9	recommend	recommend	VBP
cord-254852-qr5gdmbc	44	10	imaging	image	VBG
cord-254852-qr5gdmbc	44	11	with	with	IN
cord-254852-qr5gdmbc	44	12	a	a	DT
cord-254852-qr5gdmbc	44	13	demonstrable	demonstrable	JJ
cord-254852-qr5gdmbc	44	14	infiltrate	infiltrate	NN
cord-254852-qr5gdmbc	44	15	to	to	TO
cord-254852-qr5gdmbc	44	16	confirm	confirm	VB
cord-254852-qr5gdmbc	44	17	the	the	DT
cord-254852-qr5gdmbc	44	18	diagnosis	diagnosis	NN
cord-254852-qr5gdmbc	44	19	of	of	IN
cord-254852-qr5gdmbc	44	20	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	44	21	and	and	CC
cord-254852-qr5gdmbc	44	22	to	to	TO
cord-254852-qr5gdmbc	44	23	exclude	exclude	VB
cord-254852-qr5gdmbc	44	24	other	other	JJ
cord-254852-qr5gdmbc	44	25	causes	cause	NNS
cord-254852-qr5gdmbc	44	26	of	of	IN
cord-254852-qr5gdmbc	44	27	cough	cough	NN
cord-254852-qr5gdmbc	44	28	and	and	CC
cord-254852-qr5gdmbc	44	29	fever	fever	NN
cord-254852-qr5gdmbc	44	30	such	such	JJ
cord-254852-qr5gdmbc	44	31	as	as	IN
cord-254852-qr5gdmbc	44	32	acute	acute	JJ
cord-254852-qr5gdmbc	44	33	bronchitis	bronchitis	NN
cord-254852-qr5gdmbc	44	34	.	.	.
cord-254852-qr5gdmbc	45	1	11	11	CD
cord-254852-qr5gdmbc	46	1	Although	although	IN
cord-254852-qr5gdmbc	46	2	X	x	NN
cord-254852-qr5gdmbc	46	3	-	-	NN
cord-254852-qr5gdmbc	46	4	ray	ray	NN
cord-254852-qr5gdmbc	46	5	imaging	imaging	NN
cord-254852-qr5gdmbc	46	6	is	be	VBZ
cord-254852-qr5gdmbc	46	7	a	a	DT
cord-254852-qr5gdmbc	46	8	mainstay	mainstay	NN
cord-254852-qr5gdmbc	46	9	of	of	IN
cord-254852-qr5gdmbc	46	10	diagnosis	diagnosis	NN
cord-254852-qr5gdmbc	46	11	of	of	IN
cord-254852-qr5gdmbc	46	12	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	46	13	,	,	,
cord-254852-qr5gdmbc	46	14	the	the	DT
cord-254852-qr5gdmbc	46	15	British	British	NNP
cord-254852-qr5gdmbc	46	16	Thoracic	Thoracic	NNP
cord-254852-qr5gdmbc	46	17	Society	Society	NNP
cord-254852-qr5gdmbc	46	18	recommends	recommend	VBZ
cord-254852-qr5gdmbc	46	19	the	the	DT
cord-254852-qr5gdmbc	46	20	entire	entire	JJ
cord-254852-qr5gdmbc	46	21	clinical	clinical	JJ
cord-254852-qr5gdmbc	46	22	picture	picture	NN
cord-254852-qr5gdmbc	46	23	should	should	MD
cord-254852-qr5gdmbc	46	24	be	be	VB
cord-254852-qr5gdmbc	46	25	considered	consider	VBN
cord-254852-qr5gdmbc	46	26	when	when	WRB
cord-254852-qr5gdmbc	46	27	making	make	VBG
cord-254852-qr5gdmbc	46	28	a	a	DT
cord-254852-qr5gdmbc	46	29	decision	decision	NN
cord-254852-qr5gdmbc	46	30	to	to	TO
cord-254852-qr5gdmbc	46	31	treat	treat	VB
cord-254852-qr5gdmbc	46	32	.	.	.
cord-254852-qr5gdmbc	47	1	12	12	CD
cord-254852-qr5gdmbc	48	1	A	a	DT
cord-254852-qr5gdmbc	48	2	systematic	systematic	JJ
cord-254852-qr5gdmbc	48	3	review	review	NN
cord-254852-qr5gdmbc	48	4	found	find	VBD
cord-254852-qr5gdmbc	48	5	that	that	IN
cord-254852-qr5gdmbc	48	6	among	among	IN
cord-254852-qr5gdmbc	48	7	patients	patient	NNS
cord-254852-qr5gdmbc	48	8	who	who	WP
cord-254852-qr5gdmbc	48	9	are	be	VBP
cord-254852-qr5gdmbc	48	10	sick	sick	JJ
cord-254852-qr5gdmbc	48	11	enough	enough	RB
cord-254852-qr5gdmbc	48	12	to	to	TO
cord-254852-qr5gdmbc	48	13	be	be	VB
cord-254852-qr5gdmbc	48	14	admitted	admit	VBN
cord-254852-qr5gdmbc	48	15	with	with	IN
cord-254852-qr5gdmbc	48	16	a	a	DT
cord-254852-qr5gdmbc	48	17	clinical	clinical	JJ
cord-254852-qr5gdmbc	48	18	diagnosis	diagnosis	NN
cord-254852-qr5gdmbc	48	19	of	of	IN
cord-254852-qr5gdmbc	48	20	CAP	cap	NN
cord-254852-qr5gdmbc	48	21	but	but	CC
cord-254852-qr5gdmbc	48	22	have	have	VBP
cord-254852-qr5gdmbc	48	23	a	a	DT
cord-254852-qr5gdmbc	48	24	normal	normal	JJ
cord-254852-qr5gdmbc	48	25	initial	initial	JJ
cord-254852-qr5gdmbc	48	26	chest	chest	NN
cord-254852-qr5gdmbc	48	27	radiograph	radiograph	NN
cord-254852-qr5gdmbc	48	28	,	,	,
cord-254852-qr5gdmbc	48	29	approximately	approximately	RB
cord-254852-qr5gdmbc	48	30	1	1	CD
cord-254852-qr5gdmbc	48	31	in	in	IN
cord-254852-qr5gdmbc	48	32	10	10	CD
cord-254852-qr5gdmbc	48	33	will	will	MD
cord-254852-qr5gdmbc	48	34	develop	develop	VB
cord-254852-qr5gdmbc	48	35	radiographic	radiographic	JJ
cord-254852-qr5gdmbc	48	36	evidence	evidence	NN
cord-254852-qr5gdmbc	48	37	of	of	IN
cord-254852-qr5gdmbc	48	38	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	48	39	within	within	IN
cord-254852-qr5gdmbc	48	40	72	72	CD
cord-254852-qr5gdmbc	48	41	hours	hour	NNS
cord-254852-qr5gdmbc	48	42	.	.	.
cord-254852-qr5gdmbc	49	1	8	8	CD
cord-254852-qr5gdmbc	50	1	In	in	IN
cord-254852-qr5gdmbc	50	2	such	such	JJ
cord-254852-qr5gdmbc	50	3	cases	case	NNS
cord-254852-qr5gdmbc	50	4	,	,	,
cord-254852-qr5gdmbc	50	5	it	-PRON-	PRP
cord-254852-qr5gdmbc	50	6	is	be	VBZ
cord-254852-qr5gdmbc	50	7	appropriate	appropriate	JJ
cord-254852-qr5gdmbc	50	8	to	to	TO
cord-254852-qr5gdmbc	50	9	treat	treat	VB
cord-254852-qr5gdmbc	50	10	the	the	DT
cord-254852-qr5gdmbc	50	11	patient	patient	NN
cord-254852-qr5gdmbc	50	12	empirically	empirically	RB
cord-254852-qr5gdmbc	50	13	for	for	IN
cord-254852-qr5gdmbc	50	14	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	50	15	and	and	CC
cord-254852-qr5gdmbc	50	16	repeat	repeat	NN
cord-254852-qr5gdmbc	50	17	imaging	image	VBG
cord-254852-qr5gdmbc	50	18	in	in	IN
cord-254852-qr5gdmbc	50	19	24	24	CD
cord-254852-qr5gdmbc	50	20	to	to	TO
cord-254852-qr5gdmbc	50	21	48	48	CD
cord-254852-qr5gdmbc	50	22	hours	hour	NNS
cord-254852-qr5gdmbc	50	23	.	.	.
cord-254852-qr5gdmbc	51	1	11	11	CD
cord-254852-qr5gdmbc	51	2	Community	Community	NNP
cord-254852-qr5gdmbc	51	3	resources	resource	NNS
cord-254852-qr5gdmbc	51	4	and	and	CC
cord-254852-qr5gdmbc	51	5	access	access	NN
cord-254852-qr5gdmbc	51	6	to	to	IN
cord-254852-qr5gdmbc	51	7	imaging	imaging	NN
cord-254852-qr5gdmbc	51	8	may	may	MD
cord-254852-qr5gdmbc	51	9	also	also	RB
cord-254852-qr5gdmbc	51	10	affect	affect	VB
cord-254852-qr5gdmbc	51	11	decision	decision	NN
cord-254852-qr5gdmbc	51	12	to	to	TO
cord-254852-qr5gdmbc	51	13	treat	treat	VB
cord-254852-qr5gdmbc	51	14	without	without	IN
cord-254852-qr5gdmbc	51	15	imaging	imaging	NN
cord-254852-qr5gdmbc	51	16	.	.	.
cord-254852-qr5gdmbc	52	1	Routine	routine	JJ
cord-254852-qr5gdmbc	52	2	blood	blood	NN
cord-254852-qr5gdmbc	52	3	and	and	CC
cord-254852-qr5gdmbc	52	4	sputum	sputum	NN
cord-254852-qr5gdmbc	52	5	culture	culture	NN
cord-254852-qr5gdmbc	52	6	testing	testing	NN
cord-254852-qr5gdmbc	52	7	is	be	VBZ
cord-254852-qr5gdmbc	52	8	costly	costly	JJ
cord-254852-qr5gdmbc	52	9	and	and	CC
cord-254852-qr5gdmbc	52	10	often	often	RB
cord-254852-qr5gdmbc	52	11	low	low	JJ
cord-254852-qr5gdmbc	52	12	-	-	HYPH
cord-254852-qr5gdmbc	52	13	yield	yield	NN
cord-254852-qr5gdmbc	52	14	.	.	.
cord-254852-qr5gdmbc	52	15	13	13	CD
cord-254852-qr5gdmbc	53	1	However	however	RB
cord-254852-qr5gdmbc	53	2	,	,	,
cord-254852-qr5gdmbc	53	3	more	more	RBR
cord-254852-qr5gdmbc	53	4	extensive	extensive	JJ
cord-254852-qr5gdmbc	53	5	diagnostic	diagnostic	JJ
cord-254852-qr5gdmbc	53	6	testing	testing	NN
cord-254852-qr5gdmbc	53	7	should	should	MD
cord-254852-qr5gdmbc	53	8	be	be	VB
cord-254852-qr5gdmbc	53	9	considered	consider	VBN
cord-254852-qr5gdmbc	53	10	in	in	IN
cord-254852-qr5gdmbc	53	11	patients	patient	NNS
cord-254852-qr5gdmbc	53	12	who	who	WP
cord-254852-qr5gdmbc	53	13	are	be	VBP
cord-254852-qr5gdmbc	53	14	at	at	IN
cord-254852-qr5gdmbc	53	15	risk	risk	NN
cord-254852-qr5gdmbc	53	16	for	for	IN
cord-254852-qr5gdmbc	53	17	infection	infection	NN
cord-254852-qr5gdmbc	53	18	with	with	IN
cord-254852-qr5gdmbc	53	19	unusual	unusual	JJ
cord-254852-qr5gdmbc	53	20	pathogens	pathogen	NNS
cord-254852-qr5gdmbc	53	21	,	,	,
cord-254852-qr5gdmbc	53	22	who	who	WP
cord-254852-qr5gdmbc	53	23	are	be	VBP
cord-254852-qr5gdmbc	53	24	not	not	RB
cord-254852-qr5gdmbc	53	25	responding	respond	VBG
cord-254852-qr5gdmbc	53	26	to	to	IN
cord-254852-qr5gdmbc	53	27	treatment	treatment	NN
cord-254852-qr5gdmbc	53	28	,	,	,
cord-254852-qr5gdmbc	53	29	or	or	CC
cord-254852-qr5gdmbc	53	30	when	when	WRB
cord-254852-qr5gdmbc	53	31	additional	additional	JJ
cord-254852-qr5gdmbc	53	32	testing	testing	NN
cord-254852-qr5gdmbc	53	33	is	be	VBZ
cord-254852-qr5gdmbc	53	34	likely	likely	JJ
cord-254852-qr5gdmbc	53	35	to	to	TO
cord-254852-qr5gdmbc	53	36	change	change	VB
cord-254852-qr5gdmbc	53	37	antibiotic	antibiotic	JJ
cord-254852-qr5gdmbc	53	38	management	management	NN
cord-254852-qr5gdmbc	53	39	(	(	-LRB-
cord-254852-qr5gdmbc	53	40	Table	Table	NNP
cord-254852-qr5gdmbc	53	41	3	3	CD
cord-254852-qr5gdmbc	53	42	)	)	-RRB-
cord-254852-qr5gdmbc	53	43	.	.	.
cord-254852-qr5gdmbc	54	1	11	11	CD
cord-254852-qr5gdmbc	54	2	,	,	,
cord-254852-qr5gdmbc	54	3	12	12	CD
cord-254852-qr5gdmbc	54	4	It	-PRON-	PRP
cord-254852-qr5gdmbc	54	5	is	be	VBZ
cord-254852-qr5gdmbc	54	6	reasonable	reasonable	JJ
cord-254852-qr5gdmbc	54	7	to	to	TO
cord-254852-qr5gdmbc	54	8	consider	consider	VB
cord-254852-qr5gdmbc	54	9	respiratory	respiratory	JJ
cord-254852-qr5gdmbc	54	10	viral	viral	JJ
cord-254852-qr5gdmbc	54	11	polymerase	polymerase	NN
cord-254852-qr5gdmbc	54	12	chain	chain	NN
cord-254852-qr5gdmbc	54	13	reaction	reaction	NN
cord-254852-qr5gdmbc	54	14	(	(	-LRB-
cord-254852-qr5gdmbc	54	15	PCR	PCR	NNP
cord-254852-qr5gdmbc	54	16	)	)	-RRB-
cord-254852-qr5gdmbc	54	17	to	to	TO
cord-254852-qr5gdmbc	54	18	determine	determine	VB
cord-254852-qr5gdmbc	54	19	viral	viral	JJ
cord-254852-qr5gdmbc	54	20	causes	cause	NNS
cord-254852-qr5gdmbc	54	21	of	of	IN
cord-254852-qr5gdmbc	54	22	symptoms	symptom	NNS
cord-254852-qr5gdmbc	54	23	,	,	,
cord-254852-qr5gdmbc	54	24	so	so	IN
cord-254852-qr5gdmbc	54	25	that	that	DT
cord-254852-qr5gdmbc	54	26	inappropriate	inappropriate	JJ
cord-254852-qr5gdmbc	54	27	antibiotic	antibiotic	JJ
cord-254852-qr5gdmbc	54	28	use	use	NN
cord-254852-qr5gdmbc	54	29	can	can	MD
cord-254852-qr5gdmbc	54	30	be	be	VB
cord-254852-qr5gdmbc	54	31	limited	limit	VBN
cord-254852-qr5gdmbc	54	32	.	.	.
cord-254852-qr5gdmbc	55	1	Additional	additional	JJ
cord-254852-qr5gdmbc	55	2	testing	testing	NN
cord-254852-qr5gdmbc	55	3	for	for	IN
cord-254852-qr5gdmbc	55	4	M.	M.	NNP
cord-254852-qr5gdmbc	55	5	tuberculosis	tuberculosis	NN
cord-254852-qr5gdmbc	55	6	should	should	MD
cord-254852-qr5gdmbc	55	7	be	be	VB
cord-254852-qr5gdmbc	55	8	considered	consider	VBN
cord-254852-qr5gdmbc	55	9	in	in	IN
cord-254852-qr5gdmbc	55	10	a	a	DT
cord-254852-qr5gdmbc	55	11	patient	patient	NN
cord-254852-qr5gdmbc	55	12	presenting	present	VBG
cord-254852-qr5gdmbc	55	13	with	with	IN
cord-254852-qr5gdmbc	55	14	persistent	persistent	JJ
cord-254852-qr5gdmbc	55	15	cough	cough	NN
cord-254852-qr5gdmbc	55	16	,	,	,
cord-254852-qr5gdmbc	55	17	particularly	particularly	RB
cord-254852-qr5gdmbc	55	18	in	in	IN
cord-254852-qr5gdmbc	55	19	the	the	DT
cord-254852-qr5gdmbc	55	20	setting	setting	NN
cord-254852-qr5gdmbc	55	21	of	of	IN
cord-254852-qr5gdmbc	55	22	weight	weight	NN
cord-254852-qr5gdmbc	55	23	loss	loss	NN
cord-254852-qr5gdmbc	55	24	,	,	,
cord-254852-qr5gdmbc	55	25	malaise	malaise	NN
cord-254852-qr5gdmbc	55	26	,	,	,
cord-254852-qr5gdmbc	55	27	night	night	NN
cord-254852-qr5gdmbc	55	28	sweats	sweat	NNS
cord-254852-qr5gdmbc	55	29	,	,	,
cord-254852-qr5gdmbc	55	30	or	or	CC
cord-254852-qr5gdmbc	55	31	hemoptysis	hemoptysis	NN
cord-254852-qr5gdmbc	55	32	.	.	.
cord-254852-qr5gdmbc	56	1	Additional	additional	JJ
cord-254852-qr5gdmbc	56	2	risk	risk	NN
cord-254852-qr5gdmbc	56	3	factors	factor	NNS
cord-254852-qr5gdmbc	56	4	for	for	IN
cord-254852-qr5gdmbc	56	5	tuberculosis	tuberculosis	NN
cord-254852-qr5gdmbc	56	6	(	(	-LRB-
cord-254852-qr5gdmbc	56	7	TB	TB	NNP
cord-254852-qr5gdmbc	56	8	)	)	-RRB-
cord-254852-qr5gdmbc	56	9	include	include	VBP
cord-254852-qr5gdmbc	56	10	immigration	immigration	NN
cord-254852-qr5gdmbc	56	11	from	from	IN
cord-254852-qr5gdmbc	56	12	an	an	DT
cord-254852-qr5gdmbc	56	13	endemic	endemic	JJ
cord-254852-qr5gdmbc	56	14	country	country	NN
cord-254852-qr5gdmbc	56	15	,	,	,
cord-254852-qr5gdmbc	56	16	residing	reside	VBG
cord-254852-qr5gdmbc	56	17	in	in	IN
cord-254852-qr5gdmbc	56	18	a	a	DT
cord-254852-qr5gdmbc	56	19	homeless	homeless	JJ
cord-254852-qr5gdmbc	56	20	shelter	shelter	NN
cord-254852-qr5gdmbc	56	21	,	,	,
cord-254852-qr5gdmbc	56	22	intravenous	intravenous	JJ
cord-254852-qr5gdmbc	56	23	drug	drug	NN
cord-254852-qr5gdmbc	56	24	use	use	NN
cord-254852-qr5gdmbc	56	25	,	,	,
cord-254852-qr5gdmbc	56	26	or	or	CC
cord-254852-qr5gdmbc	56	27	human	human	JJ
cord-254852-qr5gdmbc	56	28	immunodeficiency	immunodeficiency	NN
cord-254852-qr5gdmbc	56	29	virus	virus	NN
cord-254852-qr5gdmbc	56	30	(	(	-LRB-
cord-254852-qr5gdmbc	56	31	HIV	HIV	NNP
cord-254852-qr5gdmbc	56	32	)	)	-RRB-
cord-254852-qr5gdmbc	56	33	infection	infection	NN
cord-254852-qr5gdmbc	56	34	.	.	.
cord-254852-qr5gdmbc	57	1	Persons	person	NNS
cord-254852-qr5gdmbc	57	2	who	who	WP
cord-254852-qr5gdmbc	57	3	work	work	VBP
cord-254852-qr5gdmbc	57	4	with	with	IN
cord-254852-qr5gdmbc	57	5	people	people	NNS
cord-254852-qr5gdmbc	57	6	at	at	IN
cord-254852-qr5gdmbc	57	7	high	high	JJ
cord-254852-qr5gdmbc	57	8	risk	risk	NN
cord-254852-qr5gdmbc	57	9	for	for	IN
cord-254852-qr5gdmbc	57	10	TB	TB	NNP
cord-254852-qr5gdmbc	57	11	infection	infection	NN
cord-254852-qr5gdmbc	57	12	are	be	VBP
cord-254852-qr5gdmbc	57	13	also	also	RB
cord-254852-qr5gdmbc	57	14	considered	consider	VBN
cord-254852-qr5gdmbc	57	15	high	high	JJ
cord-254852-qr5gdmbc	57	16	risk	risk	NN
cord-254852-qr5gdmbc	57	17	.	.	.
cord-254852-qr5gdmbc	58	1	12	12	CD
cord-254852-qr5gdmbc	58	2	,	,	,
cord-254852-qr5gdmbc	58	3	14	14	CD
cord-254852-qr5gdmbc	58	4	TREATMENT	treatment	NN
cord-254852-qr5gdmbc	59	1	Most	Most	JJS
cord-254852-qr5gdmbc	59	2	cases	case	NNS
cord-254852-qr5gdmbc	59	3	of	of	IN
cord-254852-qr5gdmbc	59	4	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	59	5	can	can	MD
cord-254852-qr5gdmbc	59	6	be	be	VB
cord-254852-qr5gdmbc	59	7	managed	manage	VBN
cord-254852-qr5gdmbc	59	8	in	in	IN
cord-254852-qr5gdmbc	59	9	the	the	DT
cord-254852-qr5gdmbc	59	10	outpatient	outpatient	NN
cord-254852-qr5gdmbc	59	11	setting	setting	NN
cord-254852-qr5gdmbc	59	12	.	.	.
cord-254852-qr5gdmbc	60	1	Several	several	JJ
cord-254852-qr5gdmbc	60	2	severity	severity	NN
cord-254852-qr5gdmbc	60	3	assessment	assessment	NN
cord-254852-qr5gdmbc	60	4	tools	tool	NNS
cord-254852-qr5gdmbc	60	5	have	have	VBP
cord-254852-qr5gdmbc	60	6	been	be	VBN
cord-254852-qr5gdmbc	60	7	developed	develop	VBN
cord-254852-qr5gdmbc	60	8	to	to	TO
cord-254852-qr5gdmbc	60	9	help	help	VB
cord-254852-qr5gdmbc	60	10	determine	determine	VB
cord-254852-qr5gdmbc	60	11	appropriate	appropriate	JJ
cord-254852-qr5gdmbc	60	12	treatment	treatment	NN
cord-254852-qr5gdmbc	60	13	settings	setting	NNS
cord-254852-qr5gdmbc	60	14	.	.	.
cord-254852-qr5gdmbc	61	1	The	the	DT
cord-254852-qr5gdmbc	61	2	Pneumonia	Pneumonia	NNP
cord-254852-qr5gdmbc	61	3	Severity	Severity	NNP
cord-254852-qr5gdmbc	61	4	Index	Index	NNP
cord-254852-qr5gdmbc	61	5	(	(	-LRB-
cord-254852-qr5gdmbc	61	6	PSI	PSI	NNP
cord-254852-qr5gdmbc	61	7	)	)	-RRB-
cord-254852-qr5gdmbc	61	8	considers	consider	VBZ
cord-254852-qr5gdmbc	61	9	20	20	CD
cord-254852-qr5gdmbc	61	10	variables	variable	NNS
cord-254852-qr5gdmbc	61	11	to	to	TO
cord-254852-qr5gdmbc	61	12	stratify	stratify	VB
cord-254852-qr5gdmbc	61	13	patients	patient	NNS
cord-254852-qr5gdmbc	61	14	into	into	IN
cord-254852-qr5gdmbc	61	15	1	1	CD
cord-254852-qr5gdmbc	61	16	of	of	IN
cord-254852-qr5gdmbc	61	17	5	5	CD
cord-254852-qr5gdmbc	61	18	risk	risk	NN
cord-254852-qr5gdmbc	61	19	categories	category	NNS
cord-254852-qr5gdmbc	61	20	(	(	-LRB-
cord-254852-qr5gdmbc	61	21	I	i	NN
cord-254852-qr5gdmbc	61	22	-	-	HYPH
cord-254852-qr5gdmbc	61	23	V	v	NN
cord-254852-qr5gdmbc	61	24	)	)	-RRB-
cord-254852-qr5gdmbc	61	25	based	base	VBN
cord-254852-qr5gdmbc	61	26	on	on	IN
cord-254852-qr5gdmbc	61	27	risk	risk	NN
cord-254852-qr5gdmbc	61	28	of	of	IN
cord-254852-qr5gdmbc	61	29	death	death	NN
cord-254852-qr5gdmbc	61	30	within	within	IN
cord-254852-qr5gdmbc	61	31	30	30	CD
cord-254852-qr5gdmbc	61	32	days	day	NNS
cord-254852-qr5gdmbc	61	33	.	.	.
cord-254852-qr5gdmbc	62	1	15	15	CD
cord-254852-qr5gdmbc	63	1	Given	give	VBN
cord-254852-qr5gdmbc	63	2	the	the	DT
cord-254852-qr5gdmbc	63	3	number	number	NN
cord-254852-qr5gdmbc	63	4	of	of	IN
cord-254852-qr5gdmbc	63	5	parameters	parameter	NNS
cord-254852-qr5gdmbc	63	6	required	require	VBN
cord-254852-qr5gdmbc	63	7	,	,	,
cord-254852-qr5gdmbc	63	8	it	-PRON-	PRP
cord-254852-qr5gdmbc	63	9	is	be	VBZ
cord-254852-qr5gdmbc	63	10	not	not	RB
cord-254852-qr5gdmbc	63	11	frequently	frequently	RB
cord-254852-qr5gdmbc	63	12	used	use	VBN
cord-254852-qr5gdmbc	63	13	in	in	IN
cord-254852-qr5gdmbc	63	14	general	general	JJ
cord-254852-qr5gdmbc	63	15	practice	practice	NN
cord-254852-qr5gdmbc	63	16	.	.	.
cord-254852-qr5gdmbc	64	1	The	the	DT
cord-254852-qr5gdmbc	64	2	CURB65	CURB65	NNP
cord-254852-qr5gdmbc	64	3	assessment	assessment	NN
cord-254852-qr5gdmbc	64	4	tool	tool	NN
cord-254852-qr5gdmbc	64	5	was	be	VBD
cord-254852-qr5gdmbc	64	6	introduced	introduce	VBN
cord-254852-qr5gdmbc	64	7	in	in	IN
cord-254852-qr5gdmbc	64	8	2003	2003	CD
cord-254852-qr5gdmbc	64	9	by	by	IN
cord-254852-qr5gdmbc	64	10	the	the	DT
cord-254852-qr5gdmbc	64	11	British	British	NNP
cord-254852-qr5gdmbc	64	12	Thoracic	Thoracic	NNP
cord-254852-qr5gdmbc	64	13	Society	Society	NNP
cord-254852-qr5gdmbc	64	14	.	.	.
cord-254852-qr5gdmbc	65	1	16	16	CD
cord-254852-qr5gdmbc	65	2	Similar	similar	JJ
cord-254852-qr5gdmbc	65	3	to	to	IN
cord-254852-qr5gdmbc	65	4	the	the	DT
cord-254852-qr5gdmbc	65	5	PSI	PSI	NNP
cord-254852-qr5gdmbc	65	6	,	,	,
cord-254852-qr5gdmbc	65	7	it	-PRON-	PRP
cord-254852-qr5gdmbc	65	8	calculates	calculate	VBZ
cord-254852-qr5gdmbc	65	9	risk	risk	NN
cord-254852-qr5gdmbc	65	10	of	of	IN
cord-254852-qr5gdmbc	65	11	30-day	30-day	CD
cord-254852-qr5gdmbc	65	12	mortality	mortality	NN
cord-254852-qr5gdmbc	65	13	,	,	,
cord-254852-qr5gdmbc	65	14	but	but	CC
cord-254852-qr5gdmbc	65	15	instead	instead	RB
cord-254852-qr5gdmbc	65	16	only	only	RB
cord-254852-qr5gdmbc	65	17	uses	use	VBZ
cord-254852-qr5gdmbc	65	18	5	5	CD
cord-254852-qr5gdmbc	65	19	variables	variable	NNS
cord-254852-qr5gdmbc	65	20	(	(	-LRB-
cord-254852-qr5gdmbc	65	21	confusion	confusion	NN
cord-254852-qr5gdmbc	65	22	,	,	,
cord-254852-qr5gdmbc	65	23	urea	urea	NN
cord-254852-qr5gdmbc	65	24	,	,	,
cord-254852-qr5gdmbc	65	25	respiratory	respiratory	JJ
cord-254852-qr5gdmbc	65	26	rate	rate	NN
cord-254852-qr5gdmbc	65	27	,	,	,
cord-254852-qr5gdmbc	65	28	blood	blood	NN
cord-254852-qr5gdmbc	65	29	pressure	pressure	NN
cord-254852-qr5gdmbc	65	30	,	,	,
cord-254852-qr5gdmbc	65	31	and	and	CC
cord-254852-qr5gdmbc	65	32	age	age	NN
cord-254852-qr5gdmbc	65	33	>	>	XX
cord-254852-qr5gdmbc	65	34	65	65	CD
cord-254852-qr5gdmbc	65	35	)	)	-RRB-
cord-254852-qr5gdmbc	65	36	,	,	,
cord-254852-qr5gdmbc	65	37	with	with	IN
cord-254852-qr5gdmbc	65	38	one	one	CD
cord-254852-qr5gdmbc	65	39	point	point	NN
cord-254852-qr5gdmbc	65	40	awarded	award	VBN
cord-254852-qr5gdmbc	65	41	for	for	IN
cord-254852-qr5gdmbc	65	42	each	each	DT
cord-254852-qr5gdmbc	65	43	if	if	IN
cord-254852-qr5gdmbc	65	44	present	present	JJ
cord-254852-qr5gdmbc	65	45	,	,	,
cord-254852-qr5gdmbc	65	46	allowing	allow	VBG
cord-254852-qr5gdmbc	65	47	for	for	IN
cord-254852-qr5gdmbc	65	48	greater	great	JJR
cord-254852-qr5gdmbc	65	49	ease	ease	NN
cord-254852-qr5gdmbc	65	50	of	of	IN
cord-254852-qr5gdmbc	65	51	use	use	NN
cord-254852-qr5gdmbc	65	52	.	.	.
cord-254852-qr5gdmbc	66	1	15	15	CD
cord-254852-qr5gdmbc	66	2	,	,	,
cord-254852-qr5gdmbc	66	3	16	16	CD
cord-254852-qr5gdmbc	66	4	The	the	DT
cord-254852-qr5gdmbc	66	5	CRB65	CRB65	NNPS
cord-254852-qr5gdmbc	66	6	can	can	MD
cord-254852-qr5gdmbc	66	7	be	be	VB
cord-254852-qr5gdmbc	66	8	calculated	calculate	VBN
cord-254852-qr5gdmbc	66	9	without	without	IN
cord-254852-qr5gdmbc	66	10	blood	blood	NN
cord-254852-qr5gdmbc	66	11	urea	urea	NN
cord-254852-qr5gdmbc	66	12	and	and	CC
cord-254852-qr5gdmbc	66	13	thus	thus	RB
cord-254852-qr5gdmbc	66	14	is	be	VBZ
cord-254852-qr5gdmbc	66	15	useful	useful	JJ
cord-254852-qr5gdmbc	66	16	in	in	IN
cord-254852-qr5gdmbc	66	17	the	the	DT
cord-254852-qr5gdmbc	66	18	outpatient	outpatient	NN
cord-254852-qr5gdmbc	66	19	setting	setting	NN
cord-254852-qr5gdmbc	66	20	.	.	.
cord-254852-qr5gdmbc	67	1	A	a	DT
cord-254852-qr5gdmbc	67	2	recent	recent	JJ
cord-254852-qr5gdmbc	67	3	systematic	systematic	JJ
cord-254852-qr5gdmbc	67	4	review	review	NN
cord-254852-qr5gdmbc	67	5	and	and	CC
cord-254852-qr5gdmbc	67	6	meta	meta	NNP
cord-254852-qr5gdmbc	67	7	-	-	HYPH
cord-254852-qr5gdmbc	67	8	analysis	analysis	NN
cord-254852-qr5gdmbc	67	9	found	find	VBD
cord-254852-qr5gdmbc	67	10	no	no	DT
cord-254852-qr5gdmbc	67	11	significant	significant	JJ
cord-254852-qr5gdmbc	67	12	difference	difference	NN
cord-254852-qr5gdmbc	67	13	in	in	IN
cord-254852-qr5gdmbc	67	14	test	test	NN
cord-254852-qr5gdmbc	67	15	performance	performance	NN
cord-254852-qr5gdmbc	67	16	when	when	WRB
cord-254852-qr5gdmbc	67	17	comparing	compare	VBG
cord-254852-qr5gdmbc	67	18	the	the	DT
cord-254852-qr5gdmbc	67	19	3	3	CD
cord-254852-qr5gdmbc	67	20	severity	severity	NN
cord-254852-qr5gdmbc	67	21	tools	tool	NNS
cord-254852-qr5gdmbc	67	22	.	.	.
cord-254852-qr5gdmbc	68	1	15	15	CD
cord-254852-qr5gdmbc	69	1	It	-PRON-	PRP
cord-254852-qr5gdmbc	69	2	was	be	VBD
cord-254852-qr5gdmbc	69	3	noted	note	VBN
cord-254852-qr5gdmbc	69	4	that	that	IN
cord-254852-qr5gdmbc	69	5	the	the	DT
cord-254852-qr5gdmbc	69	6	PSI	PSI	NNP
cord-254852-qr5gdmbc	69	7	negative	negative	JJ
cord-254852-qr5gdmbc	69	8	likelihood	likelihood	NN
cord-254852-qr5gdmbc	69	9	ratio	ratio	NN
cord-254852-qr5gdmbc	69	10	suggests	suggest	VBZ
cord-254852-qr5gdmbc	69	11	it	-PRON-	PRP
cord-254852-qr5gdmbc	69	12	may	may	MD
cord-254852-qr5gdmbc	69	13	be	be	VB
cord-254852-qr5gdmbc	69	14	superior	superior	JJ
cord-254852-qr5gdmbc	69	15	in	in	IN
cord-254852-qr5gdmbc	69	16	identifying	identify	VBG
cord-254852-qr5gdmbc	69	17	low	low	JJ
cord-254852-qr5gdmbc	69	18	-	-	HYPH
cord-254852-qr5gdmbc	69	19	risk	risk	NN
cord-254852-qr5gdmbc	69	20	patients	patient	NNS
cord-254852-qr5gdmbc	69	21	,	,	,
cord-254852-qr5gdmbc	69	22	and	and	CC
cord-254852-qr5gdmbc	69	23	the	the	DT
cord-254852-qr5gdmbc	69	24	CURB65	CURB65	NNP
cord-254852-qr5gdmbc	69	25	and	and	CC
cord-254852-qr5gdmbc	69	26	CRB65	CRB65	NNPS
cord-254852-qr5gdmbc	69	27	may	may	MD
cord-254852-qr5gdmbc	69	28	be	be	VB
cord-254852-qr5gdmbc	69	29	superior	superior	JJ
cord-254852-qr5gdmbc	69	30	in	in	IN
cord-254852-qr5gdmbc	69	31	identifying	identify	VBG
cord-254852-qr5gdmbc	69	32	high	high	JJ
cord-254852-qr5gdmbc	69	33	-	-	HYPH
cord-254852-qr5gdmbc	69	34	risk	risk	NN
cord-254852-qr5gdmbc	69	35	patients	patient	NNS
cord-254852-qr5gdmbc	69	36	.	.	.
cord-254852-qr5gdmbc	70	1	15	15	CD
cord-254852-qr5gdmbc	71	1	A	a	DT
cord-254852-qr5gdmbc	71	2	CURB65	CURB65	NNP
cord-254852-qr5gdmbc	71	3	or	or	CC
cord-254852-qr5gdmbc	71	4	CRB65	CRB65	NNPS
cord-254852-qr5gdmbc	71	5	score	score	NN
cord-254852-qr5gdmbc	71	6	of	of	IN
cord-254852-qr5gdmbc	71	7	0	0	CD
cord-254852-qr5gdmbc	71	8	or	or	CC
cord-254852-qr5gdmbc	71	9	1	1	CD
cord-254852-qr5gdmbc	71	10	demonstrates	demonstrate	VBZ
cord-254852-qr5gdmbc	71	11	low	low	JJ
cord-254852-qr5gdmbc	71	12	risk	risk	NN
cord-254852-qr5gdmbc	71	13	of	of	IN
cord-254852-qr5gdmbc	71	14	mortality	mortality	NN
cord-254852-qr5gdmbc	71	15	and	and	CC
cord-254852-qr5gdmbc	71	16	suggests	suggest	VBZ
cord-254852-qr5gdmbc	71	17	a	a	DT
cord-254852-qr5gdmbc	71	18	patient	patient	NN
cord-254852-qr5gdmbc	71	19	can	can	MD
cord-254852-qr5gdmbc	71	20	be	be	VB
cord-254852-qr5gdmbc	71	21	managed	manage	VBN
cord-254852-qr5gdmbc	71	22	in	in	IN
cord-254852-qr5gdmbc	71	23	the	the	DT
cord-254852-qr5gdmbc	71	24	outpatient	outpatient	NN
cord-254852-qr5gdmbc	71	25	setting	setting	NN
cord-254852-qr5gdmbc	71	26	.	.	.
cord-254852-qr5gdmbc	72	1	A	a	DT
cord-254852-qr5gdmbc	72	2	score	score	NN
cord-254852-qr5gdmbc	72	3	of	of	IN
cord-254852-qr5gdmbc	72	4	3	3	CD
cord-254852-qr5gdmbc	72	5	or	or	CC
cord-254852-qr5gdmbc	72	6	higher	high	JJR
cord-254852-qr5gdmbc	72	7	should	should	MD
cord-254852-qr5gdmbc	72	8	warrant	warrant	VB
cord-254852-qr5gdmbc	72	9	hospital	hospital	NN
cord-254852-qr5gdmbc	72	10	admission	admission	NN
cord-254852-qr5gdmbc	72	11	.	.	.
cord-254852-qr5gdmbc	73	1	It	-PRON-	PRP
cord-254852-qr5gdmbc	73	2	is	be	VBZ
cord-254852-qr5gdmbc	73	3	always	always	RB
cord-254852-qr5gdmbc	73	4	appropriate	appropriate	JJ
cord-254852-qr5gdmbc	73	5	to	to	TO
cord-254852-qr5gdmbc	73	6	consider	consider	VB
cord-254852-qr5gdmbc	73	7	a	a	DT
cord-254852-qr5gdmbc	73	8	patient	patient	NN
cord-254852-qr5gdmbc	73	9	's	's	POS
cord-254852-qr5gdmbc	73	10	social	social	JJ
cord-254852-qr5gdmbc	73	11	circumstances	circumstance	NNS
cord-254852-qr5gdmbc	73	12	and	and	CC
cord-254852-qr5gdmbc	73	13	treatment	treatment	NN
cord-254852-qr5gdmbc	73	14	wishes	wish	VBZ
cord-254852-qr5gdmbc	73	15	when	when	WRB
cord-254852-qr5gdmbc	73	16	making	make	VBG
cord-254852-qr5gdmbc	73	17	treatment	treatment	NN
cord-254852-qr5gdmbc	73	18	decisions	decision	NNS
cord-254852-qr5gdmbc	74	1	12,16	12,16	CD
cord-254852-qr5gdmbc	75	1	(	(	-LRB-
cord-254852-qr5gdmbc	75	2	Fig	Fig	NNP
cord-254852-qr5gdmbc	75	3	.	.	NNP
cord-254852-qr5gdmbc	75	4	1	1	CD
cord-254852-qr5gdmbc	75	5	;	;	:
cord-254852-qr5gdmbc	75	6	CURB65	CURB65	NNP
cord-254852-qr5gdmbc	75	7	score	score	NN
cord-254852-qr5gdmbc	75	8	12	12	CD
cord-254852-qr5gdmbc	75	9	)	)	-RRB-
cord-254852-qr5gdmbc	75	10	.	.	.
cord-254852-qr5gdmbc	76	1	When	when	WRB
cord-254852-qr5gdmbc	76	2	available	available	JJ
cord-254852-qr5gdmbc	76	3	,	,	,
cord-254852-qr5gdmbc	76	4	treatment	treatment	NN
cord-254852-qr5gdmbc	76	5	of	of	IN
cord-254852-qr5gdmbc	76	6	CAP	cap	NN
cord-254852-qr5gdmbc	76	7	should	should	MD
cord-254852-qr5gdmbc	76	8	be	be	VB
cord-254852-qr5gdmbc	76	9	guided	guide	VBN
cord-254852-qr5gdmbc	76	10	by	by	IN
cord-254852-qr5gdmbc	76	11	local	local	JJ
cord-254852-qr5gdmbc	76	12	resistance	resistance	NN
cord-254852-qr5gdmbc	76	13	patterns	pattern	NNS
cord-254852-qr5gdmbc	76	14	.	.	.
cord-254852-qr5gdmbc	77	1	In	in	IN
cord-254852-qr5gdmbc	77	2	previously	previously	RB
cord-254852-qr5gdmbc	77	3	healthy	healthy	JJ
cord-254852-qr5gdmbc	77	4	patients	patient	NNS
cord-254852-qr5gdmbc	77	5	who	who	WP
cord-254852-qr5gdmbc	77	6	are	be	VBP
cord-254852-qr5gdmbc	77	7	appropriate	appropriate	JJ
cord-254852-qr5gdmbc	77	8	for	for	IN
cord-254852-qr5gdmbc	77	9	outpatient	outpatient	NN
cord-254852-qr5gdmbc	77	10	treatment	treatment	NN
cord-254852-qr5gdmbc	77	11	,	,	,
cord-254852-qr5gdmbc	77	12	recommended	recommend	VBD
cord-254852-qr5gdmbc	77	13	first	first	JJ
cord-254852-qr5gdmbc	77	14	-	-	HYPH
cord-254852-qr5gdmbc	77	15	line	line	NN
cord-254852-qr5gdmbc	77	16	treatment	treatment	NN
cord-254852-qr5gdmbc	77	17	is	be	VBZ
cord-254852-qr5gdmbc	77	18	with	with	IN
cord-254852-qr5gdmbc	77	19	a	a	DT
cord-254852-qr5gdmbc	77	20	macrolide	macrolide	NN
cord-254852-qr5gdmbc	77	21	antibiotic	antibiotic	NN
cord-254852-qr5gdmbc	77	22	such	such	JJ
cord-254852-qr5gdmbc	77	23	as	as	IN
cord-254852-qr5gdmbc	77	24	azithromycin	azithromycin	NNP
cord-254852-qr5gdmbc	77	25	targeting	target	VBG
cord-254852-qr5gdmbc	77	26	the	the	DT
cord-254852-qr5gdmbc	77	27	most	most	RBS
cord-254852-qr5gdmbc	77	28	common	common	JJ
cord-254852-qr5gdmbc	77	29	causal	causal	JJ
cord-254852-qr5gdmbc	77	30	pathogen	pathogen	NN
cord-254852-qr5gdmbc	77	31	S.	S.	NNP
cord-254852-qr5gdmbc	77	32	pneumoniae	pneumoniae	NN
cord-254852-qr5gdmbc	77	33	.	.	.
cord-254852-qr5gdmbc	78	1	Doxycycline	Doxycycline	NNP
cord-254852-qr5gdmbc	78	2	is	be	VBZ
cord-254852-qr5gdmbc	78	3	an	an	DT
cord-254852-qr5gdmbc	78	4	alternative	alternative	JJ
cord-254852-qr5gdmbc	78	5	option	option	NN
cord-254852-qr5gdmbc	78	6	.	.	.
cord-254852-qr5gdmbc	79	1	Patients	patient	NNS
cord-254852-qr5gdmbc	79	2	with	with	IN
cord-254852-qr5gdmbc	79	3	comorbidities	comorbiditie	NNS
cord-254852-qr5gdmbc	79	4	such	such	JJ
cord-254852-qr5gdmbc	79	5	as	as	IN
cord-254852-qr5gdmbc	79	6	diabetes	diabetes	NN
cord-254852-qr5gdmbc	79	7	;	;	,
cord-254852-qr5gdmbc	79	8	chronic	chronic	JJ
cord-254852-qr5gdmbc	79	9	heart	heart	NN
cord-254852-qr5gdmbc	79	10	,	,	,
cord-254852-qr5gdmbc	79	11	lung	lung	NN
cord-254852-qr5gdmbc	79	12	,	,	,
cord-254852-qr5gdmbc	79	13	renal	renal	JJ
cord-254852-qr5gdmbc	79	14	,	,	,
cord-254852-qr5gdmbc	79	15	or	or	CC
cord-254852-qr5gdmbc	79	16	liver	liver	NN
cord-254852-qr5gdmbc	79	17	disease	disease	NN
cord-254852-qr5gdmbc	79	18	;	;	:
cord-254852-qr5gdmbc	79	19	alcoholism	alcoholism	NN
cord-254852-qr5gdmbc	79	20	;	;	,
cord-254852-qr5gdmbc	79	21	asplenia	asplenia	NN
cord-254852-qr5gdmbc	79	22	;	;	,
cord-254852-qr5gdmbc	79	23	impaired	impaired	JJ
cord-254852-qr5gdmbc	79	24	immune	immune	JJ
cord-254852-qr5gdmbc	79	25	system	system	NN
cord-254852-qr5gdmbc	79	26	;	;	:
cord-254852-qr5gdmbc	79	27	or	or	CC
cord-254852-qr5gdmbc	79	28	recent	recent	JJ
cord-254852-qr5gdmbc	79	29	antibiotic	antibiotic	JJ
cord-254852-qr5gdmbc	79	30	use	use	NN
cord-254852-qr5gdmbc	79	31	within	within	IN
cord-254852-qr5gdmbc	79	32	the	the	DT
cord-254852-qr5gdmbc	79	33	last	last	JJ
cord-254852-qr5gdmbc	79	34	3	3	CD
cord-254852-qr5gdmbc	79	35	months	month	NNS
cord-254852-qr5gdmbc	79	36	have	have	VBP
cord-254852-qr5gdmbc	79	37	an	an	DT
cord-254852-qr5gdmbc	79	38	increased	increase	VBN
cord-254852-qr5gdmbc	79	39	risk	risk	NN
cord-254852-qr5gdmbc	79	40	for	for	IN
cord-254852-qr5gdmbc	79	41	drug	drug	NN
cord-254852-qr5gdmbc	79	42	-	-	HYPH
cord-254852-qr5gdmbc	79	43	resistant	resistant	JJ
cord-254852-qr5gdmbc	79	44	S	S	NNP
cord-254852-qr5gdmbc	79	45	pneumoniae	pneumoniae	NN
cord-254852-qr5gdmbc	79	46	.	.	.
cord-254852-qr5gdmbc	80	1	As	as	IN
cord-254852-qr5gdmbc	80	2	such	such	JJ
cord-254852-qr5gdmbc	80	3	,	,	,
cord-254852-qr5gdmbc	80	4	a	a	DT
cord-254852-qr5gdmbc	80	5	respiratory	respiratory	JJ
cord-254852-qr5gdmbc	80	6	fluoroquinolone	fluoroquinolone	NN
cord-254852-qr5gdmbc	80	7	or	or	CC
cord-254852-qr5gdmbc	80	8	b	b	NN
cord-254852-qr5gdmbc	80	9	-	-	:
cord-254852-qr5gdmbc	80	10	lactam	lactam	NNS
cord-254852-qr5gdmbc	80	11	plus	plus	CC
cord-254852-qr5gdmbc	80	12	a	a	DT
cord-254852-qr5gdmbc	80	13	macrolide	macrolide	NN
cord-254852-qr5gdmbc	80	14	is	be	VBZ
cord-254852-qr5gdmbc	80	15	recommended	recommend	VBN
cord-254852-qr5gdmbc	80	16	(	(	-LRB-
cord-254852-qr5gdmbc	80	17	Table	table	NN
cord-254852-qr5gdmbc	80	18	4	4	CD
cord-254852-qr5gdmbc	80	19	)	)	-RRB-
cord-254852-qr5gdmbc	80	20	.	.	.
cord-254852-qr5gdmbc	81	1	11	11	CD
cord-254852-qr5gdmbc	82	1	A	a	DT
cord-254852-qr5gdmbc	82	2	2014	2014	CD
cord-254852-qr5gdmbc	82	3	Cochrane	Cochrane	NNP
cord-254852-qr5gdmbc	82	4	review	review	NN
cord-254852-qr5gdmbc	82	5	found	find	VBD
cord-254852-qr5gdmbc	82	6	no	no	DT
cord-254852-qr5gdmbc	82	7	significant	significant	JJ
cord-254852-qr5gdmbc	82	8	differences	difference	NNS
cord-254852-qr5gdmbc	82	9	in	in	IN
cord-254852-qr5gdmbc	82	10	efficacy	efficacy	NN
cord-254852-qr5gdmbc	82	11	between	between	IN
cord-254852-qr5gdmbc	82	12	antibiotic	antibiotic	JJ
cord-254852-qr5gdmbc	82	13	regimens	regimen	NNS
cord-254852-qr5gdmbc	82	14	,	,	,
cord-254852-qr5gdmbc	82	15	although	although	IN
cord-254852-qr5gdmbc	82	16	there	there	EX
cord-254852-qr5gdmbc	82	17	were	be	VBD
cord-254852-qr5gdmbc	82	18	differences	difference	NNS
cord-254852-qr5gdmbc	82	19	in	in	IN
cord-254852-qr5gdmbc	82	20	adverse	adverse	JJ
cord-254852-qr5gdmbc	82	21	effects	effect	NNS
cord-254852-qr5gdmbc	82	22	when	when	WRB
cord-254852-qr5gdmbc	82	23	comparing	compare	VBG
cord-254852-qr5gdmbc	82	24	antibiotics	antibiotic	NNS
cord-254852-qr5gdmbc	82	25	within	within	IN
cord-254852-qr5gdmbc	82	26	a	a	DT
cord-254852-qr5gdmbc	82	27	single	single	JJ
cord-254852-qr5gdmbc	82	28	class	class	NN
cord-254852-qr5gdmbc	82	29	.	.	.
cord-254852-qr5gdmbc	83	1	17	17	CD
cord-254852-qr5gdmbc	83	2	Patients	patient	NNS
cord-254852-qr5gdmbc	83	3	appropriate	appropriate	JJ
cord-254852-qr5gdmbc	83	4	for	for	IN
cord-254852-qr5gdmbc	83	5	inpatient	inpatient	JJ
cord-254852-qr5gdmbc	83	6	non	non	JJ
cord-254852-qr5gdmbc	83	7	-	-	JJ
cord-254852-qr5gdmbc	83	8	ICU	icu	JJ
cord-254852-qr5gdmbc	83	9	treatment	treatment	NN
cord-254852-qr5gdmbc	83	10	should	should	MD
cord-254852-qr5gdmbc	83	11	also	also	RB
cord-254852-qr5gdmbc	83	12	be	be	VB
cord-254852-qr5gdmbc	83	13	treated	treat	VBN
cord-254852-qr5gdmbc	83	14	with	with	IN
cord-254852-qr5gdmbc	83	15	a	a	DT
cord-254852-qr5gdmbc	83	16	respiratory	respiratory	JJ
cord-254852-qr5gdmbc	83	17	fluoroquinolone	fluoroquinolone	NN
cord-254852-qr5gdmbc	83	18	or	or	CC
cord-254852-qr5gdmbc	83	19	macrolide	macrolide	NN
cord-254852-qr5gdmbc	83	20	with	with	IN
cord-254852-qr5gdmbc	83	21	b	b	NN
cord-254852-qr5gdmbc	83	22	-	-	HYPH
cord-254852-qr5gdmbc	83	23	lactam	lactam	NNS
cord-254852-qr5gdmbc	83	24	.	.	.
cord-254852-qr5gdmbc	84	1	Patients	patient	NNS
cord-254852-qr5gdmbc	84	2	should	should	MD
cord-254852-qr5gdmbc	84	3	be	be	VB
cord-254852-qr5gdmbc	84	4	treated	treat	VBN
cord-254852-qr5gdmbc	84	5	for	for	IN
cord-254852-qr5gdmbc	84	6	a	a	DT
cord-254852-qr5gdmbc	84	7	minimum	minimum	NN
cord-254852-qr5gdmbc	84	8	of	of	IN
cord-254852-qr5gdmbc	84	9	5	5	CD
cord-254852-qr5gdmbc	84	10	days	day	NNS
cord-254852-qr5gdmbc	84	11	and	and	CC
cord-254852-qr5gdmbc	84	12	should	should	MD
cord-254852-qr5gdmbc	84	13	be	be	VB
cord-254852-qr5gdmbc	84	14	clinically	clinically	RB
cord-254852-qr5gdmbc	84	15	stable	stable	JJ
cord-254852-qr5gdmbc	84	16	with	with	IN
cord-254852-qr5gdmbc	84	17	resolving	resolve	VBG
cord-254852-qr5gdmbc	84	18	symptoms	symptom	NNS
cord-254852-qr5gdmbc	84	19	before	before	IN
cord-254852-qr5gdmbc	84	20	treatment	treatment	NN
cord-254852-qr5gdmbc	84	21	is	be	VBZ
cord-254852-qr5gdmbc	84	22	discontinued	discontinue	VBN
cord-254852-qr5gdmbc	84	23	.	.	.
cord-254852-qr5gdmbc	85	1	11	11	CD
cord-254852-qr5gdmbc	85	2	,	,	,
cord-254852-qr5gdmbc	85	3	18	18	CD
cord-254852-qr5gdmbc	85	4	Patients	patient	NNS
cord-254852-qr5gdmbc	85	5	with	with	IN
cord-254852-qr5gdmbc	85	6	high	high	JJ
cord-254852-qr5gdmbc	85	7	severity	severity	NN
cord-254852-qr5gdmbc	85	8	of	of	IN
cord-254852-qr5gdmbc	85	9	infection	infection	NN
cord-254852-qr5gdmbc	85	10	or	or	CC
cord-254852-qr5gdmbc	85	11	with	with	IN
cord-254852-qr5gdmbc	85	12	extrapulmonary	extrapulmonary	JJ
cord-254852-qr5gdmbc	85	13	manifestations	manifestation	NNS
cord-254852-qr5gdmbc	85	14	may	may	MD
cord-254852-qr5gdmbc	85	15	benefit	benefit	VB
cord-254852-qr5gdmbc	85	16	from	from	IN
cord-254852-qr5gdmbc	85	17	longer	long	JJR
cord-254852-qr5gdmbc	85	18	duration	duration	NN
cord-254852-qr5gdmbc	85	19	of	of	IN
cord-254852-qr5gdmbc	85	20	therapy	therapy	NN
cord-254852-qr5gdmbc	85	21	,	,	,
cord-254852-qr5gdmbc	85	22	such	such	JJ
cord-254852-qr5gdmbc	85	23	as	as	IN
cord-254852-qr5gdmbc	85	24	7	7	CD
cord-254852-qr5gdmbc	85	25	to	to	TO
cord-254852-qr5gdmbc	85	26	10	10	CD
cord-254852-qr5gdmbc	85	27	days	day	NNS
cord-254852-qr5gdmbc	85	28	or	or	CC
cord-254852-qr5gdmbc	85	29	until	until	IN
cord-254852-qr5gdmbc	85	30	improving	improve	VBG
cord-254852-qr5gdmbc	85	31	.	.	.
cord-254852-qr5gdmbc	86	1	11	11	CD
cord-254852-qr5gdmbc	86	2	,	,	,
cord-254852-qr5gdmbc	86	3	12	12	CD
cord-254852-qr5gdmbc	87	1	In	in	IN
cord-254852-qr5gdmbc	87	2	recent	recent	JJ
cord-254852-qr5gdmbc	87	3	years	year	NNS
cord-254852-qr5gdmbc	87	4	,	,	,
cord-254852-qr5gdmbc	87	5	there	there	EX
cord-254852-qr5gdmbc	87	6	has	have	VBZ
cord-254852-qr5gdmbc	87	7	been	be	VBN
cord-254852-qr5gdmbc	87	8	emerging	emerge	VBG
cord-254852-qr5gdmbc	87	9	data	datum	NNS
cord-254852-qr5gdmbc	87	10	supporting	support	VBG
cord-254852-qr5gdmbc	87	11	the	the	DT
cord-254852-qr5gdmbc	87	12	use	use	NN
cord-254852-qr5gdmbc	87	13	of	of	IN
cord-254852-qr5gdmbc	87	14	adjunctive	adjunctive	JJ
cord-254852-qr5gdmbc	87	15	corticosteroids	corticosteroid	NNS
cord-254852-qr5gdmbc	87	16	in	in	IN
cord-254852-qr5gdmbc	87	17	the	the	DT
cord-254852-qr5gdmbc	87	18	inpatient	inpatient	JJ
cord-254852-qr5gdmbc	87	19	treatment	treatment	NN
cord-254852-qr5gdmbc	87	20	of	of	IN
cord-254852-qr5gdmbc	87	21	CAP	CAP	NNP
cord-254852-qr5gdmbc	87	22	.	.	.
cord-254852-qr5gdmbc	88	1	As	as	IN
cord-254852-qr5gdmbc	88	2	this	this	DT
cord-254852-qr5gdmbc	88	3	is	be	VBZ
cord-254852-qr5gdmbc	88	4	an	an	DT
cord-254852-qr5gdmbc	88	5	area	area	NN
cord-254852-qr5gdmbc	88	6	of	of	IN
cord-254852-qr5gdmbc	88	7	research	research	NN
cord-254852-qr5gdmbc	88	8	,	,	,
cord-254852-qr5gdmbc	88	9	multiple	multiple	JJ
cord-254852-qr5gdmbc	88	10	recent	recent	JJ
cord-254852-qr5gdmbc	88	11	systematic	systematic	JJ
cord-254852-qr5gdmbc	88	12	reviews	review	NNS
cord-254852-qr5gdmbc	88	13	and	and	CC
cord-254852-qr5gdmbc	88	14	meta	meta	NNP
cord-254852-qr5gdmbc	88	15	-	-	HYPH
cord-254852-qr5gdmbc	88	16	analyses	analysis	NNS
cord-254852-qr5gdmbc	88	17	have	have	VBP
cord-254852-qr5gdmbc	88	18	been	be	VBN
cord-254852-qr5gdmbc	88	19	published	publish	VBN
cord-254852-qr5gdmbc	88	20	,	,	,
cord-254852-qr5gdmbc	88	21	some	some	DT
cord-254852-qr5gdmbc	88	22	with	with	IN
cord-254852-qr5gdmbc	88	23	conflicting	conflicting	JJ
cord-254852-qr5gdmbc	88	24	findings	finding	NNS
cord-254852-qr5gdmbc	88	25	.	.	.
cord-254852-qr5gdmbc	89	1	A	a	DT
cord-254852-qr5gdmbc	89	2	2011	2011	CD
cord-254852-qr5gdmbc	89	3	Cochrane	Cochrane	NNP
cord-254852-qr5gdmbc	89	4	review	review	NN
cord-254852-qr5gdmbc	89	5	that	that	WDT
cord-254852-qr5gdmbc	89	6	included	include	VBD
cord-254852-qr5gdmbc	89	7	relevant	relevant	JJ
cord-254852-qr5gdmbc	89	8	CAP	cap	NN
cord-254852-qr5gdmbc	89	9	studies	study	NNS
cord-254852-qr5gdmbc	89	10	through	through	IN
cord-254852-qr5gdmbc	89	11	the	the	DT
cord-254852-qr5gdmbc	89	12	year	year	NN
cord-254852-qr5gdmbc	89	13	2010	2010	CD
cord-254852-qr5gdmbc	89	14	showed	show	VBD
cord-254852-qr5gdmbc	89	15	that	that	IN
cord-254852-qr5gdmbc	89	16	corticosteroid	corticosteroid	NN
cord-254852-qr5gdmbc	89	17	use	use	NN
cord-254852-qr5gdmbc	89	18	accelerates	accelerate	VBZ
cord-254852-qr5gdmbc	89	19	time	time	NN
cord-254852-qr5gdmbc	89	20	to	to	IN
cord-254852-qr5gdmbc	89	21	symptom	symptom	NN
cord-254852-qr5gdmbc	89	22	resolution	resolution	NN
cord-254852-qr5gdmbc	89	23	and	and	CC
cord-254852-qr5gdmbc	89	24	clinical	clinical	JJ
cord-254852-qr5gdmbc	89	25	stability	stability	NN
cord-254852-qr5gdmbc	89	26	,	,	,
cord-254852-qr5gdmbc	89	27	with	with	IN
cord-254852-qr5gdmbc	89	28	infrequent	infrequent	JJ
cord-254852-qr5gdmbc	89	29	adverse	adverse	JJ
cord-254852-qr5gdmbc	89	30	effects	effect	NNS
cord-254852-qr5gdmbc	89	31	.	.	.
cord-254852-qr5gdmbc	90	1	19	19	CD
cord-254852-qr5gdmbc	91	1	Similarly	similarly	RB
cord-254852-qr5gdmbc	91	2	,	,	,
cord-254852-qr5gdmbc	91	3	a	a	DT
cord-254852-qr5gdmbc	91	4	2015	2015	CD
cord-254852-qr5gdmbc	91	5	systematic	systematic	JJ
cord-254852-qr5gdmbc	91	6	review	review	NN
cord-254852-qr5gdmbc	91	7	by	by	IN
cord-254852-qr5gdmbc	91	8	Siemieniuk	Siemieniuk	NNP
cord-254852-qr5gdmbc	91	9	and	and	CC
cord-254852-qr5gdmbc	91	10	colleagues	colleague	NNS
cord-254852-qr5gdmbc	91	11	20	20	CD
cord-254852-qr5gdmbc	91	12	included	include	VBD
cord-254852-qr5gdmbc	91	13	studies	study	NNS
cord-254852-qr5gdmbc	91	14	from	from	IN
cord-254852-qr5gdmbc	91	15	2011	2011	CD
cord-254852-qr5gdmbc	91	16	through	through	IN
cord-254852-qr5gdmbc	91	17	mid-2015	mid-2015	NN
cord-254852-qr5gdmbc	91	18	.	.	.
cord-254852-qr5gdmbc	92	1	Their	-PRON-	PRP$
cord-254852-qr5gdmbc	92	2	analysis	analysis	NN
cord-254852-qr5gdmbc	92	3	of	of	IN
cord-254852-qr5gdmbc	92	4	13	13	CD
cord-254852-qr5gdmbc	92	5	randomized	randomized	JJ
cord-254852-qr5gdmbc	92	6	controlled	control	VBN
cord-254852-qr5gdmbc	92	7	trials	trial	NNS
cord-254852-qr5gdmbc	92	8	found	find	VBN
cord-254852-qr5gdmbc	92	9	significantly	significantly	RB
cord-254852-qr5gdmbc	92	10	decreased	decrease	VBD
cord-254852-qr5gdmbc	92	11	mortality	mortality	NN
cord-254852-qr5gdmbc	92	12	in	in	IN
cord-254852-qr5gdmbc	92	13	severe	severe	JJ
cord-254852-qr5gdmbc	92	14	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	92	15	,	,	,
cord-254852-qr5gdmbc	92	16	decreased	decrease	VBD
cord-254852-qr5gdmbc	92	17	need	need	NN
cord-254852-qr5gdmbc	92	18	for	for	IN
cord-254852-qr5gdmbc	92	19	mechanical	mechanical	JJ
cord-254852-qr5gdmbc	92	20	ventilation	ventilation	NN
cord-254852-qr5gdmbc	92	21	,	,	,
cord-254852-qr5gdmbc	92	22	decreased	decrease	VBD
cord-254852-qr5gdmbc	92	23	occurrence	occurrence	NN
cord-254852-qr5gdmbc	92	24	of	of	IN
cord-254852-qr5gdmbc	92	25	acute	acute	JJ
cord-254852-qr5gdmbc	92	26	respiratory	respiratory	JJ
cord-254852-qr5gdmbc	92	27	distress	distress	NN
cord-254852-qr5gdmbc	92	28	syndrome	syndrome	NN
cord-254852-qr5gdmbc	92	29	,	,	,
cord-254852-qr5gdmbc	92	30	decreased	decrease	VBD
cord-254852-qr5gdmbc	92	31	time	time	NN
cord-254852-qr5gdmbc	92	32	to	to	IN
cord-254852-qr5gdmbc	92	33	clinical	clinical	JJ
cord-254852-qr5gdmbc	92	34	stability	stability	NN
cord-254852-qr5gdmbc	92	35	,	,	,
cord-254852-qr5gdmbc	92	36	and	and	CC
cord-254852-qr5gdmbc	92	37	shorter	short	JJR
cord-254852-qr5gdmbc	92	38	duration	duration	NN
cord-254852-qr5gdmbc	92	39	of	of	IN
cord-254852-qr5gdmbc	92	40	hospitalization	hospitalization	NN
cord-254852-qr5gdmbc	92	41	.	.	.
cord-254852-qr5gdmbc	93	1	20	20	CD
cord-254852-qr5gdmbc	93	2	Hyperglycemia	hyperglycemia	NN
cord-254852-qr5gdmbc	93	3	requiring	require	VBG
cord-254852-qr5gdmbc	93	4	treatment	treatment	NN
cord-254852-qr5gdmbc	93	5	occurred	occur	VBD
cord-254852-qr5gdmbc	93	6	more	more	RBR
cord-254852-qr5gdmbc	93	7	frequently	frequently	RB
cord-254852-qr5gdmbc	93	8	in	in	IN
cord-254852-qr5gdmbc	93	9	patients	patient	NNS
cord-254852-qr5gdmbc	93	10	treated	treat	VBN
cord-254852-qr5gdmbc	93	11	with	with	IN
cord-254852-qr5gdmbc	93	12	corticosteroids	corticosteroid	NNS
cord-254852-qr5gdmbc	93	13	.	.	.
cord-254852-qr5gdmbc	94	1	20	20	CD
cord-254852-qr5gdmbc	94	2	,	,	,
cord-254852-qr5gdmbc	94	3	21	21	CD
cord-254852-qr5gdmbc	94	4	The	the	DT
cord-254852-qr5gdmbc	94	5	most	most	RBS
cord-254852-qr5gdmbc	94	6	recent	recent	JJ
cord-254852-qr5gdmbc	94	7	IDSA	IDSA	NNP
cord-254852-qr5gdmbc	94	8	and	and	CC
cord-254852-qr5gdmbc	94	9	BTS	BTS	NNP
cord-254852-qr5gdmbc	94	10	guidelines	guideline	NNS
cord-254852-qr5gdmbc	94	11	do	do	VBP
cord-254852-qr5gdmbc	94	12	not	not	RB
cord-254852-qr5gdmbc	94	13	make	make	VB
cord-254852-qr5gdmbc	94	14	recommendations	recommendation	NNS
cord-254852-qr5gdmbc	94	15	regarding	regard	VBG
cord-254852-qr5gdmbc	94	16	the	the	DT
cord-254852-qr5gdmbc	94	17	routine	routine	JJ
cord-254852-qr5gdmbc	94	18	use	use	NN
cord-254852-qr5gdmbc	94	19	of	of	IN
cord-254852-qr5gdmbc	94	20	adjunctive	adjunctive	JJ
cord-254852-qr5gdmbc	94	21	corticosteroid	corticosteroid	NN
cord-254852-qr5gdmbc	94	22	for	for	IN
cord-254852-qr5gdmbc	94	23	CAP	CAP	NNP
cord-254852-qr5gdmbc	94	24	.	.	.
cord-254852-qr5gdmbc	95	1	11	11	CD
cord-254852-qr5gdmbc	95	2	,	,	,
cord-254852-qr5gdmbc	95	3	12	12	CD
cord-254852-qr5gdmbc	95	4	Given	give	VBN
cord-254852-qr5gdmbc	95	5	the	the	DT
cord-254852-qr5gdmbc	95	6	variations	variation	NNS
cord-254852-qr5gdmbc	95	7	in	in	IN
cord-254852-qr5gdmbc	95	8	dose	dose	NN
cord-254852-qr5gdmbc	95	9	and	and	CC
cord-254852-qr5gdmbc	95	10	route	route	NN
cord-254852-qr5gdmbc	95	11	of	of	IN
cord-254852-qr5gdmbc	95	12	administration	administration	NN
cord-254852-qr5gdmbc	95	13	,	,	,
cord-254852-qr5gdmbc	95	14	an	an	DT
cord-254852-qr5gdmbc	95	15	optimal	optimal	JJ
cord-254852-qr5gdmbc	95	16	agent	agent	NN
cord-254852-qr5gdmbc	95	17	and	and	CC
cord-254852-qr5gdmbc	95	18	dose	dose	NN
cord-254852-qr5gdmbc	95	19	is	be	VBZ
cord-254852-qr5gdmbc	95	20	unknown	unknown	JJ
cord-254852-qr5gdmbc	95	21	.	.	.
cord-254852-qr5gdmbc	96	1	Further	further	JJ
cord-254852-qr5gdmbc	96	2	research	research	NN
cord-254852-qr5gdmbc	96	3	is	be	VBZ
cord-254852-qr5gdmbc	96	4	needed	need	VBN
cord-254852-qr5gdmbc	96	5	to	to	TO
cord-254852-qr5gdmbc	96	6	determine	determine	VB
cord-254852-qr5gdmbc	96	7	steroid	steroid	NN
cord-254852-qr5gdmbc	96	8	dosing	dosing	NN
cord-254852-qr5gdmbc	96	9	and	and	CC
cord-254852-qr5gdmbc	96	10	duration	duration	NN
cord-254852-qr5gdmbc	96	11	,	,	,
cord-254852-qr5gdmbc	96	12	as	as	RB
cord-254852-qr5gdmbc	96	13	well	well	RB
cord-254852-qr5gdmbc	96	14	as	as	IN
cord-254852-qr5gdmbc	96	15	what	what	WDT
cord-254852-qr5gdmbc	96	16	patient	patient	JJ
cord-254852-qr5gdmbc	96	17	populations	population	NNS
cord-254852-qr5gdmbc	96	18	are	be	VBP
cord-254852-qr5gdmbc	96	19	most	most	RBS
cord-254852-qr5gdmbc	96	20	likely	likely	JJ
cord-254852-qr5gdmbc	96	21	to	to	TO
cord-254852-qr5gdmbc	96	22	benefit	benefit	VB
cord-254852-qr5gdmbc	96	23	from	from	IN
cord-254852-qr5gdmbc	96	24	its	-PRON-	PRP$
cord-254852-qr5gdmbc	96	25	use	use	NN
cord-254852-qr5gdmbc	96	26	.	.	.
cord-254852-qr5gdmbc	97	1	20	20	CD
cord-254852-qr5gdmbc	97	2	,	,	,
cord-254852-qr5gdmbc	97	3	21	21	CD
cord-254852-qr5gdmbc	97	4	There	there	EX
cord-254852-qr5gdmbc	97	5	are	be	VBP
cord-254852-qr5gdmbc	97	6	a	a	DT
cord-254852-qr5gdmbc	97	7	large	large	JJ
cord-254852-qr5gdmbc	97	8	number	number	NN
cord-254852-qr5gdmbc	97	9	of	of	IN
cord-254852-qr5gdmbc	97	10	studies	study	NNS
cord-254852-qr5gdmbc	97	11	assessing	assess	VBG
cord-254852-qr5gdmbc	97	12	the	the	DT
cord-254852-qr5gdmbc	97	13	role	role	NN
cord-254852-qr5gdmbc	97	14	of	of	IN
cord-254852-qr5gdmbc	97	15	the	the	DT
cord-254852-qr5gdmbc	97	16	infection	infection	NN
cord-254852-qr5gdmbc	97	17	biomarker	biomarker	NN
cord-254852-qr5gdmbc	97	18	procalcitonin	procalcitonin	NNS
cord-254852-qr5gdmbc	97	19	in	in	IN
cord-254852-qr5gdmbc	97	20	diagnosis	diagnosis	NN
cord-254852-qr5gdmbc	97	21	and	and	CC
cord-254852-qr5gdmbc	97	22	monitoring	monitoring	NN
cord-254852-qr5gdmbc	97	23	of	of	IN
cord-254852-qr5gdmbc	97	24	patients	patient	NNS
cord-254852-qr5gdmbc	97	25	with	with	IN
cord-254852-qr5gdmbc	97	26	bacterial	bacterial	JJ
cord-254852-qr5gdmbc	97	27	infections	infection	NNS
cord-254852-qr5gdmbc	97	28	.	.	.
cord-254852-qr5gdmbc	98	1	22	22	CD
cord-254852-qr5gdmbc	99	1	A	a	DT
cord-254852-qr5gdmbc	99	2	Cochrane	Cochrane	NNP
cord-254852-qr5gdmbc	99	3	2017	2017	CD
cord-254852-qr5gdmbc	99	4	meta	meta	NN
cord-254852-qr5gdmbc	99	5	-	-	HYPH
cord-254852-qr5gdmbc	99	6	analysis	analysis	NN
cord-254852-qr5gdmbc	99	7	in	in	IN
cord-254852-qr5gdmbc	99	8	the	the	DT
cord-254852-qr5gdmbc	99	9	primary	primary	JJ
cord-254852-qr5gdmbc	99	10	care	care	NN
cord-254852-qr5gdmbc	99	11	setting	setting	NN
cord-254852-qr5gdmbc	99	12	concluded	conclude	VBD
cord-254852-qr5gdmbc	99	13	that	that	IN
cord-254852-qr5gdmbc	99	14	the	the	DT
cord-254852-qr5gdmbc	99	15	use	use	NN
cord-254852-qr5gdmbc	99	16	of	of	IN
cord-254852-qr5gdmbc	99	17	procalcitonin	procalcitonin	NNS
cord-254852-qr5gdmbc	99	18	to	to	TO
cord-254852-qr5gdmbc	99	19	guide	guide	VB
cord-254852-qr5gdmbc	99	20	initiation	initiation	NN
cord-254852-qr5gdmbc	99	21	and	and	CC
cord-254852-qr5gdmbc	99	22	duration	duration	NN
cord-254852-qr5gdmbc	99	23	of	of	IN
cord-254852-qr5gdmbc	99	24	antibiotic	antibiotic	JJ
cord-254852-qr5gdmbc	99	25	treatment	treatment	NN
cord-254852-qr5gdmbc	99	26	results	result	NNS
cord-254852-qr5gdmbc	99	27	in	in	IN
cord-254852-qr5gdmbc	99	28	lower	low	JJR
cord-254852-qr5gdmbc	99	29	risks	risk	NNS
cord-254852-qr5gdmbc	99	30	of	of	IN
cord-254852-qr5gdmbc	99	31	mortality	mortality	NN
cord-254852-qr5gdmbc	99	32	,	,	,
cord-254852-qr5gdmbc	99	33	lower	lower	VB
cord-254852-qr5gdmbc	99	34	antibiotic	antibiotic	JJ
cord-254852-qr5gdmbc	99	35	consumption	consumption	NN
cord-254852-qr5gdmbc	99	36	,	,	,
cord-254852-qr5gdmbc	99	37	and	and	CC
cord-254852-qr5gdmbc	99	38	lower	low	JJR
cord-254852-qr5gdmbc	99	39	risk	risk	NN
cord-254852-qr5gdmbc	99	40	for	for	IN
cord-254852-qr5gdmbc	99	41	antibiotic	antibiotic	NN
cord-254852-qr5gdmbc	99	42	-	-	HYPH
cord-254852-qr5gdmbc	99	43	related	relate	VBN
cord-254852-qr5gdmbc	99	44	side	side	NN
cord-254852-qr5gdmbc	99	45	effects	effect	NNS
cord-254852-qr5gdmbc	99	46	.	.	.
cord-254852-qr5gdmbc	100	1	23	23	CD
cord-254852-qr5gdmbc	101	1	Procalcitonin	Procalcitonin	NNS
cord-254852-qr5gdmbc	101	2	values	value	VBZ
cord-254852-qr5gdmbc	101	3	too	too	RB
cord-254852-qr5gdmbc	101	4	low	low	JJ
cord-254852-qr5gdmbc	101	5	or	or	CC
cord-254852-qr5gdmbc	101	6	too	too	RB
cord-254852-qr5gdmbc	101	7	high	high	JJ
cord-254852-qr5gdmbc	101	8	usually	usually	RB
cord-254852-qr5gdmbc	101	9	exclude	exclude	VBP
cord-254852-qr5gdmbc	101	10	bacterial	bacterial	JJ
cord-254852-qr5gdmbc	101	11	infection	infection	NN
cord-254852-qr5gdmbc	101	12	,	,	,
cord-254852-qr5gdmbc	101	13	but	but	CC
cord-254852-qr5gdmbc	101	14	not	not	RB
cord-254852-qr5gdmbc	101	15	always	always	RB
cord-254852-qr5gdmbc	101	16	.	.	.
cord-254852-qr5gdmbc	102	1	24	24	CD
cord-254852-qr5gdmbc	102	2	Per	per	IN
cord-254852-qr5gdmbc	102	3	practitioner	practitioner	NN
cord-254852-qr5gdmbc	102	4	discretion	discretion	NN
cord-254852-qr5gdmbc	102	5	and	and	CC
cord-254852-qr5gdmbc	102	6	,	,	,
cord-254852-qr5gdmbc	102	7	depending	depend	VBG
cord-254852-qr5gdmbc	102	8	on	on	IN
cord-254852-qr5gdmbc	102	9	patient	patient	JJ
cord-254852-qr5gdmbc	102	10	complexity	complexity	NN
cord-254852-qr5gdmbc	102	11	and	and	CC
cord-254852-qr5gdmbc	102	12	other	other	JJ
cord-254852-qr5gdmbc	102	13	comorbidities	comorbiditie	NNS
cord-254852-qr5gdmbc	102	14	,	,	,
cord-254852-qr5gdmbc	102	15	a	a	DT
cord-254852-qr5gdmbc	102	16	follow	follow	VB
cord-254852-qr5gdmbc	102	17	-	-	HYPH
cord-254852-qr5gdmbc	102	18	up	up	NN
cord-254852-qr5gdmbc	102	19	appointment	appointment	NN
cord-254852-qr5gdmbc	102	20	after	after	IN
cord-254852-qr5gdmbc	102	21	successful	successful	JJ
cord-254852-qr5gdmbc	102	22	management	management	NN
cord-254852-qr5gdmbc	102	23	in	in	IN
cord-254852-qr5gdmbc	102	24	the	the	DT
cord-254852-qr5gdmbc	102	25	primary	primary	JJ
cord-254852-qr5gdmbc	102	26	care	care	NN
cord-254852-qr5gdmbc	102	27	setting	setting	NN
cord-254852-qr5gdmbc	102	28	may	may	MD
cord-254852-qr5gdmbc	102	29	be	be	VB
cord-254852-qr5gdmbc	102	30	arranged	arrange	VBN
cord-254852-qr5gdmbc	102	31	.	.	.
cord-254852-qr5gdmbc	103	1	At	at	IN
cord-254852-qr5gdmbc	103	2	this	this	DT
cord-254852-qr5gdmbc	103	3	appointment	appointment	NN
cord-254852-qr5gdmbc	103	4	,	,	,
cord-254852-qr5gdmbc	103	5	repeat	repeat	NN
cord-254852-qr5gdmbc	103	6	X	x	NN
cord-254852-qr5gdmbc	103	7	-	-	NN
cord-254852-qr5gdmbc	103	8	ray	ray	NN
cord-254852-qr5gdmbc	103	9	imaging	imaging	NN
cord-254852-qr5gdmbc	103	10	to	to	TO
cord-254852-qr5gdmbc	103	11	confirm	confirm	VB
cord-254852-qr5gdmbc	103	12	resolution	resolution	NN
cord-254852-qr5gdmbc	103	13	of	of	IN
cord-254852-qr5gdmbc	103	14	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	103	15	is	be	VBZ
cord-254852-qr5gdmbc	103	16	not	not	RB
cord-254852-qr5gdmbc	103	17	indicated	indicate	VBN
cord-254852-qr5gdmbc	103	18	if	if	IN
cord-254852-qr5gdmbc	103	19	the	the	DT
cord-254852-qr5gdmbc	103	20	patient	patient	NN
cord-254852-qr5gdmbc	103	21	seems	seem	VBZ
cord-254852-qr5gdmbc	103	22	clinically	clinically	RB
cord-254852-qr5gdmbc	103	23	well	well	JJ
cord-254852-qr5gdmbc	103	24	.	.	.
cord-254852-qr5gdmbc	104	1	In	in	IN
cord-254852-qr5gdmbc	104	2	patients	patient	NNS
cord-254852-qr5gdmbc	104	3	with	with	IN
cord-254852-qr5gdmbc	104	4	persistence	persistence	NN
cord-254852-qr5gdmbc	104	5	of	of	IN
cord-254852-qr5gdmbc	104	6	symptoms	symptom	NNS
cord-254852-qr5gdmbc	104	7	or	or	CC
cord-254852-qr5gdmbc	104	8	who	who	WP
cord-254852-qr5gdmbc	104	9	have	have	VBP
cord-254852-qr5gdmbc	104	10	a	a	DT
cord-254852-qr5gdmbc	104	11	high	high	JJ
cord-254852-qr5gdmbc	104	12	risk	risk	NN
cord-254852-qr5gdmbc	104	13	of	of	IN
cord-254852-qr5gdmbc	104	14	lung	lung	NN
cord-254852-qr5gdmbc	104	15	cancer	cancer	NN
cord-254852-qr5gdmbc	104	16	(	(	-LRB-
cord-254852-qr5gdmbc	104	17	age	age	NN
cord-254852-qr5gdmbc	104	18	>	>	XX
cord-254852-qr5gdmbc	104	19	50	50	CD
cord-254852-qr5gdmbc	104	20	,	,	,
cord-254852-qr5gdmbc	104	21	>	>	XX
cord-254852-qr5gdmbc	104	22	30	30	CD
cord-254852-qr5gdmbc	104	23	pack	pack	NN
cord-254852-qr5gdmbc	104	24	year	year	NN
cord-254852-qr5gdmbc	104	25	smoking	smoking	NN
cord-254852-qr5gdmbc	104	26	history	history	NN
cord-254852-qr5gdmbc	104	27	)	)	-RRB-
cord-254852-qr5gdmbc	104	28	,	,	,
cord-254852-qr5gdmbc	104	29	repeat	repeat	NN
cord-254852-qr5gdmbc	104	30	X	x	NN
cord-254852-qr5gdmbc	104	31	-	-	NN
cord-254852-qr5gdmbc	104	32	ray	ray	NN
cord-254852-qr5gdmbc	104	33	imaging	imaging	NN
cord-254852-qr5gdmbc	104	34	or	or	CC
cord-254852-qr5gdmbc	104	35	low	low	JJ
cord-254852-qr5gdmbc	104	36	-	-	HYPH
cord-254852-qr5gdmbc	104	37	dose	dose	NN
cord-254852-qr5gdmbc	104	38	computerized	computerized	JJ
cord-254852-qr5gdmbc	104	39	tomography	tomography	NN
cord-254852-qr5gdmbc	104	40	(	(	-LRB-
cord-254852-qr5gdmbc	104	41	CT	CT	NNP
cord-254852-qr5gdmbc	104	42	)	)	-RRB-
cord-254852-qr5gdmbc	104	43	scan	scan	VBP
cord-254852-qr5gdmbc	104	44	to	to	TO
cord-254852-qr5gdmbc	104	45	screen	screen	NN
cord-254852-qr5gdmbc	104	46	for	for	IN
cord-254852-qr5gdmbc	104	47	lung	lung	NN
cord-254852-qr5gdmbc	104	48	cancer	cancer	NN
cord-254852-qr5gdmbc	104	49	can	can	MD
cord-254852-qr5gdmbc	104	50	be	be	VB
cord-254852-qr5gdmbc	104	51	considered	consider	VBN
cord-254852-qr5gdmbc	104	52	.	.	.
cord-254852-qr5gdmbc	105	1	12	12	CD
cord-254852-qr5gdmbc	105	2	 	 	_SP
cord-254852-qr5gdmbc	106	1	In	in	IN
cord-254852-qr5gdmbc	106	2	the	the	DT
cord-254852-qr5gdmbc	106	3	United	United	NNP
cord-254852-qr5gdmbc	106	4	States	States	NNP
cord-254852-qr5gdmbc	106	5	,	,	,
cord-254852-qr5gdmbc	106	6	the	the	DT
cord-254852-qr5gdmbc	106	7	pneumococcal	pneumococcal	JJ
cord-254852-qr5gdmbc	106	8	conjugate	conjugate	NN
cord-254852-qr5gdmbc	106	9	vaccine	vaccine	NN
cord-254852-qr5gdmbc	106	10	(	(	-LRB-
cord-254852-qr5gdmbc	106	11	PCV13	PCV13	NNP
cord-254852-qr5gdmbc	106	12	or	or	CC
cord-254852-qr5gdmbc	106	13	Prevnar-13	Prevnar-13	NNP
cord-254852-qr5gdmbc	106	14	)	)	-RRB-
cord-254852-qr5gdmbc	106	15	is	be	VBZ
cord-254852-qr5gdmbc	106	16	recommended	recommend	VBN
cord-254852-qr5gdmbc	106	17	for	for	IN
cord-254852-qr5gdmbc	106	18	all	all	DT
cord-254852-qr5gdmbc	106	19	babies	baby	NNS
cord-254852-qr5gdmbc	106	20	and	and	CC
cord-254852-qr5gdmbc	106	21	children	child	NNS
cord-254852-qr5gdmbc	106	22	younger	young	JJR
cord-254852-qr5gdmbc	106	23	than	than	IN
cord-254852-qr5gdmbc	106	24	2	2	CD
cord-254852-qr5gdmbc	106	25	years	year	NNS
cord-254852-qr5gdmbc	106	26	,	,	,
cord-254852-qr5gdmbc	106	27	all	all	DT
cord-254852-qr5gdmbc	106	28	adults	adult	NNS
cord-254852-qr5gdmbc	106	29	aged	age	VBN
cord-254852-qr5gdmbc	106	30	65	65	CD
cord-254852-qr5gdmbc	106	31	years	year	NNS
cord-254852-qr5gdmbc	106	32	or	or	CC
cord-254852-qr5gdmbc	106	33	older	old	JJR
cord-254852-qr5gdmbc	106	34	,	,	,
cord-254852-qr5gdmbc	106	35	as	as	RB
cord-254852-qr5gdmbc	106	36	well	well	RB
cord-254852-qr5gdmbc	106	37	as	as	IN
cord-254852-qr5gdmbc	106	38	children	child	NNS
cord-254852-qr5gdmbc	106	39	and	and	CC
cord-254852-qr5gdmbc	106	40	adults	adult	NNS
cord-254852-qr5gdmbc	106	41	aged	age	VBN
cord-254852-qr5gdmbc	106	42	2	2	CD
cord-254852-qr5gdmbc	106	43	years	year	NNS
cord-254852-qr5gdmbc	106	44	through	through	IN
cord-254852-qr5gdmbc	106	45	64	64	CD
cord-254852-qr5gdmbc	106	46	years	year	NNS
cord-254852-qr5gdmbc	106	47	who	who	WP
cord-254852-qr5gdmbc	106	48	are	be	VBP
cord-254852-qr5gdmbc	106	49	at	at	IN
cord-254852-qr5gdmbc	106	50	increased	increase	VBN
cord-254852-qr5gdmbc	106	51	risk	risk	NN
cord-254852-qr5gdmbc	106	52	for	for	IN
cord-254852-qr5gdmbc	106	53	pneumococcal	pneumococcal	JJ
cord-254852-qr5gdmbc	106	54	disease	disease	NN
cord-254852-qr5gdmbc	106	55	due	due	JJ
cord-254852-qr5gdmbc	106	56	to	to	IN
cord-254852-qr5gdmbc	106	57	certain	certain	JJ
cord-254852-qr5gdmbc	106	58	medical	medical	JJ
cord-254852-qr5gdmbc	106	59	conditions	condition	NNS
cord-254852-qr5gdmbc	106	60	.	.	.
cord-254852-qr5gdmbc	107	1	24	24	CD
cord-254852-qr5gdmbc	108	1	The	the	DT
cord-254852-qr5gdmbc	108	2	pneumococcal	pneumococcal	JJ
cord-254852-qr5gdmbc	108	3	conjugate	conjugate	NN
cord-254852-qr5gdmbc	108	4	vaccine	vaccine	NN
cord-254852-qr5gdmbc	108	5	has	have	VBZ
cord-254852-qr5gdmbc	108	6	been	be	VBN
cord-254852-qr5gdmbc	108	7	shown	show	VBN
cord-254852-qr5gdmbc	108	8	to	to	TO
cord-254852-qr5gdmbc	108	9	have	have	VB
cord-254852-qr5gdmbc	108	10	an	an	DT
cord-254852-qr5gdmbc	108	11	observed	observed	JJ
cord-254852-qr5gdmbc	108	12	46	46	CD
cord-254852-qr5gdmbc	108	13	%	%	NN
cord-254852-qr5gdmbc	108	14	reduction	reduction	NN
cord-254852-qr5gdmbc	108	15	in	in	IN
cord-254852-qr5gdmbc	108	16	vaccine	vaccine	NN
cord-254852-qr5gdmbc	108	17	-	-	HYPH
cord-254852-qr5gdmbc	108	18	type	type	NN
cord-254852-qr5gdmbc	108	19	pneumococcal	pneumococcal	JJ
cord-254852-qr5gdmbc	108	20	CAP	cap	NN
cord-254852-qr5gdmbc	108	21	,	,	,
cord-254852-qr5gdmbc	108	22	persisting	persist	VBG
cord-254852-qr5gdmbc	108	23	for	for	IN
cord-254852-qr5gdmbc	108	24	at	at	RB
cord-254852-qr5gdmbc	108	25	least	least	JJS
cord-254852-qr5gdmbc	108	26	4	4	CD
cord-254852-qr5gdmbc	108	27	years	year	NNS
cord-254852-qr5gdmbc	108	28	after	after	IN
cord-254852-qr5gdmbc	108	29	receiving	receive	VBG
cord-254852-qr5gdmbc	108	30	the	the	DT
cord-254852-qr5gdmbc	108	31	vaccine	vaccine	NN
cord-254852-qr5gdmbc	108	32	.	.	.
cord-254852-qr5gdmbc	109	1	25	25	CD
cord-254852-qr5gdmbc	109	2	,	,	,
cord-254852-qr5gdmbc	109	3	26	26	CD
cord-254852-qr5gdmbc	110	1	The	the	DT
cord-254852-qr5gdmbc	110	2	pneumococcal	pneumococcal	JJ
cord-254852-qr5gdmbc	110	3	polysaccharide	polysaccharide	NN
cord-254852-qr5gdmbc	110	4	vaccine	vaccine	NN
cord-254852-qr5gdmbc	110	5	(	(	-LRB-
cord-254852-qr5gdmbc	110	6	PPSV23	PPSV23	NNP
cord-254852-qr5gdmbc	110	7	or	or	CC
cord-254852-qr5gdmbc	110	8	Pneumovax	Pneumovax	NNP
cord-254852-qr5gdmbc	110	9	23	23	CD
cord-254852-qr5gdmbc	110	10	)	)	-RRB-
cord-254852-qr5gdmbc	110	11	is	be	VBZ
cord-254852-qr5gdmbc	110	12	recommended	recommend	VBN
cord-254852-qr5gdmbc	110	13	for	for	IN
cord-254852-qr5gdmbc	110	14	all	all	DT
cord-254852-qr5gdmbc	110	15	adults	adult	NNS
cord-254852-qr5gdmbc	110	16	aged	age	VBN
cord-254852-qr5gdmbc	110	17	65	65	CD
cord-254852-qr5gdmbc	110	18	years	year	NNS
cord-254852-qr5gdmbc	110	19	or	or	CC
cord-254852-qr5gdmbc	110	20	older	old	JJR
cord-254852-qr5gdmbc	110	21	,	,	,
cord-254852-qr5gdmbc	110	22	all	all	DT
cord-254852-qr5gdmbc	110	23	cigarette	cigarette	NN
cord-254852-qr5gdmbc	110	24	smokers	smoker	NNS
cord-254852-qr5gdmbc	110	25	aged	age	VBN
cord-254852-qr5gdmbc	110	26	19	19	CD
cord-254852-qr5gdmbc	110	27	to	to	TO
cord-254852-qr5gdmbc	110	28	64	64	CD
cord-254852-qr5gdmbc	110	29	years	year	NNS
cord-254852-qr5gdmbc	110	30	,	,	,
cord-254852-qr5gdmbc	110	31	as	as	RB
cord-254852-qr5gdmbc	110	32	well	well	RB
cord-254852-qr5gdmbc	110	33	as	as	IN
cord-254852-qr5gdmbc	110	34	children	child	NNS
cord-254852-qr5gdmbc	110	35	and	and	CC
cord-254852-qr5gdmbc	110	36	adults	adult	NNS
cord-254852-qr5gdmbc	110	37	aged	age	VBN
cord-254852-qr5gdmbc	110	38	2	2	CD
cord-254852-qr5gdmbc	110	39	to	to	IN
cord-254852-qr5gdmbc	110	40	64	64	CD
cord-254852-qr5gdmbc	110	41	years	year	NNS
cord-254852-qr5gdmbc	110	42	with	with	IN
cord-254852-qr5gdmbc	110	43	certain	certain	JJ
cord-254852-qr5gdmbc	110	44	medical	medical	JJ
cord-254852-qr5gdmbc	110	45	conditions	condition	NNS
cord-254852-qr5gdmbc	110	46	.	.	.
cord-254852-qr5gdmbc	111	1	27	27	CD
cord-254852-qr5gdmbc	112	1	A	a	DT
cord-254852-qr5gdmbc	112	2	2013	2013	CD
cord-254852-qr5gdmbc	112	3	Cochrane	Cochrane	NNP
cord-254852-qr5gdmbc	112	4	review	review	NN
cord-254852-qr5gdmbc	112	5	found	find	VBD
cord-254852-qr5gdmbc	112	6	that	that	IN
cord-254852-qr5gdmbc	112	7	the	the	DT
cord-254852-qr5gdmbc	112	8	polysaccharide	polysaccharide	NN
cord-254852-qr5gdmbc	112	9	vaccine	vaccine	NN
cord-254852-qr5gdmbc	112	10	is	be	VBZ
cord-254852-qr5gdmbc	112	11	effective	effective	JJ
cord-254852-qr5gdmbc	112	12	in	in	IN
cord-254852-qr5gdmbc	112	13	preventing	prevent	VBG
cord-254852-qr5gdmbc	112	14	invasive	invasive	JJ
cord-254852-qr5gdmbc	112	15	pneumococcal	pneumococcal	JJ
cord-254852-qr5gdmbc	112	16	disease	disease	NN
cord-254852-qr5gdmbc	112	17	in	in	IN
cord-254852-qr5gdmbc	112	18	healthy	healthy	JJ
cord-254852-qr5gdmbc	112	19	adults	adult	NNS
cord-254852-qr5gdmbc	112	20	.	.	.
cord-254852-qr5gdmbc	113	1	Vaccine	vaccine	NN
cord-254852-qr5gdmbc	113	2	efficacy	efficacy	NN
cord-254852-qr5gdmbc	113	3	was	be	VBD
cord-254852-qr5gdmbc	113	4	,	,	,
cord-254852-qr5gdmbc	113	5	however	however	RB
cord-254852-qr5gdmbc	113	6	,	,	,
cord-254852-qr5gdmbc	113	7	poorer	poor	JJR
cord-254852-qr5gdmbc	113	8	in	in	IN
cord-254852-qr5gdmbc	113	9	adults	adult	NNS
cord-254852-qr5gdmbc	113	10	with	with	IN
cord-254852-qr5gdmbc	113	11	chronic	chronic	JJ
cord-254852-qr5gdmbc	113	12	illnesses	illness	NNS
cord-254852-qr5gdmbc	113	13	.	.	.
cord-254852-qr5gdmbc	114	1	28	28	CD
cord-254852-qr5gdmbc	114	2	 	 	_SP
cord-254852-qr5gdmbc	115	1	Pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	115	2	is	be	VBZ
cord-254852-qr5gdmbc	115	3	considered	consider	VBN
cord-254852-qr5gdmbc	115	4	"	"	``
cord-254852-qr5gdmbc	115	5	nonresolving	nonresolving	JJ
cord-254852-qr5gdmbc	115	6	"	"	''
cord-254852-qr5gdmbc	115	7	if	if	IN
cord-254852-qr5gdmbc	115	8	there	there	EX
cord-254852-qr5gdmbc	115	9	is	be	VBZ
cord-254852-qr5gdmbc	115	10	an	an	DT
cord-254852-qr5gdmbc	115	11	inadequate	inadequate	JJ
cord-254852-qr5gdmbc	115	12	clinical	clinical	JJ
cord-254852-qr5gdmbc	115	13	response	response	NN
cord-254852-qr5gdmbc	115	14	despite	despite	IN
cord-254852-qr5gdmbc	115	15	antibiotic	antibiotic	JJ
cord-254852-qr5gdmbc	115	16	treatment	treatment	NN
cord-254852-qr5gdmbc	115	17	.	.	.
cord-254852-qr5gdmbc	116	1	11	11	CD
cord-254852-qr5gdmbc	117	1	The	the	DT
cord-254852-qr5gdmbc	117	2	incidence	incidence	NN
cord-254852-qr5gdmbc	117	3	of	of	IN
cord-254852-qr5gdmbc	117	4	treatment	treatment	NN
cord-254852-qr5gdmbc	117	5	failure	failure	NN
cord-254852-qr5gdmbc	117	6	is	be	VBZ
cord-254852-qr5gdmbc	117	7	6	6	CD
cord-254852-qr5gdmbc	117	8	%	%	NN
cord-254852-qr5gdmbc	117	9	to	to	TO
cord-254852-qr5gdmbc	117	10	15	15	CD
cord-254852-qr5gdmbc	117	11	%	%	NN
cord-254852-qr5gdmbc	117	12	and	and	CC
cord-254852-qr5gdmbc	117	13	is	be	VBZ
cord-254852-qr5gdmbc	117	14	associated	associate	VBN
cord-254852-qr5gdmbc	117	15	with	with	IN
cord-254852-qr5gdmbc	117	16	a	a	DT
cord-254852-qr5gdmbc	117	17	5-fold	5-fold	CD
cord-254852-qr5gdmbc	117	18	increase	increase	NN
cord-254852-qr5gdmbc	117	19	in	in	IN
cord-254852-qr5gdmbc	117	20	mortality	mortality	NN
cord-254852-qr5gdmbc	117	21	.	.	.
cord-254852-qr5gdmbc	118	1	29	29	CD
cord-254852-qr5gdmbc	118	2	IDSA	IDSA	NNP
cord-254852-qr5gdmbc	118	3	broadly	broadly	RB
cord-254852-qr5gdmbc	118	4	classifies	classify	VBZ
cord-254852-qr5gdmbc	118	5	nonresponse	nonresponse	NN
cord-254852-qr5gdmbc	118	6	into	into	IN
cord-254852-qr5gdmbc	118	7	2	2	CD
cord-254852-qr5gdmbc	118	8	different	different	JJ
cord-254852-qr5gdmbc	118	9	groups	group	NNS
cord-254852-qr5gdmbc	118	10	:	:	:
cord-254852-qr5gdmbc	118	11	(	(	-LRB-
cord-254852-qr5gdmbc	118	12	1	1	LS
cord-254852-qr5gdmbc	118	13	)	)	-RRB-
cord-254852-qr5gdmbc	118	14	progressive	progressive	JJ
cord-254852-qr5gdmbc	118	15	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	118	16	characterized	characterize	VBN
cord-254852-qr5gdmbc	118	17	by	by	IN
cord-254852-qr5gdmbc	118	18	clinical	clinical	JJ
cord-254852-qr5gdmbc	118	19	deterioration	deterioration	NN
cord-254852-qr5gdmbc	118	20	and	and	CC
cord-254852-qr5gdmbc	118	21	(	(	-LRB-
cord-254852-qr5gdmbc	118	22	2	2	LS
cord-254852-qr5gdmbc	118	23	)	)	-RRB-
cord-254852-qr5gdmbc	118	24	persistent	persistent	JJ
cord-254852-qr5gdmbc	118	25	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	118	26	with	with	IN
cord-254852-qr5gdmbc	118	27	absence	absence	NN
cord-254852-qr5gdmbc	118	28	or	or	CC
cord-254852-qr5gdmbc	118	29	delay	delay	NN
cord-254852-qr5gdmbc	118	30	of	of	IN
cord-254852-qr5gdmbc	118	31	clinical	clinical	JJ
cord-254852-qr5gdmbc	118	32	stability	stability	NN
cord-254852-qr5gdmbc	118	33	.	.	.
cord-254852-qr5gdmbc	119	1	11	11	CD
cord-254852-qr5gdmbc	119	2	Progressive	progressive	JJ
cord-254852-qr5gdmbc	119	3	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	119	4	with	with	IN
cord-254852-qr5gdmbc	119	5	deterioration	deterioration	NN
cord-254852-qr5gdmbc	119	6	is	be	VBZ
cord-254852-qr5gdmbc	119	7	characterized	characterize	VBN
cord-254852-qr5gdmbc	119	8	by	by	IN
cord-254852-qr5gdmbc	119	9	respiratory	respiratory	JJ
cord-254852-qr5gdmbc	119	10	failure	failure	NN
cord-254852-qr5gdmbc	119	11	and/	and/	CD
cord-254852-qr5gdmbc	119	12	or	or	CC
cord-254852-qr5gdmbc	119	13	septic	septic	JJ
cord-254852-qr5gdmbc	119	14	shock	shock	NN
cord-254852-qr5gdmbc	119	15	and	and	CC
cord-254852-qr5gdmbc	119	16	typically	typically	RB
cord-254852-qr5gdmbc	119	17	occurs	occur	VBZ
cord-254852-qr5gdmbc	119	18	within	within	IN
cord-254852-qr5gdmbc	119	19	72	72	CD
cord-254852-qr5gdmbc	119	20	hours	hour	NNS
cord-254852-qr5gdmbc	119	21	.	.	.
cord-254852-qr5gdmbc	120	1	Persistent	persistent	JJ
cord-254852-qr5gdmbc	120	2	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	120	3	with	with	IN
cord-254852-qr5gdmbc	120	4	absent	absent	JJ
cord-254852-qr5gdmbc	120	5	or	or	CC
cord-254852-qr5gdmbc	120	6	delayed	delayed	JJ
cord-254852-qr5gdmbc	120	7	response	response	NN
cord-254852-qr5gdmbc	120	8	is	be	VBZ
cord-254852-qr5gdmbc	120	9	typically	typically	RB
cord-254852-qr5gdmbc	120	10	considered	consider	VBN
cord-254852-qr5gdmbc	120	11	after	after	IN
cord-254852-qr5gdmbc	120	12	a	a	DT
cord-254852-qr5gdmbc	120	13	time	time	NN
cord-254852-qr5gdmbc	120	14	period	period	NN
cord-254852-qr5gdmbc	120	15	of	of	IN
cord-254852-qr5gdmbc	120	16	72	72	CD
cord-254852-qr5gdmbc	120	17	hours	hour	NNS
cord-254852-qr5gdmbc	120	18	,	,	,
cord-254852-qr5gdmbc	120	19	because	because	IN
cord-254852-qr5gdmbc	120	20	this	this	DT
cord-254852-qr5gdmbc	120	21	is	be	VBZ
cord-254852-qr5gdmbc	120	22	often	often	RB
cord-254852-qr5gdmbc	120	23	regarded	regard	VBN
cord-254852-qr5gdmbc	120	24	as	as	IN
cord-254852-qr5gdmbc	120	25	the	the	DT
cord-254852-qr5gdmbc	120	26	median	median	JJ
cord-254852-qr5gdmbc	120	27	time	time	NN
cord-254852-qr5gdmbc	120	28	required	require	VBN
cord-254852-qr5gdmbc	120	29	for	for	IN
cord-254852-qr5gdmbc	120	30	clinical	clinical	JJ
cord-254852-qr5gdmbc	120	31	stability	stability	NN
cord-254852-qr5gdmbc	120	32	.	.	.
cord-254852-qr5gdmbc	121	1	11	11	CD
cord-254852-qr5gdmbc	121	2	,	,	,
cord-254852-qr5gdmbc	121	3	29	29	CD
cord-254852-qr5gdmbc	121	4	Concern	concern	NN
cord-254852-qr5gdmbc	121	5	for	for	IN
cord-254852-qr5gdmbc	121	6	nonresponse	nonresponse	NN
cord-254852-qr5gdmbc	121	7	in	in	IN
cord-254852-qr5gdmbc	121	8	a	a	DT
cord-254852-qr5gdmbc	121	9	patient	patient	NN
cord-254852-qr5gdmbc	121	10	with	with	IN
cord-254852-qr5gdmbc	121	11	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	121	12	should	should	MD
cord-254852-qr5gdmbc	121	13	initiate	initiate	VB
cord-254852-qr5gdmbc	121	14	a	a	DT
cord-254852-qr5gdmbc	121	15	systematic	systematic	JJ
cord-254852-qr5gdmbc	121	16	evaluation	evaluation	NN
cord-254852-qr5gdmbc	121	17	of	of	IN
cord-254852-qr5gdmbc	121	18	possible	possible	JJ
cord-254852-qr5gdmbc	121	19	causes	cause	NNS
cord-254852-qr5gdmbc	121	20	.	.	.
cord-254852-qr5gdmbc	122	1	Host	host	NN
cord-254852-qr5gdmbc	122	2	factors	factor	NNS
cord-254852-qr5gdmbc	122	3	that	that	WDT
cord-254852-qr5gdmbc	122	4	may	may	MD
cord-254852-qr5gdmbc	122	5	explain	explain	VB
cord-254852-qr5gdmbc	122	6	poor	poor	JJ
cord-254852-qr5gdmbc	122	7	response	response	NN
cord-254852-qr5gdmbc	122	8	should	should	MD
cord-254852-qr5gdmbc	122	9	be	be	VB
cord-254852-qr5gdmbc	122	10	considered	consider	VBN
cord-254852-qr5gdmbc	122	11	,	,	,
cord-254852-qr5gdmbc	122	12	including	include	VBG
cord-254852-qr5gdmbc	122	13	high	high	JJ
cord-254852-qr5gdmbc	122	14	initial	initial	JJ
cord-254852-qr5gdmbc	122	15	severity	severity	NN
cord-254852-qr5gdmbc	122	16	score	score	NN
cord-254852-qr5gdmbc	122	17	,	,	,
cord-254852-qr5gdmbc	122	18	risk	risk	NN
cord-254852-qr5gdmbc	122	19	factors	factor	NNS
cord-254852-qr5gdmbc	122	20	for	for	IN
cord-254852-qr5gdmbc	122	21	infection	infection	NN
cord-254852-qr5gdmbc	122	22	with	with	IN
cord-254852-qr5gdmbc	122	23	unusual	unusual	JJ
cord-254852-qr5gdmbc	122	24	organisms	organism	NNS
cord-254852-qr5gdmbc	122	25	,	,	,
cord-254852-qr5gdmbc	122	26	underlying	underlie	VBG
cord-254852-qr5gdmbc	122	27	comorbidities	comorbiditie	NNS
cord-254852-qr5gdmbc	122	28	,	,	,
cord-254852-qr5gdmbc	122	29	or	or	CC
cord-254852-qr5gdmbc	122	30	risk	risk	NN
cord-254852-qr5gdmbc	122	31	factors	factor	NNS
cord-254852-qr5gdmbc	122	32	for	for	IN
cord-254852-qr5gdmbc	122	33	multi	multi	JJ
cord-254852-qr5gdmbc	122	34	-	-	JJ
cord-254852-qr5gdmbc	122	35	drug	drug	JJ
cord-254852-qr5gdmbc	122	36	-	-	HYPH
cord-254852-qr5gdmbc	122	37	resistant	resistant	JJ
cord-254852-qr5gdmbc	122	38	pathogens	pathogen	NNS
cord-254852-qr5gdmbc	122	39	(	(	-LRB-
cord-254852-qr5gdmbc	122	40	Table	table	NN
cord-254852-qr5gdmbc	122	41	5	5	CD
cord-254852-qr5gdmbc	122	42	)	)	-RRB-
cord-254852-qr5gdmbc	122	43	.	.	.
cord-254852-qr5gdmbc	123	1	24	24	CD
cord-254852-qr5gdmbc	124	1	In	in	IN
cord-254852-qr5gdmbc	124	2	areas	area	NNS
cord-254852-qr5gdmbc	124	3	with	with	IN
cord-254852-qr5gdmbc	124	4	high	high	JJ
cord-254852-qr5gdmbc	124	5	prevalence	prevalence	NN
cord-254852-qr5gdmbc	124	6	of	of	IN
cord-254852-qr5gdmbc	124	7	HIV	HIV	NNP
cord-254852-qr5gdmbc	124	8	or	or	CC
cord-254852-qr5gdmbc	124	9	TB	TB	NNP
cord-254852-qr5gdmbc	124	10	,	,	,
cord-254852-qr5gdmbc	124	11	testing	testing	NN
cord-254852-qr5gdmbc	124	12	is	be	VBZ
cord-254852-qr5gdmbc	124	13	recommended	recommend	VBN
cord-254852-qr5gdmbc	124	14	.	.	.
cord-254852-qr5gdmbc	125	1	30	30	CD
cord-254852-qr5gdmbc	125	2	Results	result	NNS
cord-254852-qr5gdmbc	125	3	of	of	IN
cord-254852-qr5gdmbc	125	4	initial	initial	JJ
cord-254852-qr5gdmbc	125	5	microbiological	microbiological	JJ
cord-254852-qr5gdmbc	125	6	tests	test	NNS
cord-254852-qr5gdmbc	125	7	such	such	JJ
cord-254852-qr5gdmbc	125	8	as	as	IN
cord-254852-qr5gdmbc	125	9	blood	blood	NN
cord-254852-qr5gdmbc	125	10	or	or	CC
cord-254852-qr5gdmbc	125	11	sputum	sputum	NN
cord-254852-qr5gdmbc	125	12	cultures	culture	NNS
cord-254852-qr5gdmbc	125	13	should	should	MD
cord-254852-qr5gdmbc	125	14	be	be	VB
cord-254852-qr5gdmbc	125	15	reviewed	review	VBN
cord-254852-qr5gdmbc	125	16	,	,	,
cord-254852-qr5gdmbc	125	17	including	include	VBG
cord-254852-qr5gdmbc	125	18	any	any	DT
cord-254852-qr5gdmbc	125	19	sensitivity	sensitivity	NN
cord-254852-qr5gdmbc	125	20	data	datum	NNS
cord-254852-qr5gdmbc	125	21	.	.	.
cord-254852-qr5gdmbc	126	1	Repeat	repeat	VB
cord-254852-qr5gdmbc	126	2	blood	blood	NN
cord-254852-qr5gdmbc	126	3	cultures	culture	NNS
cord-254852-qr5gdmbc	126	4	should	should	MD
cord-254852-qr5gdmbc	126	5	be	be	VB
cord-254852-qr5gdmbc	126	6	obtained	obtain	VBN
cord-254852-qr5gdmbc	126	7	in	in	IN
cord-254852-qr5gdmbc	126	8	the	the	DT
cord-254852-qr5gdmbc	126	9	setting	setting	NN
cord-254852-qr5gdmbc	126	10	of	of	IN
cord-254852-qr5gdmbc	126	11	clinical	clinical	JJ
cord-254852-qr5gdmbc	126	12	deterioration	deterioration	NN
cord-254852-qr5gdmbc	126	13	.	.	.
cord-254852-qr5gdmbc	127	1	Additional	additional	JJ
cord-254852-qr5gdmbc	127	2	laboratory	laboratory	NN
cord-254852-qr5gdmbc	127	3	testing	testing	NN
cord-254852-qr5gdmbc	127	4	for	for	IN
cord-254852-qr5gdmbc	127	5	S.	S.	NNP
cord-254852-qr5gdmbc	127	6	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	127	7	and	and	CC
cord-254852-qr5gdmbc	127	8	Legionella	Legionella	NNP
cord-254852-qr5gdmbc	127	9	pneumophila	pneumophila	NN
cord-254852-qr5gdmbc	127	10	via	via	IN
cord-254852-qr5gdmbc	127	11	urine	urine	NN
cord-254852-qr5gdmbc	127	12	antigen	antigen	NN
cord-254852-qr5gdmbc	127	13	testing	testing	NN
cord-254852-qr5gdmbc	127	14	may	may	MD
cord-254852-qr5gdmbc	127	15	be	be	VB
cord-254852-qr5gdmbc	127	16	performed	perform	VBN
cord-254852-qr5gdmbc	127	17	,	,	,
cord-254852-qr5gdmbc	127	18	because	because	IN
cord-254852-qr5gdmbc	127	19	they	-PRON-	PRP
cord-254852-qr5gdmbc	127	20	may	may	MD
cord-254852-qr5gdmbc	127	21	remain	remain	VB
cord-254852-qr5gdmbc	127	22	positive	positive	JJ
cord-254852-qr5gdmbc	127	23	for	for	IN
cord-254852-qr5gdmbc	127	24	days	day	NNS
cord-254852-qr5gdmbc	127	25	after	after	IN
cord-254852-qr5gdmbc	127	26	initiating	initiate	VBG
cord-254852-qr5gdmbc	127	27	antibiotic	antibiotic	JJ
cord-254852-qr5gdmbc	127	28	treatment	treatment	NN
cord-254852-qr5gdmbc	127	29	.	.	.
cord-254852-qr5gdmbc	128	1	Additional	additional	JJ
cord-254852-qr5gdmbc	128	2	imaging	imaging	NN
cord-254852-qr5gdmbc	128	3	such	such	JJ
cord-254852-qr5gdmbc	128	4	as	as	IN
cord-254852-qr5gdmbc	128	5	chest	chest	NN
cord-254852-qr5gdmbc	128	6	CT	CT	NNP
cord-254852-qr5gdmbc	128	7	may	may	MD
cord-254852-qr5gdmbc	128	8	be	be	VB
cord-254852-qr5gdmbc	128	9	beneficial	beneficial	JJ
cord-254852-qr5gdmbc	128	10	for	for	IN
cord-254852-qr5gdmbc	128	11	assessing	assess	VBG
cord-254852-qr5gdmbc	128	12	interval	interval	NN
cord-254852-qr5gdmbc	128	13	progression	progression	NN
cord-254852-qr5gdmbc	128	14	or	or	CC
cord-254852-qr5gdmbc	128	15	improvement	improvement	NN
cord-254852-qr5gdmbc	128	16	or	or	CC
cord-254852-qr5gdmbc	128	17	identifying	identify	VBG
cord-254852-qr5gdmbc	128	18	pleural	pleural	JJ
cord-254852-qr5gdmbc	128	19	effusions	effusion	NNS
cord-254852-qr5gdmbc	128	20	,	,	,
cord-254852-qr5gdmbc	128	21	lung	lung	NN
cord-254852-qr5gdmbc	128	22	abscesses	abscess	NNS
cord-254852-qr5gdmbc	128	23	,	,	,
cord-254852-qr5gdmbc	128	24	or	or	CC
cord-254852-qr5gdmbc	128	25	pulmonary	pulmonary	JJ
cord-254852-qr5gdmbc	128	26	embolism	embolism	NN
cord-254852-qr5gdmbc	128	27	.	.	.
cord-254852-qr5gdmbc	129	1	If	if	IN
cord-254852-qr5gdmbc	129	2	pleural	pleural	JJ
cord-254852-qr5gdmbc	129	3	effusions	effusion	NNS
cord-254852-qr5gdmbc	129	4	are	be	VBP
cord-254852-qr5gdmbc	129	5	identified	identify	VBN
cord-254852-qr5gdmbc	129	6	in	in	IN
cord-254852-qr5gdmbc	129	7	a	a	DT
cord-254852-qr5gdmbc	129	8	patient	patient	NN
cord-254852-qr5gdmbc	129	9	with	with	IN
cord-254852-qr5gdmbc	129	10	treatment	treatment	NN
cord-254852-qr5gdmbc	129	11	failure	failure	NN
cord-254852-qr5gdmbc	129	12	,	,	,
cord-254852-qr5gdmbc	129	13	thoracentesis	thoracentesis	NN
cord-254852-qr5gdmbc	129	14	should	should	MD
cord-254852-qr5gdmbc	129	15	be	be	VB
cord-254852-qr5gdmbc	129	16	performed	perform	VBN
cord-254852-qr5gdmbc	129	17	to	to	TO
cord-254852-qr5gdmbc	129	18	evaluate	evaluate	VB
cord-254852-qr5gdmbc	129	19	for	for	IN
cord-254852-qr5gdmbc	129	20	empyema	empyema	NNP
cord-254852-qr5gdmbc	129	21	.	.	.
cord-254852-qr5gdmbc	130	1	In	in	IN
cord-254852-qr5gdmbc	130	2	select	select	JJ
cord-254852-qr5gdmbc	130	3	patients	patient	NNS
cord-254852-qr5gdmbc	130	4	,	,	,
cord-254852-qr5gdmbc	130	5	bronchoscopy	bronchoscopy	RB
cord-254852-qr5gdmbc	130	6	with	with	IN
cord-254852-qr5gdmbc	130	7	protected	protect	VBN
cord-254852-qr5gdmbc	130	8	bronchial	bronchial	JJ
cord-254852-qr5gdmbc	130	9	sampling	sampling	NN
cord-254852-qr5gdmbc	130	10	or	or	CC
cord-254852-qr5gdmbc	130	11	bronchoalveolar	bronchoalveolar	NNP
cord-254852-qr5gdmbc	130	12	lavage	lavage	NNP
cord-254852-qr5gdmbc	130	13	(	(	-LRB-
cord-254852-qr5gdmbc	130	14	BAL	BAL	NNP
cord-254852-qr5gdmbc	130	15	)	)	-RRB-
cord-254852-qr5gdmbc	130	16	may	may	MD
cord-254852-qr5gdmbc	130	17	be	be	VB
cord-254852-qr5gdmbc	130	18	beneficial	beneficial	JJ
cord-254852-qr5gdmbc	130	19	to	to	TO
cord-254852-qr5gdmbc	130	20	provide	provide	VB
cord-254852-qr5gdmbc	130	21	diagnostic	diagnostic	JJ
cord-254852-qr5gdmbc	130	22	information	information	NN
cord-254852-qr5gdmbc	130	23	for	for	IN
cord-254852-qr5gdmbc	130	24	infectious	infectious	JJ
cord-254852-qr5gdmbc	130	25	causes	cause	NNS
cord-254852-qr5gdmbc	130	26	and	and	CC
cord-254852-qr5gdmbc	130	27	noninfectious	noninfectious	JJ
cord-254852-qr5gdmbc	130	28	mimics	mimic	NNS
cord-254852-qr5gdmbc	130	29	,	,	,
cord-254852-qr5gdmbc	130	30	such	such	JJ
cord-254852-qr5gdmbc	130	31	as	as	IN
cord-254852-qr5gdmbc	130	32	pulmonary	pulmonary	JJ
cord-254852-qr5gdmbc	130	33	eosinophilia	eosinophilia	NN
cord-254852-qr5gdmbc	130	34	,	,	,
cord-254852-qr5gdmbc	130	35	drug	drug	NN
cord-254852-qr5gdmbc	130	36	-	-	HYPH
cord-254852-qr5gdmbc	130	37	induced	induce	VBN
cord-254852-qr5gdmbc	130	38	pneumonitis	pneumonitis	NN
cord-254852-qr5gdmbc	130	39	,	,	,
cord-254852-qr5gdmbc	130	40	sarcoidosis	sarcoidosis	NN
cord-254852-qr5gdmbc	130	41	,	,	,
cord-254852-qr5gdmbc	130	42	or	or	CC
cord-254852-qr5gdmbc	130	43	pulmonary	pulmonary	JJ
cord-254852-qr5gdmbc	130	44	fibrosis	fibrosis	NN
cord-254852-qr5gdmbc	130	45	.	.	.
cord-254852-qr5gdmbc	131	1	11	11	CD
cord-254852-qr5gdmbc	131	2	,	,	,
cord-254852-qr5gdmbc	131	3	29	29	CD
cord-254852-qr5gdmbc	131	4	Primary	primary	JJ
cord-254852-qr5gdmbc	131	5	or	or	CC
cord-254852-qr5gdmbc	131	6	metastatic	metastatic	JJ
cord-254852-qr5gdmbc	131	7	neoplastic	neoplastic	JJ
cord-254852-qr5gdmbc	131	8	lesions	lesion	NNS
cord-254852-qr5gdmbc	131	9	obstructing	obstruct	VBG
cord-254852-qr5gdmbc	131	10	the	the	DT
cord-254852-qr5gdmbc	131	11	bronchus	bronchus	NN
cord-254852-qr5gdmbc	131	12	may	may	MD
cord-254852-qr5gdmbc	131	13	cause	cause	VB
cord-254852-qr5gdmbc	131	14	accumulation	accumulation	NN
cord-254852-qr5gdmbc	131	15	of	of	IN
cord-254852-qr5gdmbc	131	16	secretions	secretion	NNS
cord-254852-qr5gdmbc	131	17	distal	distal	JJ
cord-254852-qr5gdmbc	131	18	to	to	IN
cord-254852-qr5gdmbc	131	19	the	the	DT
cord-254852-qr5gdmbc	131	20	obstruction	obstruction	NN
cord-254852-qr5gdmbc	131	21	,	,	,
cord-254852-qr5gdmbc	131	22	predisposing	predispose	VBG
cord-254852-qr5gdmbc	131	23	to	to	IN
cord-254852-qr5gdmbc	131	24	infection	infection	NN
cord-254852-qr5gdmbc	131	25	.	.	.
cord-254852-qr5gdmbc	132	1	Both	both	DT
cord-254852-qr5gdmbc	132	2	Hodgkin	Hodgkin	NNP
cord-254852-qr5gdmbc	132	3	and	and	CC
cord-254852-qr5gdmbc	132	4	non	non	JJ
cord-254852-qr5gdmbc	132	5	-	-	JJ
cord-254852-qr5gdmbc	132	6	Hodgkin	Hodgkin	NNP
cord-254852-qr5gdmbc	132	7	lymphoma	lymphoma	NN
cord-254852-qr5gdmbc	132	8	can	can	MD
cord-254852-qr5gdmbc	132	9	present	present	VB
cord-254852-qr5gdmbc	132	10	with	with	IN
cord-254852-qr5gdmbc	132	11	lung	lung	NN
cord-254852-qr5gdmbc	132	12	involvement	involvement	NN
cord-254852-qr5gdmbc	132	13	,	,	,
cord-254852-qr5gdmbc	132	14	with	with	IN
cord-254852-qr5gdmbc	132	15	typical	typical	JJ
cord-254852-qr5gdmbc	132	16	radiographic	radiographic	JJ
cord-254852-qr5gdmbc	132	17	findings	finding	NNS
cord-254852-qr5gdmbc	132	18	of	of	IN
cord-254852-qr5gdmbc	132	19	hilar	hilar	JJ
cord-254852-qr5gdmbc	132	20	or	or	CC
cord-254852-qr5gdmbc	132	21	mediastinal	mediastinal	JJ
cord-254852-qr5gdmbc	132	22	adenopathy	adenopathy	NN
cord-254852-qr5gdmbc	132	23	,	,	,
cord-254852-qr5gdmbc	132	24	but	but	CC
cord-254852-qr5gdmbc	132	25	may	may	MD
cord-254852-qr5gdmbc	132	26	also	also	RB
cord-254852-qr5gdmbc	132	27	have	have	VB
cord-254852-qr5gdmbc	132	28	a	a	DT
cord-254852-qr5gdmbc	132	29	presenting	present	VBG
cord-254852-qr5gdmbc	132	30	pattern	pattern	NN
cord-254852-qr5gdmbc	132	31	that	that	WDT
cord-254852-qr5gdmbc	132	32	suggests	suggest	VBZ
cord-254852-qr5gdmbc	132	33	infection	infection	NN
cord-254852-qr5gdmbc	132	34	.	.	.
cord-254852-qr5gdmbc	133	1	31	31	CD
cord-254852-qr5gdmbc	133	2	 	 	_SP
cord-254852-qr5gdmbc	134	1	Elderly	elderly	JJ
cord-254852-qr5gdmbc	134	2	patients	patient	NNS
cord-254852-qr5gdmbc	134	3	with	with	IN
cord-254852-qr5gdmbc	134	4	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	134	5	may	may	MD
cord-254852-qr5gdmbc	134	6	not	not	RB
cord-254852-qr5gdmbc	134	7	exhibit	exhibit	VB
cord-254852-qr5gdmbc	134	8	typical	typical	JJ
cord-254852-qr5gdmbc	134	9	symptoms	symptom	NNS
cord-254852-qr5gdmbc	134	10	or	or	CC
cord-254852-qr5gdmbc	134	11	physical	physical	JJ
cord-254852-qr5gdmbc	134	12	examination	examination	NN
cord-254852-qr5gdmbc	134	13	findings	finding	NNS
cord-254852-qr5gdmbc	134	14	seen	see	VBN
cord-254852-qr5gdmbc	134	15	in	in	IN
cord-254852-qr5gdmbc	134	16	younger	young	JJR
cord-254852-qr5gdmbc	134	17	adults	adult	NNS
cord-254852-qr5gdmbc	134	18	,	,	,
cord-254852-qr5gdmbc	134	19	such	such	JJ
cord-254852-qr5gdmbc	134	20	as	as	IN
cord-254852-qr5gdmbc	134	21	pleuritic	pleuritic	JJ
cord-254852-qr5gdmbc	134	22	chest	chest	NN
cord-254852-qr5gdmbc	134	23	pain	pain	NN
cord-254852-qr5gdmbc	134	24	,	,	,
cord-254852-qr5gdmbc	134	25	cough	cough	NN
cord-254852-qr5gdmbc	134	26	,	,	,
cord-254852-qr5gdmbc	134	27	fever	fever	NN
cord-254852-qr5gdmbc	134	28	,	,	,
cord-254852-qr5gdmbc	134	29	and	and	CC
cord-254852-qr5gdmbc	134	30	leukocytosis	leukocytosis	NNP
cord-254852-qr5gdmbc	134	31	.	.	.
cord-254852-qr5gdmbc	135	1	32	32	CD
cord-254852-qr5gdmbc	135	2	Signs	sign	NNS
cord-254852-qr5gdmbc	135	3	and	and	CC
cord-254852-qr5gdmbc	135	4	symptoms	symptom	NNS
cord-254852-qr5gdmbc	135	5	more	more	RBR
cord-254852-qr5gdmbc	135	6	frequently	frequently	RB
cord-254852-qr5gdmbc	135	7	seen	see	VBN
cord-254852-qr5gdmbc	135	8	in	in	IN
cord-254852-qr5gdmbc	135	9	older	old	JJR
cord-254852-qr5gdmbc	135	10	adults	adult	NNS
cord-254852-qr5gdmbc	135	11	include	include	VBP
cord-254852-qr5gdmbc	135	12	falls	fall	NNS
cord-254852-qr5gdmbc	135	13	,	,	,
cord-254852-qr5gdmbc	135	14	decreased	decrease	VBD
cord-254852-qr5gdmbc	135	15	appetite	appetite	NN
cord-254852-qr5gdmbc	135	16	,	,	,
cord-254852-qr5gdmbc	135	17	or	or	CC
cord-254852-qr5gdmbc	135	18	functional	functional	JJ
cord-254852-qr5gdmbc	135	19	impairment	impairment	NN
cord-254852-qr5gdmbc	135	20	.	.	.
cord-254852-qr5gdmbc	136	1	32	32	CD
cord-254852-qr5gdmbc	137	1	A	a	DT
cord-254852-qr5gdmbc	137	2	change	change	NN
cord-254852-qr5gdmbc	137	3	in	in	IN
cord-254852-qr5gdmbc	137	4	mental	mental	JJ
cord-254852-qr5gdmbc	137	5	status	status	NN
cord-254852-qr5gdmbc	137	6	should	should	MD
cord-254852-qr5gdmbc	137	7	prompt	prompt	VB
cord-254852-qr5gdmbc	137	8	evaluation	evaluation	NN
cord-254852-qr5gdmbc	137	9	for	for	IN
cord-254852-qr5gdmbc	137	10	an	an	DT
cord-254852-qr5gdmbc	137	11	infectious	infectious	JJ
cord-254852-qr5gdmbc	137	12	cause	cause	NN
cord-254852-qr5gdmbc	137	13	.	.	.
cord-254852-qr5gdmbc	138	1	9	9	CD
cord-254852-qr5gdmbc	138	2	,	,	,
cord-254852-qr5gdmbc	138	3	11	11	CD
cord-254852-qr5gdmbc	139	1	As	as	IN
cord-254852-qr5gdmbc	139	2	with	with	IN
cord-254852-qr5gdmbc	139	3	any	any	DT
cord-254852-qr5gdmbc	139	4	adult	adult	NN
cord-254852-qr5gdmbc	139	5	,	,	,
cord-254852-qr5gdmbc	139	6	risk	risk	NN
cord-254852-qr5gdmbc	139	7	factors	factor	NNS
cord-254852-qr5gdmbc	139	8	for	for	IN
cord-254852-qr5gdmbc	139	9	atypical	atypical	JJ
cord-254852-qr5gdmbc	139	10	or	or	CC
cord-254852-qr5gdmbc	139	11	drug	drug	NN
cord-254852-qr5gdmbc	139	12	-	-	HYPH
cord-254852-qr5gdmbc	139	13	resistant	resistant	JJ
cord-254852-qr5gdmbc	139	14	pathogens	pathogen	NNS
cord-254852-qr5gdmbc	139	15	should	should	MD
cord-254852-qr5gdmbc	139	16	guide	guide	VB
cord-254852-qr5gdmbc	139	17	treatment	treatment	NN
cord-254852-qr5gdmbc	139	18	.	.	.
cord-254852-qr5gdmbc	140	1	Elderly	elderly	JJ
cord-254852-qr5gdmbc	140	2	patients	patient	NNS
cord-254852-qr5gdmbc	140	3	with	with	IN
cord-254852-qr5gdmbc	140	4	history	history	NN
cord-254852-qr5gdmbc	140	5	of	of	IN
cord-254852-qr5gdmbc	140	6	stroke	stroke	NN
cord-254852-qr5gdmbc	140	7	or	or	CC
cord-254852-qr5gdmbc	140	8	known	know	VBN
cord-254852-qr5gdmbc	140	9	dysphagia	dysphagia	NN
cord-254852-qr5gdmbc	140	10	are	be	VBP
cord-254852-qr5gdmbc	140	11	at	at	IN
cord-254852-qr5gdmbc	140	12	an	an	DT
cord-254852-qr5gdmbc	140	13	increased	increase	VBN
cord-254852-qr5gdmbc	140	14	risk	risk	NN
cord-254852-qr5gdmbc	140	15	for	for	IN
cord-254852-qr5gdmbc	140	16	aspiration	aspiration	NN
cord-254852-qr5gdmbc	140	17	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	140	18	.	.	.
cord-254852-qr5gdmbc	141	1	Residents	resident	NNS
cord-254852-qr5gdmbc	141	2	of	of	IN
cord-254852-qr5gdmbc	141	3	nursing	nursing	NN
cord-254852-qr5gdmbc	141	4	homes	home	NNS
cord-254852-qr5gdmbc	141	5	or	or	CC
cord-254852-qr5gdmbc	141	6	long	long	JJ
cord-254852-qr5gdmbc	141	7	-	-	HYPH
cord-254852-qr5gdmbc	141	8	term	term	NN
cord-254852-qr5gdmbc	141	9	care	care	NN
cord-254852-qr5gdmbc	141	10	facilities	facility	NNS
cord-254852-qr5gdmbc	141	11	are	be	VBP
cord-254852-qr5gdmbc	141	12	at	at	IN
cord-254852-qr5gdmbc	141	13	an	an	DT
cord-254852-qr5gdmbc	141	14	increased	increase	VBN
cord-254852-qr5gdmbc	141	15	risk	risk	NN
cord-254852-qr5gdmbc	141	16	for	for	IN
cord-254852-qr5gdmbc	141	17	methicillinresistant	methicillinresistant	JJ
cord-254852-qr5gdmbc	141	18	Staphylococcus	Staphylococcus	NNP
cord-254852-qr5gdmbc	141	19	aureus	aureus	NN
cord-254852-qr5gdmbc	141	20	(	(	-LRB-
cord-254852-qr5gdmbc	141	21	MRSA	MRSA	NNP
cord-254852-qr5gdmbc	141	22	)	)	-RRB-
cord-254852-qr5gdmbc	141	23	or	or	CC
cord-254852-qr5gdmbc	141	24	multidrug	multidrug	NN
cord-254852-qr5gdmbc	141	25	-	-	HYPH
cord-254852-qr5gdmbc	141	26	resistant	resistant	JJ
cord-254852-qr5gdmbc	141	27	(	(	-LRB-
cord-254852-qr5gdmbc	141	28	MDR	MDR	NNP
cord-254852-qr5gdmbc	141	29	)	)	-RRB-
cord-254852-qr5gdmbc	141	30	pathogens	pathogen	NNS
cord-254852-qr5gdmbc	141	31	.	.	.
cord-254852-qr5gdmbc	142	1	32	32	CD
cord-254852-qr5gdmbc	142	2	 	 	_SP
cord-254852-qr5gdmbc	142	3	Evaluation	Evaluation	NNP
cord-254852-qr5gdmbc	142	4	of	of	IN
cord-254852-qr5gdmbc	142	5	a	a	DT
cord-254852-qr5gdmbc	142	6	returned	return	VBN
cord-254852-qr5gdmbc	142	7	traveler	traveler	NN
cord-254852-qr5gdmbc	142	8	should	should	MD
cord-254852-qr5gdmbc	142	9	include	include	VB
cord-254852-qr5gdmbc	142	10	the	the	DT
cord-254852-qr5gdmbc	142	11	following	follow	VBG
cord-254852-qr5gdmbc	142	12	:	:	:
cord-254852-qr5gdmbc	142	13	appropriate	appropriate	JJ
cord-254852-qr5gdmbc	142	14	history	history	NN
cord-254852-qr5gdmbc	142	15	covering	cover	VBG
cord-254852-qr5gdmbc	142	16	the	the	DT
cord-254852-qr5gdmbc	142	17	travel	travel	NN
cord-254852-qr5gdmbc	142	18	itinerary	itinerary	NN
cord-254852-qr5gdmbc	142	19	(	(	-LRB-
cord-254852-qr5gdmbc	142	20	location	location	NN
cord-254852-qr5gdmbc	142	21	and	and	CC
cord-254852-qr5gdmbc	142	22	activities	activity	NNS
cord-254852-qr5gdmbc	142	23	)	)	-RRB-
cord-254852-qr5gdmbc	142	24	,	,	,
cord-254852-qr5gdmbc	142	25	onset	onset	NN
cord-254852-qr5gdmbc	142	26	of	of	IN
cord-254852-qr5gdmbc	142	27	illness	illness	NN
cord-254852-qr5gdmbc	142	28	related	relate	VBN
cord-254852-qr5gdmbc	142	29	to	to	IN
cord-254852-qr5gdmbc	142	30	travel	travel	NN
cord-254852-qr5gdmbc	142	31	,	,	,
cord-254852-qr5gdmbc	142	32	vaccines	vaccine	NNS
cord-254852-qr5gdmbc	142	33	or	or	CC
cord-254852-qr5gdmbc	142	34	prophylaxis	prophylaxis	NN
cord-254852-qr5gdmbc	142	35	received	receive	VBN
cord-254852-qr5gdmbc	142	36	,	,	,
cord-254852-qr5gdmbc	142	37	diet	diet	NN
cord-254852-qr5gdmbc	142	38	,	,	,
cord-254852-qr5gdmbc	142	39	sexual	sexual	JJ
cord-254852-qr5gdmbc	142	40	history	history	NN
cord-254852-qr5gdmbc	142	41	,	,	,
cord-254852-qr5gdmbc	142	42	and	and	CC
cord-254852-qr5gdmbc	142	43	exposure	exposure	NN
cord-254852-qr5gdmbc	142	44	to	to	IN
cord-254852-qr5gdmbc	142	45	animals	animal	NNS
cord-254852-qr5gdmbc	142	46	.	.	.
cord-254852-qr5gdmbc	143	1	30	30	CD
cord-254852-qr5gdmbc	143	2	,	,	,
cord-254852-qr5gdmbc	143	3	33	33	CD
cord-254852-qr5gdmbc	143	4	Respiratory	respiratory	JJ
cord-254852-qr5gdmbc	143	5	tract	tract	NN
cord-254852-qr5gdmbc	143	6	infections	infection	NNS
cord-254852-qr5gdmbc	143	7	are	be	VBP
cord-254852-qr5gdmbc	143	8	among	among	IN
cord-254852-qr5gdmbc	143	9	the	the	DT
cord-254852-qr5gdmbc	143	10	most	most	RBS
cord-254852-qr5gdmbc	143	11	common	common	JJ
cord-254852-qr5gdmbc	143	12	health	health	NN
cord-254852-qr5gdmbc	143	13	care	care	NN
cord-254852-qr5gdmbc	143	14	complaints	complaint	NNS
cord-254852-qr5gdmbc	143	15	affecting	affect	VBG
cord-254852-qr5gdmbc	143	16	returned	return	VBD
cord-254852-qr5gdmbc	143	17	travelers	traveler	NNS
cord-254852-qr5gdmbc	143	18	and	and	CC
cord-254852-qr5gdmbc	143	19	are	be	VBP
cord-254852-qr5gdmbc	143	20	diagnosed	diagnose	VBN
cord-254852-qr5gdmbc	143	21	in	in	IN
cord-254852-qr5gdmbc	143	22	up	up	IN
cord-254852-qr5gdmbc	143	23	to	to	TO
cord-254852-qr5gdmbc	143	24	24	24	CD
cord-254852-qr5gdmbc	143	25	%	%	NN
cord-254852-qr5gdmbc	143	26	of	of	IN
cord-254852-qr5gdmbc	143	27	returned	return	VBN
cord-254852-qr5gdmbc	143	28	patients	patient	NNS
cord-254852-qr5gdmbc	143	29	with	with	IN
cord-254852-qr5gdmbc	143	30	fever	fever	NN
cord-254852-qr5gdmbc	143	31	.	.	.
cord-254852-qr5gdmbc	144	1	30	30	CD
cord-254852-qr5gdmbc	144	2	,	,	,
cord-254852-qr5gdmbc	144	3	34	34	CD
cord-254852-qr5gdmbc	145	1	Although	although	IN
cord-254852-qr5gdmbc	145	2	upper	upper	JJ
cord-254852-qr5gdmbc	145	3	respiratory	respiratory	JJ
cord-254852-qr5gdmbc	145	4	tract	tract	NN
cord-254852-qr5gdmbc	145	5	infections	infection	NNS
cord-254852-qr5gdmbc	145	6	are	be	VBP
cord-254852-qr5gdmbc	145	7	more	more	RBR
cord-254852-qr5gdmbc	145	8	common	common	JJ
cord-254852-qr5gdmbc	145	9	,	,	,
cord-254852-qr5gdmbc	145	10	the	the	DT
cord-254852-qr5gdmbc	145	11	severity	severity	NN
cord-254852-qr5gdmbc	145	12	and	and	CC
cord-254852-qr5gdmbc	145	13	possible	possible	JJ
cord-254852-qr5gdmbc	145	14	mortality	mortality	NN
cord-254852-qr5gdmbc	145	15	associated	associate	VBN
cord-254852-qr5gdmbc	145	16	with	with	IN
cord-254852-qr5gdmbc	145	17	lower	low	JJR
cord-254852-qr5gdmbc	145	18	respiratory	respiratory	JJ
cord-254852-qr5gdmbc	145	19	tract	tract	NN
cord-254852-qr5gdmbc	145	20	infections	infection	NNS
cord-254852-qr5gdmbc	145	21	such	such	JJ
cord-254852-qr5gdmbc	145	22	as	as	IN
cord-254852-qr5gdmbc	145	23	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	145	24	make	make	VBP
cord-254852-qr5gdmbc	145	25	it	-PRON-	PRP
cord-254852-qr5gdmbc	145	26	a	a	DT
cord-254852-qr5gdmbc	145	27	must	must	MD
cord-254852-qr5gdmbc	145	28	-	-	HYPH
cord-254852-qr5gdmbc	145	29	not	not	RB
cord-254852-qr5gdmbc	145	30	-	-	HYPH
cord-254852-qr5gdmbc	145	31	miss	miss	VB
cord-254852-qr5gdmbc	145	32	diagnosis	diagnosis	NN
cord-254852-qr5gdmbc	145	33	in	in	IN
cord-254852-qr5gdmbc	145	34	the	the	DT
cord-254852-qr5gdmbc	145	35	returned	return	VBN
cord-254852-qr5gdmbc	145	36	traveler	traveler	NN
cord-254852-qr5gdmbc	145	37	.	.	.
cord-254852-qr5gdmbc	146	1	As	as	IN
cord-254852-qr5gdmbc	146	2	in	in	IN
cord-254852-qr5gdmbc	146	3	the	the	DT
cord-254852-qr5gdmbc	146	4	United	United	NNP
cord-254852-qr5gdmbc	146	5	States	States	NNP
cord-254852-qr5gdmbc	146	6	,	,	,
cord-254852-qr5gdmbc	146	7	S	S	NNP
cord-254852-qr5gdmbc	146	8	pneumoniae	pneumoniae	NN
cord-254852-qr5gdmbc	146	9	,	,	,
cord-254852-qr5gdmbc	146	10	H.	H.	NNP
cord-254852-qr5gdmbc	146	11	influenzae	influenzae	NN
cord-254852-qr5gdmbc	146	12	,	,	,
cord-254852-qr5gdmbc	146	13	and	and	CC
cord-254852-qr5gdmbc	146	14	S.	S.	NNP
cord-254852-qr5gdmbc	146	15	aureus	aureu	NNS
cord-254852-qr5gdmbc	146	16	are	be	VBP
cord-254852-qr5gdmbc	146	17	the	the	DT
cord-254852-qr5gdmbc	146	18	dominant	dominant	JJ
cord-254852-qr5gdmbc	146	19	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	146	20	isolates	isolate	VBZ
cord-254852-qr5gdmbc	146	21	in	in	IN
cord-254852-qr5gdmbc	146	22	developing	develop	VBG
cord-254852-qr5gdmbc	146	23	countries	country	NNS
cord-254852-qr5gdmbc	146	24	.	.	.
cord-254852-qr5gdmbc	147	1	It	-PRON-	PRP
cord-254852-qr5gdmbc	147	2	must	must	MD
cord-254852-qr5gdmbc	147	3	be	be	VB
cord-254852-qr5gdmbc	147	4	considered	consider	VBN
cord-254852-qr5gdmbc	147	5	that	that	IN
cord-254852-qr5gdmbc	147	6	bacterial	bacterial	JJ
cord-254852-qr5gdmbc	147	7	resistance	resistance	NN
cord-254852-qr5gdmbc	147	8	patterns	pattern	NNS
cord-254852-qr5gdmbc	147	9	from	from	IN
cord-254852-qr5gdmbc	147	10	different	different	JJ
cord-254852-qr5gdmbc	147	11	countries	country	NNS
cord-254852-qr5gdmbc	147	12	may	may	MD
cord-254852-qr5gdmbc	147	13	differ	differ	VB
cord-254852-qr5gdmbc	147	14	in	in	IN
cord-254852-qr5gdmbc	147	15	these	these	DT
cord-254852-qr5gdmbc	147	16	otherwise	otherwise	RB
cord-254852-qr5gdmbc	147	17	commonplace	commonplace	JJ
cord-254852-qr5gdmbc	147	18	bacteria	bacteria	NNS
cord-254852-qr5gdmbc	147	19	.	.	.
cord-254852-qr5gdmbc	148	1	34	34	CD
cord-254852-qr5gdmbc	148	2	Respiratory	respiratory	JJ
cord-254852-qr5gdmbc	148	3	symptoms	symptom	NNS
cord-254852-qr5gdmbc	148	4	occur	occur	VBP
cord-254852-qr5gdmbc	148	5	in	in	IN
cord-254852-qr5gdmbc	148	6	up	up	IN
cord-254852-qr5gdmbc	148	7	to	to	TO
cord-254852-qr5gdmbc	148	8	half	half	NN
cord-254852-qr5gdmbc	148	9	of	of	IN
cord-254852-qr5gdmbc	148	10	patients	patient	NNS
cord-254852-qr5gdmbc	148	11	with	with	IN
cord-254852-qr5gdmbc	148	12	malaria	malaria	NN
cord-254852-qr5gdmbc	148	13	,	,	,
cord-254852-qr5gdmbc	148	14	and	and	CC
cord-254852-qr5gdmbc	148	15	the	the	DT
cord-254852-qr5gdmbc	148	16	presentation	presentation	NN
cord-254852-qr5gdmbc	148	17	may	may	MD
cord-254852-qr5gdmbc	148	18	seem	seem	VB
cord-254852-qr5gdmbc	148	19	similar	similar	JJ
cord-254852-qr5gdmbc	148	20	to	to	IN
cord-254852-qr5gdmbc	148	21	that	that	DT
cord-254852-qr5gdmbc	148	22	of	of	IN
cord-254852-qr5gdmbc	148	23	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	148	24	.	.	.
cord-254852-qr5gdmbc	149	1	Thus	thus	RB
cord-254852-qr5gdmbc	149	2	,	,	,
cord-254852-qr5gdmbc	149	3	in	in	IN
cord-254852-qr5gdmbc	149	4	a	a	DT
cord-254852-qr5gdmbc	149	5	patient	patient	NN
cord-254852-qr5gdmbc	149	6	returning	return	VBG
cord-254852-qr5gdmbc	149	7	from	from	IN
cord-254852-qr5gdmbc	149	8	a	a	DT
cord-254852-qr5gdmbc	149	9	malariaendemic	malariaendemic	JJ
cord-254852-qr5gdmbc	149	10	area	area	NN
cord-254852-qr5gdmbc	149	11	,	,	,
cord-254852-qr5gdmbc	149	12	blood	blood	NN
cord-254852-qr5gdmbc	149	13	smear	smear	NN
cord-254852-qr5gdmbc	149	14	testing	testing	NN
cord-254852-qr5gdmbc	149	15	for	for	IN
cord-254852-qr5gdmbc	149	16	malaria	malaria	NN
cord-254852-qr5gdmbc	149	17	should	should	MD
cord-254852-qr5gdmbc	149	18	be	be	VB
cord-254852-qr5gdmbc	149	19	performed	perform	VBN
cord-254852-qr5gdmbc	149	20	.	.	.
cord-254852-qr5gdmbc	150	1	35	35	CD
cord-254852-qr5gdmbc	150	2	Increased	increase	VBN
cord-254852-qr5gdmbc	150	3	time	time	NN
cord-254852-qr5gdmbc	150	4	spent	spend	VBN
cord-254852-qr5gdmbc	150	5	at	at	IN
cord-254852-qr5gdmbc	150	6	hotels	hotel	NNS
cord-254852-qr5gdmbc	150	7	or	or	CC
cord-254852-qr5gdmbc	150	8	on	on	IN
cord-254852-qr5gdmbc	150	9	cruise	cruise	NN
cord-254852-qr5gdmbc	150	10	ships	ship	NNS
cord-254852-qr5gdmbc	150	11	in	in	IN
cord-254852-qr5gdmbc	150	12	a	a	DT
cord-254852-qr5gdmbc	150	13	patient	patient	NN
cord-254852-qr5gdmbc	150	14	presenting	present	VBG
cord-254852-qr5gdmbc	150	15	with	with	IN
cord-254852-qr5gdmbc	150	16	symptoms	symptom	NNS
cord-254852-qr5gdmbc	150	17	of	of	IN
cord-254852-qr5gdmbc	150	18	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	150	19	should	should	MD
cord-254852-qr5gdmbc	150	20	increase	increase	VB
cord-254852-qr5gdmbc	150	21	suspicion	suspicion	NN
cord-254852-qr5gdmbc	150	22	for	for	IN
cord-254852-qr5gdmbc	150	23	Legionella	Legionella	NNP
cord-254852-qr5gdmbc	150	24	.	.	.
cord-254852-qr5gdmbc	151	1	30	30	CD
cord-254852-qr5gdmbc	151	2	Travelers	traveler	NNS
cord-254852-qr5gdmbc	151	3	returning	return	VBG
cord-254852-qr5gdmbc	151	4	from	from	IN
cord-254852-qr5gdmbc	151	5	East	East	NNP
cord-254852-qr5gdmbc	151	6	and	and	CC
cord-254852-qr5gdmbc	151	7	Southeast	Southeast	NNP
cord-254852-qr5gdmbc	151	8	Asia	Asia	NNP
cord-254852-qr5gdmbc	151	9	,	,	,
cord-254852-qr5gdmbc	151	10	as	as	RB
cord-254852-qr5gdmbc	151	11	well	well	RB
cord-254852-qr5gdmbc	151	12	as	as	IN
cord-254852-qr5gdmbc	151	13	Australia	Australia	NNP
cord-254852-qr5gdmbc	151	14	,	,	,
cord-254852-qr5gdmbc	151	15	with	with	IN
cord-254852-qr5gdmbc	151	16	a	a	DT
cord-254852-qr5gdmbc	151	17	severe	severe	JJ
cord-254852-qr5gdmbc	151	18	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	151	19	may	may	MD
cord-254852-qr5gdmbc	151	20	have	have	VB
cord-254852-qr5gdmbc	151	21	been	be	VBN
cord-254852-qr5gdmbc	151	22	exposed	expose	VBN
cord-254852-qr5gdmbc	151	23	to	to	IN
cord-254852-qr5gdmbc	151	24	Burkholderia	Burkholderia	NNP
cord-254852-qr5gdmbc	151	25	pseudomallei	pseudomallei	NN
cord-254852-qr5gdmbc	151	26	-	-	,
cord-254852-qr5gdmbc	151	27	the	the	DT
cord-254852-qr5gdmbc	151	28	causative	causative	JJ
cord-254852-qr5gdmbc	151	29	agent	agent	NN
cord-254852-qr5gdmbc	151	30	of	of	IN
cord-254852-qr5gdmbc	151	31	melioidosis	melioidosis	NNP
cord-254852-qr5gdmbc	151	32	,	,	,
cord-254852-qr5gdmbc	151	33	which	which	WDT
cord-254852-qr5gdmbc	151	34	can	can	MD
cord-254852-qr5gdmbc	151	35	cause	cause	VB
cord-254852-qr5gdmbc	151	36	severe	severe	JJ
cord-254852-qr5gdmbc	151	37	necrotizing	necrotize	VBG
cord-254852-qr5gdmbc	151	38	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	151	39	and	and	CC
cord-254852-qr5gdmbc	151	40	has	have	VBZ
cord-254852-qr5gdmbc	151	41	14	14	CD
cord-254852-qr5gdmbc	151	42	%	%	NN
cord-254852-qr5gdmbc	151	43	to	to	TO
cord-254852-qr5gdmbc	151	44	40	40	CD
cord-254852-qr5gdmbc	151	45	%	%	NN
cord-254852-qr5gdmbc	151	46	mortality	mortality	NN
cord-254852-qr5gdmbc	151	47	despite	despite	IN
cord-254852-qr5gdmbc	151	48	appropriate	appropriate	JJ
cord-254852-qr5gdmbc	151	49	antibiotic	antibiotic	JJ
cord-254852-qr5gdmbc	151	50	therapy	therapy	NN
cord-254852-qr5gdmbc	151	51	.	.	.
cord-254852-qr5gdmbc	152	1	30	30	CD
cord-254852-qr5gdmbc	152	2	Severe	severe	JJ
cord-254852-qr5gdmbc	152	3	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	152	4	may	may	MD
cord-254852-qr5gdmbc	152	5	also	also	RB
cord-254852-qr5gdmbc	152	6	be	be	VB
cord-254852-qr5gdmbc	152	7	because	because	IN
cord-254852-qr5gdmbc	152	8	of	of	IN
cord-254852-qr5gdmbc	152	9	viruses	virus	NNS
cord-254852-qr5gdmbc	152	10	such	such	JJ
cord-254852-qr5gdmbc	152	11	as	as	IN
cord-254852-qr5gdmbc	152	12	influenza	influenza	NN
cord-254852-qr5gdmbc	152	13	,	,	,
cord-254852-qr5gdmbc	152	14	Middle	middle	JJ
cord-254852-qr5gdmbc	152	15	Eastern	eastern	JJ
cord-254852-qr5gdmbc	152	16	respiratory	respiratory	JJ
cord-254852-qr5gdmbc	152	17	syndrome	syndrome	NN
cord-254852-qr5gdmbc	152	18	,	,	,
cord-254852-qr5gdmbc	152	19	or	or	CC
cord-254852-qr5gdmbc	152	20	hantavirus	hantavirus	NN
cord-254852-qr5gdmbc	152	21	.	.	.
cord-254852-qr5gdmbc	153	1	A	a	DT
cord-254852-qr5gdmbc	153	2	returned	return	VBN
cord-254852-qr5gdmbc	153	3	traveler	traveler	NN
cord-254852-qr5gdmbc	153	4	with	with	IN
cord-254852-qr5gdmbc	153	5	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	153	6	with	with	IN
cord-254852-qr5gdmbc	153	7	eosinophilia	eosinophilia	NN
cord-254852-qr5gdmbc	153	8	should	should	MD
cord-254852-qr5gdmbc	153	9	raise	raise	VB
cord-254852-qr5gdmbc	153	10	suspicion	suspicion	NN
cord-254852-qr5gdmbc	153	11	for	for	IN
cord-254852-qr5gdmbc	153	12	helminth	helminth	JJ
cord-254852-qr5gdmbc	153	13	infection	infection	NN
cord-254852-qr5gdmbc	153	14	.	.	.
cord-254852-qr5gdmbc	154	1	30	30	CD
cord-254852-qr5gdmbc	154	2	,	,	,
cord-254852-qr5gdmbc	154	3	34	34	CD
cord-254852-qr5gdmbc	154	4	Histoplasma	Histoplasma	NNP
cord-254852-qr5gdmbc	154	5	capsulatum	capsulatum	NN
cord-254852-qr5gdmbc	154	6	is	be	VBZ
cord-254852-qr5gdmbc	154	7	a	a	DT
cord-254852-qr5gdmbc	154	8	dimorphic	dimorphic	JJ
cord-254852-qr5gdmbc	154	9	fungus	fungus	NN
cord-254852-qr5gdmbc	154	10	that	that	WDT
cord-254852-qr5gdmbc	154	11	is	be	VBZ
cord-254852-qr5gdmbc	154	12	relatively	relatively	RB
cord-254852-qr5gdmbc	154	13	common	common	JJ
cord-254852-qr5gdmbc	154	14	in	in	IN
cord-254852-qr5gdmbc	154	15	North	North	NNP
cord-254852-qr5gdmbc	154	16	,	,	,
cord-254852-qr5gdmbc	154	17	Central	Central	NNP
cord-254852-qr5gdmbc	154	18	,	,	,
cord-254852-qr5gdmbc	154	19	and	and	CC
cord-254852-qr5gdmbc	154	20	South	South	NNP
cord-254852-qr5gdmbc	154	21	America	America	NNP
cord-254852-qr5gdmbc	154	22	and	and	CC
cord-254852-qr5gdmbc	154	23	given	give	VBN
cord-254852-qr5gdmbc	154	24	its	-PRON-	PRP$
cord-254852-qr5gdmbc	154	25	growth	growth	NN
cord-254852-qr5gdmbc	154	26	in	in	IN
cord-254852-qr5gdmbc	154	27	bird	bird	NN
cord-254852-qr5gdmbc	154	28	and	and	CC
cord-254852-qr5gdmbc	154	29	bat	bat	NN
cord-254852-qr5gdmbc	154	30	droppings	dropping	NNS
cord-254852-qr5gdmbc	154	31	is	be	VBZ
cord-254852-qr5gdmbc	154	32	associated	associate	VBN
cord-254852-qr5gdmbc	154	33	with	with	IN
cord-254852-qr5gdmbc	154	34	activities	activity	NNS
cord-254852-qr5gdmbc	154	35	such	such	JJ
cord-254852-qr5gdmbc	154	36	as	as	IN
cord-254852-qr5gdmbc	154	37	cave	cave	NN
cord-254852-qr5gdmbc	154	38	exploration	exploration	NN
cord-254852-qr5gdmbc	154	39	.	.	.
cord-254852-qr5gdmbc	155	1	Coccidioides	Coccidioides	NNP
cord-254852-qr5gdmbc	155	2	immitis	immitis	RB
cord-254852-qr5gdmbc	155	3	is	be	VBZ
cord-254852-qr5gdmbc	155	4	endemic	endemic	JJ
cord-254852-qr5gdmbc	155	5	in	in	IN
cord-254852-qr5gdmbc	155	6	the	the	DT
cord-254852-qr5gdmbc	155	7	southwest	southwest	NN
cord-254852-qr5gdmbc	155	8	United	United	NNP
cord-254852-qr5gdmbc	155	9	States	States	NNP
cord-254852-qr5gdmbc	155	10	and	and	CC
cord-254852-qr5gdmbc	155	11	northern	northern	JJ
cord-254852-qr5gdmbc	155	12	Mexico	Mexico	NNP
cord-254852-qr5gdmbc	155	13	,	,	,
cord-254852-qr5gdmbc	155	14	as	as	RB
cord-254852-qr5gdmbc	155	15	well	well	RB
cord-254852-qr5gdmbc	155	16	as	as	IN
cord-254852-qr5gdmbc	155	17	smaller	small	JJR
cord-254852-qr5gdmbc	155	18	areas	area	NNS
cord-254852-qr5gdmbc	155	19	in	in	IN
cord-254852-qr5gdmbc	155	20	Central	Central	NNP
cord-254852-qr5gdmbc	155	21	America	America	NNP
cord-254852-qr5gdmbc	155	22	.	.	.
cord-254852-qr5gdmbc	156	1	It	-PRON-	PRP
cord-254852-qr5gdmbc	156	2	is	be	VBZ
cord-254852-qr5gdmbc	156	3	spread	spread	VBN
cord-254852-qr5gdmbc	156	4	through	through	IN
cord-254852-qr5gdmbc	156	5	inhalation	inhalation	NN
cord-254852-qr5gdmbc	156	6	of	of	IN
cord-254852-qr5gdmbc	156	7	spores	spore	NNS
cord-254852-qr5gdmbc	156	8	found	find	VBN
cord-254852-qr5gdmbc	156	9	in	in	IN
cord-254852-qr5gdmbc	156	10	the	the	DT
cord-254852-qr5gdmbc	156	11	soil	soil	NN
cord-254852-qr5gdmbc	156	12	.	.	.
cord-254852-qr5gdmbc	157	1	Fungal	fungal	JJ
cord-254852-qr5gdmbc	157	2	infection	infection	NN
cord-254852-qr5gdmbc	157	3	with	with	IN
cord-254852-qr5gdmbc	157	4	H.	H.	NNP
cord-254852-qr5gdmbc	157	5	capsulatum	capsulatum	NN
cord-254852-qr5gdmbc	157	6	and	and	CC
cord-254852-qr5gdmbc	157	7	C	C	NNP
cord-254852-qr5gdmbc	157	8	immitis	immitis	NNP
cord-254852-qr5gdmbc	157	9	are	be	VBP
cord-254852-qr5gdmbc	157	10	often	often	RB
cord-254852-qr5gdmbc	157	11	asymptomatic	asymptomatic	JJ
cord-254852-qr5gdmbc	157	12	but	but	CC
cord-254852-qr5gdmbc	157	13	may	may	MD
cord-254852-qr5gdmbc	157	14	also	also	RB
cord-254852-qr5gdmbc	157	15	present	present	VB
cord-254852-qr5gdmbc	157	16	as	as	IN
cord-254852-qr5gdmbc	157	17	a	a	DT
cord-254852-qr5gdmbc	157	18	flulike	flulike	JJ
cord-254852-qr5gdmbc	157	19	illness	illness	NN
cord-254852-qr5gdmbc	157	20	with	with	IN
cord-254852-qr5gdmbc	157	21	fever	fever	NN
cord-254852-qr5gdmbc	157	22	,	,	,
cord-254852-qr5gdmbc	157	23	malaise	malaise	NN
cord-254852-qr5gdmbc	157	24	,	,	,
cord-254852-qr5gdmbc	157	25	and	and	CC
cord-254852-qr5gdmbc	157	26	dry	dry	JJ
cord-254852-qr5gdmbc	157	27	cough	cough	NN
cord-254852-qr5gdmbc	157	28	1	1	CD
cord-254852-qr5gdmbc	157	29	to	to	TO
cord-254852-qr5gdmbc	157	30	3	3	CD
cord-254852-qr5gdmbc	157	31	weeks	week	NNS
cord-254852-qr5gdmbc	157	32	after	after	IN
cord-254852-qr5gdmbc	157	33	exposure	exposure	NN
cord-254852-qr5gdmbc	157	34	.	.	.
cord-254852-qr5gdmbc	158	1	34	34	CD
cord-254852-qr5gdmbc	158	2	,	,	,
cord-254852-qr5gdmbc	158	3	36	36	CD
cord-254852-qr5gdmbc	158	4	Ventilator	Ventilator	NNP
cord-254852-qr5gdmbc	158	5	-	-	HYPH
cord-254852-qr5gdmbc	158	6	Associated	Associated	NNP
cord-254852-qr5gdmbc	158	7	Pneumonia	Pneumonia	NNP
cord-254852-qr5gdmbc	158	8	Ventilator	Ventilator	NNP
cord-254852-qr5gdmbc	158	9	-	-	HYPH
cord-254852-qr5gdmbc	158	10	associated	associate	VBN
cord-254852-qr5gdmbc	158	11	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	158	12	(	(	-LRB-
cord-254852-qr5gdmbc	158	13	VAP	VAP	NNP
cord-254852-qr5gdmbc	158	14	)	)	-RRB-
cord-254852-qr5gdmbc	158	15	is	be	VBZ
cord-254852-qr5gdmbc	158	16	a	a	DT
cord-254852-qr5gdmbc	158	17	type	type	NN
cord-254852-qr5gdmbc	158	18	of	of	IN
cord-254852-qr5gdmbc	158	19	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	158	20	that	that	WDT
cord-254852-qr5gdmbc	158	21	occurs	occur	VBZ
cord-254852-qr5gdmbc	158	22	in	in	IN
cord-254852-qr5gdmbc	158	23	patients	patient	NNS
cord-254852-qr5gdmbc	158	24	who	who	WP
cord-254852-qr5gdmbc	158	25	have	have	VBP
cord-254852-qr5gdmbc	158	26	been	be	VBN
cord-254852-qr5gdmbc	158	27	intubated	intubate	VBN
cord-254852-qr5gdmbc	158	28	or	or	CC
cord-254852-qr5gdmbc	158	29	mechanically	mechanically	RB
cord-254852-qr5gdmbc	158	30	ventilated	ventilate	VBN
cord-254852-qr5gdmbc	158	31	by	by	IN
cord-254852-qr5gdmbc	158	32	means	mean	NNS
cord-254852-qr5gdmbc	158	33	of	of	IN
cord-254852-qr5gdmbc	158	34	a	a	DT
cord-254852-qr5gdmbc	158	35	tracheostomy	tracheostomy	NN
cord-254852-qr5gdmbc	158	36	for	for	IN
cord-254852-qr5gdmbc	158	37	at	at	RB
cord-254852-qr5gdmbc	158	38	least	least	RBS
cord-254852-qr5gdmbc	158	39	48	48	CD
cord-254852-qr5gdmbc	158	40	hours	hour	NNS
cord-254852-qr5gdmbc	158	41	.	.	.
cord-254852-qr5gdmbc	159	1	37	37	CD
cord-254852-qr5gdmbc	159	2	,	,	,
cord-254852-qr5gdmbc	159	3	38	38	CD
cord-254852-qr5gdmbc	159	4	Mechanical	mechanical	JJ
cord-254852-qr5gdmbc	159	5	ventilation	ventilation	NN
cord-254852-qr5gdmbc	159	6	modifies	modify	VBZ
cord-254852-qr5gdmbc	159	7	the	the	DT
cord-254852-qr5gdmbc	159	8	oropharyngeal	oropharyngeal	JJ
cord-254852-qr5gdmbc	159	9	and	and	CC
cord-254852-qr5gdmbc	159	10	tracheal	tracheal	JJ
cord-254852-qr5gdmbc	159	11	environment	environment	NN
cord-254852-qr5gdmbc	159	12	,	,	,
cord-254852-qr5gdmbc	159	13	allowing	allow	VBG
cord-254852-qr5gdmbc	159	14	oral	oral	JJ
cord-254852-qr5gdmbc	159	15	and	and	CC
cord-254852-qr5gdmbc	159	16	gastric	gastric	JJ
cord-254852-qr5gdmbc	159	17	secretions	secretion	NNS
cord-254852-qr5gdmbc	159	18	to	to	TO
cord-254852-qr5gdmbc	159	19	enter	enter	VB
cord-254852-qr5gdmbc	159	20	the	the	DT
cord-254852-qr5gdmbc	159	21	lower	low	JJR
cord-254852-qr5gdmbc	159	22	airways	airway	NNS
cord-254852-qr5gdmbc	159	23	.	.	.
cord-254852-qr5gdmbc	160	1	37	37	CD
cord-254852-qr5gdmbc	161	1	It	-PRON-	PRP
cord-254852-qr5gdmbc	161	2	is	be	VBZ
cord-254852-qr5gdmbc	161	3	this	this	DT
cord-254852-qr5gdmbc	161	4	change	change	NN
cord-254852-qr5gdmbc	161	5	in	in	IN
cord-254852-qr5gdmbc	161	6	lower	low	JJR
cord-254852-qr5gdmbc	161	7	respiratory	respiratory	JJ
cord-254852-qr5gdmbc	161	8	tract	tract	NN
cord-254852-qr5gdmbc	161	9	bacterial	bacterial	JJ
cord-254852-qr5gdmbc	161	10	flora	flora	NNS
cord-254852-qr5gdmbc	161	11	that	that	WDT
cord-254852-qr5gdmbc	161	12	precipitates	precipitate	VBZ
cord-254852-qr5gdmbc	161	13	the	the	DT
cord-254852-qr5gdmbc	161	14	beginning	beginning	NN
cord-254852-qr5gdmbc	161	15	of	of	IN
cord-254852-qr5gdmbc	161	16	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	161	17	.	.	.
cord-254852-qr5gdmbc	162	1	VAP	VAP	NNP
cord-254852-qr5gdmbc	162	2	is	be	VBZ
cord-254852-qr5gdmbc	162	3	common	common	JJ
cord-254852-qr5gdmbc	162	4	.	.	.
cord-254852-qr5gdmbc	163	1	Approximately	approximately	RB
cord-254852-qr5gdmbc	163	2	30	30	CD
cord-254852-qr5gdmbc	163	3	%	%	NN
cord-254852-qr5gdmbc	163	4	of	of	IN
cord-254852-qr5gdmbc	163	5	patients	patient	NNS
cord-254852-qr5gdmbc	163	6	who	who	WP
cord-254852-qr5gdmbc	163	7	receive	receive	VBP
cord-254852-qr5gdmbc	163	8	mechanical	mechanical	JJ
cord-254852-qr5gdmbc	163	9	ventilation	ventilation	NN
cord-254852-qr5gdmbc	163	10	will	will	MD
cord-254852-qr5gdmbc	163	11	develop	develop	VB
cord-254852-qr5gdmbc	163	12	VAP	VAP	NNP
cord-254852-qr5gdmbc	163	13	.	.	.
cord-254852-qr5gdmbc	164	1	39	39	CD
cord-254852-qr5gdmbc	164	2	 	 	_SP
cord-254852-qr5gdmbc	164	3	VAP	VAP	NNP
cord-254852-qr5gdmbc	164	4	should	should	MD
cord-254852-qr5gdmbc	164	5	be	be	VB
cord-254852-qr5gdmbc	164	6	suspected	suspect	VBN
cord-254852-qr5gdmbc	164	7	when	when	WRB
cord-254852-qr5gdmbc	164	8	signs	sign	NNS
cord-254852-qr5gdmbc	164	9	of	of	IN
cord-254852-qr5gdmbc	164	10	pulmonary	pulmonary	JJ
cord-254852-qr5gdmbc	164	11	infection	infection	NN
cord-254852-qr5gdmbc	164	12	(	(	-LRB-
cord-254852-qr5gdmbc	164	13	fever	fever	NN
cord-254852-qr5gdmbc	164	14	,	,	,
cord-254852-qr5gdmbc	164	15	purulent	purulent	JJ
cord-254852-qr5gdmbc	164	16	secretions	secretion	NNS
cord-254852-qr5gdmbc	164	17	,	,	,
cord-254852-qr5gdmbc	164	18	leukocytosis	leukocytosis	NNP
cord-254852-qr5gdmbc	164	19	)	)	-RRB-
cord-254852-qr5gdmbc	164	20	and	and	CC
cord-254852-qr5gdmbc	164	21	radiologic	radiologic	JJ
cord-254852-qr5gdmbc	164	22	evidence	evidence	NN
cord-254852-qr5gdmbc	164	23	(	(	-LRB-
cord-254852-qr5gdmbc	164	24	air	air	NN
cord-254852-qr5gdmbc	164	25	bronchograms	bronchograms	NNP
cord-254852-qr5gdmbc	164	26	,	,	,
cord-254852-qr5gdmbc	164	27	infiltrates	infiltrate	VBZ
cord-254852-qr5gdmbc	164	28	)	)	-RRB-
cord-254852-qr5gdmbc	164	29	are	be	VBP
cord-254852-qr5gdmbc	164	30	present	present	JJ
cord-254852-qr5gdmbc	164	31	;	;	:
cord-254852-qr5gdmbc	164	32	bacteriologic	bacteriologic	NNP
cord-254852-qr5gdmbc	164	33	confirmation	confirmation	NN
cord-254852-qr5gdmbc	164	34	usually	usually	RB
cord-254852-qr5gdmbc	164	35	follows	follow	VBZ
cord-254852-qr5gdmbc	164	36	.	.	.
cord-254852-qr5gdmbc	165	1	40	40	CD
cord-254852-qr5gdmbc	165	2	Sensitivity	sensitivity	NN
cord-254852-qr5gdmbc	165	3	and	and	CC
cord-254852-qr5gdmbc	165	4	specificity	specificity	NN
cord-254852-qr5gdmbc	165	5	of	of	IN
cord-254852-qr5gdmbc	165	6	the	the	DT
cord-254852-qr5gdmbc	165	7	diagnostic	diagnostic	JJ
cord-254852-qr5gdmbc	165	8	criteria	criterion	NNS
cord-254852-qr5gdmbc	165	9	discussed	discuss	VBD
cord-254852-qr5gdmbc	165	10	earlier	early	RBR
cord-254852-qr5gdmbc	165	11	are	be	VBP
cord-254852-qr5gdmbc	165	12	69	69	CD
cord-254852-qr5gdmbc	165	13	%	%	NN
cord-254852-qr5gdmbc	165	14	and	and	CC
cord-254852-qr5gdmbc	165	15	75	75	CD
cord-254852-qr5gdmbc	165	16	%	%	NN
cord-254852-qr5gdmbc	165	17	,	,	,
cord-254852-qr5gdmbc	165	18	respectively	respectively	RB
cord-254852-qr5gdmbc	165	19	.	.	.
cord-254852-qr5gdmbc	166	1	40	40	CD
cord-254852-qr5gdmbc	166	2	Other	other	JJ
cord-254852-qr5gdmbc	166	3	useful	useful	JJ
cord-254852-qr5gdmbc	166	4	diagnostic	diagnostic	JJ
cord-254852-qr5gdmbc	166	5	criteria	criterion	NNS
cord-254852-qr5gdmbc	166	6	have	have	VBP
cord-254852-qr5gdmbc	166	7	been	be	VBN
cord-254852-qr5gdmbc	166	8	developed	develop	VBN
cord-254852-qr5gdmbc	166	9	,	,	,
cord-254852-qr5gdmbc	166	10	incorporating	incorporate	VBG
cord-254852-qr5gdmbc	166	11	additional	additional	JJ
cord-254852-qr5gdmbc	166	12	symptoms	symptom	NNS
cord-254852-qr5gdmbc	166	13	and	and	CC
cord-254852-qr5gdmbc	166	14	similar	similar	JJ
cord-254852-qr5gdmbc	166	15	signs	sign	NNS
cord-254852-qr5gdmbc	166	16	and	and	CC
cord-254852-qr5gdmbc	166	17	laboratory	laboratory	NN
cord-254852-qr5gdmbc	166	18	/	/	SYM
cord-254852-qr5gdmbc	166	19	radiologic	radiologic	JJ
cord-254852-qr5gdmbc	166	20	criteria	criterion	NNS
cord-254852-qr5gdmbc	166	21	.	.	.
cord-254852-qr5gdmbc	167	1	41	41	CD
cord-254852-qr5gdmbc	168	1	Once	once	IN
cord-254852-qr5gdmbc	168	2	VAP	VAP	NNP
cord-254852-qr5gdmbc	168	3	is	be	VBZ
cord-254852-qr5gdmbc	168	4	clinically	clinically	RB
cord-254852-qr5gdmbc	168	5	suspected	suspect	VBN
cord-254852-qr5gdmbc	168	6	,	,	,
cord-254852-qr5gdmbc	168	7	early	early	JJ
cord-254852-qr5gdmbc	168	8	empirical	empirical	JJ
cord-254852-qr5gdmbc	168	9	treatment	treatment	NN
cord-254852-qr5gdmbc	168	10	is	be	VBZ
cord-254852-qr5gdmbc	168	11	favored	favor	VBN
cord-254852-qr5gdmbc	168	12	.	.	.
cord-254852-qr5gdmbc	169	1	Delaying	delay	VBG
cord-254852-qr5gdmbc	169	2	treatment	treatment	NN
cord-254852-qr5gdmbc	169	3	and/or	and/or	CC
cord-254852-qr5gdmbc	169	4	not	not	RB
cord-254852-qr5gdmbc	169	5	appropriately	appropriately	RB
cord-254852-qr5gdmbc	169	6	covering	cover	VBG
cord-254852-qr5gdmbc	169	7	for	for	IN
cord-254852-qr5gdmbc	169	8	the	the	DT
cord-254852-qr5gdmbc	169	9	likely	likely	JJ
cord-254852-qr5gdmbc	169	10	microbial	microbial	JJ
cord-254852-qr5gdmbc	169	11	culprit	culprit	NN
cord-254852-qr5gdmbc	169	12	are	be	VBP
cord-254852-qr5gdmbc	169	13	both	both	DT
cord-254852-qr5gdmbc	169	14	associated	associate	VBN
cord-254852-qr5gdmbc	169	15	with	with	IN
cord-254852-qr5gdmbc	169	16	higher	high	JJR
cord-254852-qr5gdmbc	169	17	morbidity	morbidity	NN
cord-254852-qr5gdmbc	169	18	and	and	CC
cord-254852-qr5gdmbc	169	19	mortality	mortality	NN
cord-254852-qr5gdmbc	169	20	.	.	.
cord-254852-qr5gdmbc	170	1	[	[	-LRB-
cord-254852-qr5gdmbc	170	2	42	42	CD
cord-254852-qr5gdmbc	170	3	]	]	-RRB-
cord-254852-qr5gdmbc	170	4	[	[	-LRB-
cord-254852-qr5gdmbc	170	5	43	43	CD
cord-254852-qr5gdmbc	170	6	]	]	-RRB-
cord-254852-qr5gdmbc	170	7	[	[	-LRB-
cord-254852-qr5gdmbc	170	8	44	44	CD
cord-254852-qr5gdmbc	170	9	]	]	-RRB-
cord-254852-qr5gdmbc	171	1	[	[	-LRB-
cord-254852-qr5gdmbc	171	2	45	45	CD
cord-254852-qr5gdmbc	171	3	]	]	-RRB-
cord-254852-qr5gdmbc	171	4	MICROBIOLOGY	MICROBIOLOGY	NNP
cord-254852-qr5gdmbc	171	5	Microbial	microbial	JJ
cord-254852-qr5gdmbc	171	6	organisms	organism	NNS
cord-254852-qr5gdmbc	171	7	associated	associate	VBN
cord-254852-qr5gdmbc	171	8	with	with	IN
cord-254852-qr5gdmbc	171	9	VAP	VAP	NNP
cord-254852-qr5gdmbc	171	10	have	have	VBP
cord-254852-qr5gdmbc	171	11	been	be	VBN
cord-254852-qr5gdmbc	171	12	identified	identify	VBN
cord-254852-qr5gdmbc	171	13	(	(	-LRB-
cord-254852-qr5gdmbc	171	14	Table	table	NN
cord-254852-qr5gdmbc	171	15	6	6	CD
cord-254852-qr5gdmbc	171	16	)	)	-RRB-
cord-254852-qr5gdmbc	171	17	.	.	.
cord-254852-qr5gdmbc	172	1	Early	early	RB
cord-254852-qr5gdmbc	172	2	versus	versus	IN
cord-254852-qr5gdmbc	172	3	late	late	JJ
cord-254852-qr5gdmbc	172	4	-	-	HYPH
cord-254852-qr5gdmbc	172	5	onset	onset	NN
cord-254852-qr5gdmbc	172	6	VAP	VAP	NNP
cord-254852-qr5gdmbc	172	7	organisms	organism	NNS
cord-254852-qr5gdmbc	172	8	have	have	VBP
cord-254852-qr5gdmbc	172	9	also	also	RB
cord-254852-qr5gdmbc	172	10	been	be	VBN
cord-254852-qr5gdmbc	172	11	documented	document	VBN
cord-254852-qr5gdmbc	172	12	.	.	.
cord-254852-qr5gdmbc	173	1	46	46	CD
cord-254852-qr5gdmbc	173	2	,	,	,
cord-254852-qr5gdmbc	173	3	47	47	CD
cord-254852-qr5gdmbc	173	4	Acinetobacter	Acinetobacter	NNP
cord-254852-qr5gdmbc	173	5	,	,	,
cord-254852-qr5gdmbc	173	6	citrobacter	citrobacter	NNP
cord-254852-qr5gdmbc	173	7	,	,	,
cord-254852-qr5gdmbc	173	8	pseudomonas	pseudomonas	NNP
cord-254852-qr5gdmbc	173	9	,	,	,
cord-254852-qr5gdmbc	173	10	and	and	CC
cord-254852-qr5gdmbc	173	11	klebsiella	klebsiella	NNP
cord-254852-qr5gdmbc	173	12	are	be	VBP
cord-254852-qr5gdmbc	173	13	the	the	DT
cord-254852-qr5gdmbc	173	14	most	most	RBS
cord-254852-qr5gdmbc	173	15	predominant	predominant	JJ
cord-254852-qr5gdmbc	173	16	late	late	JJ
cord-254852-qr5gdmbc	173	17	-	-	HYPH
cord-254852-qr5gdmbc	173	18	onset	onset	NN
cord-254852-qr5gdmbc	173	19	organisms	organism	NNS
cord-254852-qr5gdmbc	173	20	,	,	,
cord-254852-qr5gdmbc	173	21	warranting	warrant	VBG
cord-254852-qr5gdmbc	173	22	more	more	RBR
cord-254852-qr5gdmbc	173	23	aggressive	aggressive	JJ
cord-254852-qr5gdmbc	173	24	antibacterial	antibacterial	JJ
cord-254852-qr5gdmbc	173	25	intervention	intervention	NN
cord-254852-qr5gdmbc	173	26	.	.	.
cord-254852-qr5gdmbc	174	1	47	47	CD
cord-254852-qr5gdmbc	174	2	 	 	_SP
cord-254852-qr5gdmbc	174	3	Bacterial	bacterial	JJ
cord-254852-qr5gdmbc	174	4	confirmation	confirmation	NN
cord-254852-qr5gdmbc	174	5	usually	usually	RB
cord-254852-qr5gdmbc	174	6	requires	require	VBZ
cord-254852-qr5gdmbc	174	7	secretion	secretion	NN
cord-254852-qr5gdmbc	174	8	sampling	sampling	NN
cord-254852-qr5gdmbc	174	9	,	,	,
cord-254852-qr5gdmbc	174	10	either	either	CC
cord-254852-qr5gdmbc	174	11	via	via	IN
cord-254852-qr5gdmbc	174	12	bronchoscopic	bronchoscopic	NNP
cord-254852-qr5gdmbc	174	13	or	or	CC
cord-254852-qr5gdmbc	174	14	via	via	IN
cord-254852-qr5gdmbc	174	15	nonbronchoscopic	nonbronchoscopic	NNP
cord-254852-qr5gdmbc	174	16	methods	method	NNS
cord-254852-qr5gdmbc	174	17	.	.	.
cord-254852-qr5gdmbc	175	1	Obtaining	obtain	VBG
cord-254852-qr5gdmbc	175	2	pleural	pleural	JJ
cord-254852-qr5gdmbc	175	3	fluid	fluid	NN
cord-254852-qr5gdmbc	175	4	,	,	,
cord-254852-qr5gdmbc	175	5	when	when	WRB
cord-254852-qr5gdmbc	175	6	present	present	JJ
cord-254852-qr5gdmbc	175	7	,	,	,
cord-254852-qr5gdmbc	175	8	under	under	IN
cord-254852-qr5gdmbc	175	9	ultrasound	ultrasound	NN
cord-254852-qr5gdmbc	175	10	guidance	guidance	NN
cord-254852-qr5gdmbc	175	11	,	,	,
cord-254852-qr5gdmbc	175	12	is	be	VBZ
cord-254852-qr5gdmbc	175	13	recommended	recommend	VBN
cord-254852-qr5gdmbc	175	14	.	.	.
cord-254852-qr5gdmbc	176	1	37	37	CD
cord-254852-qr5gdmbc	176	2	Endotracheal	Endotracheal	NNP
cord-254852-qr5gdmbc	176	3	aspirates	aspirate	NNS
cord-254852-qr5gdmbc	176	4	are	be	VBP
cord-254852-qr5gdmbc	176	5	easily	easily	RB
cord-254852-qr5gdmbc	176	6	retrieved	retrieve	VBN
cord-254852-qr5gdmbc	176	7	but	but	CC
cord-254852-qr5gdmbc	176	8	have	have	VBP
cord-254852-qr5gdmbc	176	9	a	a	DT
cord-254852-qr5gdmbc	176	10	high	high	JJ
cord-254852-qr5gdmbc	176	11	false	false	JJ
cord-254852-qr5gdmbc	176	12	-	-	HYPH
cord-254852-qr5gdmbc	176	13	positive	positive	JJ
cord-254852-qr5gdmbc	176	14	rate	rate	NN
cord-254852-qr5gdmbc	176	15	in	in	IN
cord-254852-qr5gdmbc	176	16	ICU	ICU	NNP
cord-254852-qr5gdmbc	176	17	patients	patient	NNS
cord-254852-qr5gdmbc	176	18	due	due	JJ
cord-254852-qr5gdmbc	176	19	to	to	IN
cord-254852-qr5gdmbc	176	20	airway	airway	NN
cord-254852-qr5gdmbc	176	21	colonization	colonization	NN
cord-254852-qr5gdmbc	176	22	.	.	.
cord-254852-qr5gdmbc	177	1	37	37	CD
cord-254852-qr5gdmbc	177	2	Bronchoscopic	Bronchoscopic	NNP
cord-254852-qr5gdmbc	177	3	retrieval	retrieval	NN
cord-254852-qr5gdmbc	177	4	of	of	IN
cord-254852-qr5gdmbc	177	5	distal	distal	JJ
cord-254852-qr5gdmbc	177	6	airway	airway	NN
cord-254852-qr5gdmbc	177	7	specimens	specimen	NNS
cord-254852-qr5gdmbc	177	8	via	via	IN
cord-254852-qr5gdmbc	177	9	BAL	bal	NN
cord-254852-qr5gdmbc	177	10	or	or	CC
cord-254852-qr5gdmbc	177	11	protected	protect	VBN
cord-254852-qr5gdmbc	177	12	-	-	HYPH
cord-254852-qr5gdmbc	177	13	specimen	specimen	NN
cord-254852-qr5gdmbc	177	14	brush	brush	NN
cord-254852-qr5gdmbc	177	15	techniques	technique	NNS
cord-254852-qr5gdmbc	177	16	is	be	VBZ
cord-254852-qr5gdmbc	177	17	the	the	DT
cord-254852-qr5gdmbc	177	18	best	good	JJS
cord-254852-qr5gdmbc	177	19	,	,	,
cord-254852-qr5gdmbc	177	20	but	but	CC
cord-254852-qr5gdmbc	177	21	requires	require	VBZ
cord-254852-qr5gdmbc	177	22	a	a	DT
cord-254852-qr5gdmbc	177	23	trained	train	VBN
cord-254852-qr5gdmbc	177	24	bronchoscopist	bronchoscopist	NN
cord-254852-qr5gdmbc	177	25	.	.	.
cord-254852-qr5gdmbc	178	1	37	37	CD
cord-254852-qr5gdmbc	178	2	 	 	_SP
cord-254852-qr5gdmbc	178	3	Selection	Selection	NNP
cord-254852-qr5gdmbc	178	4	of	of	IN
cord-254852-qr5gdmbc	178	5	antibiotics	antibiotic	NNS
cord-254852-qr5gdmbc	178	6	is	be	VBZ
cord-254852-qr5gdmbc	178	7	typically	typically	RB
cord-254852-qr5gdmbc	178	8	done	do	VBN
cord-254852-qr5gdmbc	178	9	empirically	empirically	RB
cord-254852-qr5gdmbc	178	10	and	and	CC
cord-254852-qr5gdmbc	178	11	based	base	VBN
cord-254852-qr5gdmbc	178	12	on	on	IN
cord-254852-qr5gdmbc	178	13	whether	whether	IN
cord-254852-qr5gdmbc	178	14	the	the	DT
cord-254852-qr5gdmbc	178	15	patient	patient	NN
cord-254852-qr5gdmbc	178	16	has	have	VBZ
cord-254852-qr5gdmbc	178	17	any	any	DT
cord-254852-qr5gdmbc	178	18	risk	risk	NN
cord-254852-qr5gdmbc	178	19	factors	factor	NNS
cord-254852-qr5gdmbc	178	20	for	for	IN
cord-254852-qr5gdmbc	178	21	MDR	MDR	NNP
cord-254852-qr5gdmbc	178	22	pathogens	pathogen	NNS
cord-254852-qr5gdmbc	178	23	(	(	-LRB-
cord-254852-qr5gdmbc	178	24	Table	Table	NNP
cord-254852-qr5gdmbc	178	25	7	7	CD
cord-254852-qr5gdmbc	178	26	)	)	-RRB-
cord-254852-qr5gdmbc	178	27	and	and	CC
cord-254852-qr5gdmbc	178	28	whether	whether	IN
cord-254852-qr5gdmbc	178	29	onset	onset	NN
cord-254852-qr5gdmbc	178	30	of	of	IN
cord-254852-qr5gdmbc	178	31	VAP	VAP	NNP
cord-254852-qr5gdmbc	178	32	is	be	VBZ
cord-254852-qr5gdmbc	178	33	early	early	JJ
cord-254852-qr5gdmbc	178	34	(	(	-LRB-
cord-254852-qr5gdmbc	178	35	defined	define	VBN
cord-254852-qr5gdmbc	178	36	as	as	IN
cord-254852-qr5gdmbc	178	37	within	within	IN
cord-254852-qr5gdmbc	178	38	first	first	JJ
cord-254852-qr5gdmbc	178	39	4	4	CD
cord-254852-qr5gdmbc	178	40	days	day	NNS
cord-254852-qr5gdmbc	178	41	of	of	IN
cord-254852-qr5gdmbc	178	42	being	be	VBG
cord-254852-qr5gdmbc	178	43	in	in	IN
cord-254852-qr5gdmbc	178	44	the	the	DT
cord-254852-qr5gdmbc	178	45	ICU	ICU	NNP
cord-254852-qr5gdmbc	178	46	)	)	-RRB-
cord-254852-qr5gdmbc	178	47	or	or	CC
cord-254852-qr5gdmbc	178	48	late	late	JJ
cord-254852-qr5gdmbc	178	49	(	(	-LRB-
cord-254852-qr5gdmbc	178	50	5	5	CD
cord-254852-qr5gdmbc	178	51	days	day	NNS
cord-254852-qr5gdmbc	178	52	or	or	CC
cord-254852-qr5gdmbc	178	53	later	later	RB
cord-254852-qr5gdmbc	178	54	)	)	-RRB-
cord-254852-qr5gdmbc	178	55	.	.	.
cord-254852-qr5gdmbc	179	1	37	37	CD
cord-254852-qr5gdmbc	179	2	,	,	,
cord-254852-qr5gdmbc	179	3	38	38	CD
cord-254852-qr5gdmbc	179	4	,	,	,
cord-254852-qr5gdmbc	179	5	48	48	CD
cord-254852-qr5gdmbc	179	6	Evaluation	Evaluation	NNP
cord-254852-qr5gdmbc	179	7	and	and	CC
cord-254852-qr5gdmbc	179	8	Treatment	Treatment	NNP
cord-254852-qr5gdmbc	179	9	of	of	IN
cord-254852-qr5gdmbc	179	10	Pneumonia	Pneumonia	NNP
cord-254852-qr5gdmbc	179	11	Empirical	empirical	JJ
cord-254852-qr5gdmbc	179	12	treatment	treatment	NN
cord-254852-qr5gdmbc	179	13	should	should	MD
cord-254852-qr5gdmbc	179	14	also	also	RB
cord-254852-qr5gdmbc	179	15	be	be	VB
cord-254852-qr5gdmbc	179	16	determined	determine	VBN
cord-254852-qr5gdmbc	179	17	as	as	IN
cord-254852-qr5gdmbc	179	18	a	a	DT
cord-254852-qr5gdmbc	179	19	result	result	NN
cord-254852-qr5gdmbc	179	20	of	of	IN
cord-254852-qr5gdmbc	179	21	knowledge	knowledge	NN
cord-254852-qr5gdmbc	179	22	of	of	IN
cord-254852-qr5gdmbc	179	23	local	local	JJ
cord-254852-qr5gdmbc	179	24	distribution	distribution	NN
cord-254852-qr5gdmbc	179	25	of	of	IN
cord-254852-qr5gdmbc	179	26	pathogens	pathogen	NNS
cord-254852-qr5gdmbc	179	27	and	and	CC
cord-254852-qr5gdmbc	179	28	their	-PRON-	PRP$
cord-254852-qr5gdmbc	179	29	antimicrobial	antimicrobial	JJ
cord-254852-qr5gdmbc	179	30	susceptibility	susceptibility	NN
cord-254852-qr5gdmbc	179	31	patterns	pattern	NNS
cord-254852-qr5gdmbc	179	32	.	.	.
cord-254852-qr5gdmbc	180	1	49	49	CD
cord-254852-qr5gdmbc	180	2	Early	early	JJ
cord-254852-qr5gdmbc	180	3	-	-	HYPH
cord-254852-qr5gdmbc	180	4	onset	onset	NN
cord-254852-qr5gdmbc	180	5	VAP	VAP	NNP
cord-254852-qr5gdmbc	180	6	without	without	IN
cord-254852-qr5gdmbc	180	7	MDR	MDR	NNP
cord-254852-qr5gdmbc	180	8	risk	risk	NN
cord-254852-qr5gdmbc	180	9	factors	factor	NNS
cord-254852-qr5gdmbc	180	10	typically	typically	RB
cord-254852-qr5gdmbc	180	11	should	should	MD
cord-254852-qr5gdmbc	180	12	be	be	VB
cord-254852-qr5gdmbc	180	13	prescribed	prescribe	VBN
cord-254852-qr5gdmbc	180	14	one	one	CD
cord-254852-qr5gdmbc	180	15	of	of	IN
cord-254852-qr5gdmbc	180	16	the	the	DT
cord-254852-qr5gdmbc	180	17	following	follow	VBG
cord-254852-qr5gdmbc	180	18	antibiotic	antibiotic	JJ
cord-254852-qr5gdmbc	180	19	options	option	NNS
cord-254852-qr5gdmbc	180	20	37	37	CD
cord-254852-qr5gdmbc	180	21	:	:	:
cord-254852-qr5gdmbc	181	1	For	for	IN
cord-254852-qr5gdmbc	181	2	late	late	JJ
cord-254852-qr5gdmbc	181	3	-	-	HYPH
cord-254852-qr5gdmbc	181	4	onset	onset	NN
cord-254852-qr5gdmbc	181	5	and/or	and/or	CC
cord-254852-qr5gdmbc	181	6	MDR	MDR	NNP
cord-254852-qr5gdmbc	181	7	factor	factor	NN
cord-254852-qr5gdmbc	181	8	patients	patient	NNS
cord-254852-qr5gdmbc	181	9	,	,	,
cord-254852-qr5gdmbc	181	10	appropriate	appropriate	JJ
cord-254852-qr5gdmbc	181	11	antibiotic	antibiotic	JJ
cord-254852-qr5gdmbc	181	12	options	option	NNS
cord-254852-qr5gdmbc	181	13	would	would	MD
cord-254852-qr5gdmbc	181	14	include	include	VB
cord-254852-qr5gdmbc	181	15	one	one	CD
cord-254852-qr5gdmbc	181	16	or	or	CC
cord-254852-qr5gdmbc	181	17	more	more	JJR
cord-254852-qr5gdmbc	181	18	of	of	IN
cord-254852-qr5gdmbc	181	19	the	the	DT
cord-254852-qr5gdmbc	181	20	following	following	JJ
cord-254852-qr5gdmbc	181	21	37	37	CD
cord-254852-qr5gdmbc	181	22	:	:	:
cord-254852-qr5gdmbc	182	1	Antipseudomonal	Antipseudomonal	NNP
cord-254852-qr5gdmbc	182	2	cephalosporins	cephalosporin	NNS
cord-254852-qr5gdmbc	182	3	(	(	-LRB-
cord-254852-qr5gdmbc	182	4	eg	eg	RB
cord-254852-qr5gdmbc	182	5	,	,	,
cord-254852-qr5gdmbc	182	6	Cefepime	Cefepime	NNP
cord-254852-qr5gdmbc	182	7	,	,	,
cord-254852-qr5gdmbc	182	8	ceftazidime	ceftazidime	NN
cord-254852-qr5gdmbc	182	9	)	)	-RRB-
cord-254852-qr5gdmbc	183	1	Antipseudomonal	Antipseudomonal	NNP
cord-254852-qr5gdmbc	183	2	carbapenems	carbapenems	NNP
cord-254852-qr5gdmbc	183	3	(	(	-LRB-
cord-254852-qr5gdmbc	183	4	imipenem	imipenem	NNP
cord-254852-qr5gdmbc	183	5	or	or	CC
cord-254852-qr5gdmbc	183	6	meropenem	meropenem	NNP
cord-254852-qr5gdmbc	183	7	)	)	-RRB-
cord-254852-qr5gdmbc	184	1	Beta	beta	NN
cord-254852-qr5gdmbc	184	2	-	-	HYPH
cord-254852-qr5gdmbc	184	3	lactam	lactam	NNS
cord-254852-qr5gdmbc	184	4	/	/	SYM
cord-254852-qr5gdmbc	184	5	beta	beta	NN
cord-254852-qr5gdmbc	184	6	-	-	HYPH
cord-254852-qr5gdmbc	184	7	lactamase	lactamase	NN
cord-254852-qr5gdmbc	184	8	inhibitors	inhibitor	NNS
cord-254852-qr5gdmbc	184	9	(	(	-LRB-
cord-254852-qr5gdmbc	184	10	piperacillin	piperacillin	NNP
cord-254852-qr5gdmbc	184	11	-	-	HYPH
cord-254852-qr5gdmbc	184	12	tazobactam	tazobactam	NNP
cord-254852-qr5gdmbc	184	13	)	)	-RRB-
cord-254852-qr5gdmbc	184	14	with	with	IN
cord-254852-qr5gdmbc	184	15	an	an	DT
cord-254852-qr5gdmbc	184	16	antipseudomonal	antipseudomonal	JJ
cord-254852-qr5gdmbc	184	17	fluoroquinolone	fluoroquinolone	NN
cord-254852-qr5gdmbc	184	18	(	(	-LRB-
cord-254852-qr5gdmbc	184	19	ciprofloxacin	ciprofloxacin	NNP
cord-254852-qr5gdmbc	184	20	)	)	-RRB-
cord-254852-qr5gdmbc	184	21	or	or	CC
cord-254852-qr5gdmbc	184	22	aminoglycoside	aminoglycoside	JJ
cord-254852-qr5gdmbc	184	23	plus	plus	CC
cord-254852-qr5gdmbc	184	24	linezolid	linezolid	NN
cord-254852-qr5gdmbc	184	25	or	or	CC
cord-254852-qr5gdmbc	184	26	vancomycin	vancomycin	FW
cord-254852-qr5gdmbc	184	27	(	(	-LRB-
cord-254852-qr5gdmbc	184	28	if	if	IN
cord-254852-qr5gdmbc	184	29	MRSA	MRSA	NNP
cord-254852-qr5gdmbc	184	30	risk	risk	NN
cord-254852-qr5gdmbc	184	31	factors	factor	NNS
cord-254852-qr5gdmbc	184	32	are	be	VBP
cord-254852-qr5gdmbc	184	33	present	present	JJ
cord-254852-qr5gdmbc	184	34	)	)	-RRB-
cord-254852-qr5gdmbc	185	1	Telavancin	Telavancin	NNP
cord-254852-qr5gdmbc	185	2	is	be	VBZ
cord-254852-qr5gdmbc	185	3	indicated	indicate	VBN
cord-254852-qr5gdmbc	185	4	for	for	IN
cord-254852-qr5gdmbc	185	5	VAP	VAP	NNP
cord-254852-qr5gdmbc	185	6	for	for	IN
cord-254852-qr5gdmbc	185	7	susceptible	susceptible	JJ
cord-254852-qr5gdmbc	185	8	isolates	isolate	NNS
cord-254852-qr5gdmbc	185	9	of	of	IN
cord-254852-qr5gdmbc	185	10	S.	S.	NNP
cord-254852-qr5gdmbc	185	11	aureus	aureus	NN
cord-254852-qr5gdmbc	185	12	when	when	WRB
cord-254852-qr5gdmbc	185	13	other	other	JJ
cord-254852-qr5gdmbc	185	14	therapies	therapy	NNS
cord-254852-qr5gdmbc	185	15	are	be	VBP
cord-254852-qr5gdmbc	185	16	not	not	RB
cord-254852-qr5gdmbc	185	17	suitable	suitable	JJ
cord-254852-qr5gdmbc	185	18	.	.	.
cord-254852-qr5gdmbc	186	1	Dose	dose	NN
cord-254852-qr5gdmbc	186	2	and	and	CC
cord-254852-qr5gdmbc	186	3	frequency	frequency	NN
cord-254852-qr5gdmbc	186	4	of	of	IN
cord-254852-qr5gdmbc	186	5	administration	administration	NN
cord-254852-qr5gdmbc	186	6	of	of	IN
cord-254852-qr5gdmbc	186	7	the	the	DT
cord-254852-qr5gdmbc	186	8	antibiotic	antibiotic	JJ
cord-254852-qr5gdmbc	186	9	choices	choice	NNS
cord-254852-qr5gdmbc	186	10	discussed	discuss	VBN
cord-254852-qr5gdmbc	186	11	earlier	early	RBR
cord-254852-qr5gdmbc	186	12	are	be	VBP
cord-254852-qr5gdmbc	186	13	documented	document	VBN
cord-254852-qr5gdmbc	186	14	extensively	extensively	RB
cord-254852-qr5gdmbc	186	15	elsewhere	elsewhere	RB
cord-254852-qr5gdmbc	186	16	.	.	.
cord-254852-qr5gdmbc	187	1	38	38	CD
cord-254852-qr5gdmbc	187	2	Atypical	atypical	JJ
cord-254852-qr5gdmbc	187	3	antibiotic	antibiotic	JJ
cord-254852-qr5gdmbc	187	4	choices	choice	NNS
cord-254852-qr5gdmbc	187	5	,	,	,
cord-254852-qr5gdmbc	187	6	such	such	JJ
cord-254852-qr5gdmbc	187	7	as	as	IN
cord-254852-qr5gdmbc	187	8	colistin	colistin	NNP
cord-254852-qr5gdmbc	187	9	,	,	,
cord-254852-qr5gdmbc	187	10	polymyxin	polymyxin	NNP
cord-254852-qr5gdmbc	187	11	B	b	NN
cord-254852-qr5gdmbc	187	12	,	,	,
cord-254852-qr5gdmbc	187	13	telavancin	telavancin	NNS
cord-254852-qr5gdmbc	187	14	,	,	,
cord-254852-qr5gdmbc	187	15	inter	inter	NNP
cord-254852-qr5gdmbc	187	16	alia	alia	NNP
cord-254852-qr5gdmbc	187	17	,	,	,
cord-254852-qr5gdmbc	187	18	are	be	VBP
cord-254852-qr5gdmbc	187	19	rarely	rarely	RB
cord-254852-qr5gdmbc	187	20	indicated	indicate	VBN
cord-254852-qr5gdmbc	187	21	but	but	CC
cord-254852-qr5gdmbc	187	22	can	can	MD
cord-254852-qr5gdmbc	187	23	be	be	VB
cord-254852-qr5gdmbc	187	24	used	use	VBN
cord-254852-qr5gdmbc	187	25	when	when	WRB
cord-254852-qr5gdmbc	187	26	antimicrobial	antimicrobial	JJ
cord-254852-qr5gdmbc	187	27	resistance	resistance	NN
cord-254852-qr5gdmbc	187	28	warrants	warrant	NNS
cord-254852-qr5gdmbc	187	29	these	these	DT
cord-254852-qr5gdmbc	187	30	agents	agent	NNS
cord-254852-qr5gdmbc	187	31	.	.	.
cord-254852-qr5gdmbc	188	1	48	48	CD
cord-254852-qr5gdmbc	189	1	Typically	typically	RB
cord-254852-qr5gdmbc	189	2	,	,	,
cord-254852-qr5gdmbc	189	3	consultation	consultation	NN
cord-254852-qr5gdmbc	189	4	with	with	IN
cord-254852-qr5gdmbc	189	5	an	an	DT
cord-254852-qr5gdmbc	189	6	infectious	infectious	JJ
cord-254852-qr5gdmbc	189	7	disease	disease	NN
cord-254852-qr5gdmbc	189	8	physician	physician	NN
cord-254852-qr5gdmbc	189	9	or	or	CC
cord-254852-qr5gdmbc	189	10	clinical	clinical	JJ
cord-254852-qr5gdmbc	189	11	pharmacist	pharmacist	NN
cord-254852-qr5gdmbc	189	12	with	with	IN
cord-254852-qr5gdmbc	189	13	expertise	expertise	NN
cord-254852-qr5gdmbc	189	14	and	and	CC
cord-254852-qr5gdmbc	189	15	familiarity	familiarity	NN
cord-254852-qr5gdmbc	189	16	when	when	WRB
cord-254852-qr5gdmbc	189	17	using	use	VBG
cord-254852-qr5gdmbc	189	18	these	these	DT
cord-254852-qr5gdmbc	189	19	drugs	drug	NNS
cord-254852-qr5gdmbc	189	20	is	be	VBZ
cord-254852-qr5gdmbc	189	21	a	a	DT
cord-254852-qr5gdmbc	189	22	sine	sine	FW
cord-254852-qr5gdmbc	189	23	qua	qua	FW
cord-254852-qr5gdmbc	189	24	non	non	FW
cord-254852-qr5gdmbc	189	25	.	.	.
cord-254852-qr5gdmbc	190	1	48	48	CD
cord-254852-qr5gdmbc	190	2	Pediatric	Pediatric	NNP
cord-254852-qr5gdmbc	190	3	Pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	190	4	Epidemiology	Epidemiology	NNP
cord-254852-qr5gdmbc	190	5	Pneumonia	Pneumonia	NNP
cord-254852-qr5gdmbc	190	6	is	be	VBZ
cord-254852-qr5gdmbc	190	7	a	a	DT
cord-254852-qr5gdmbc	190	8	very	very	RB
cord-254852-qr5gdmbc	190	9	common	common	JJ
cord-254852-qr5gdmbc	190	10	affliction	affliction	NN
cord-254852-qr5gdmbc	190	11	of	of	IN
cord-254852-qr5gdmbc	190	12	childhood	childhood	NN
cord-254852-qr5gdmbc	190	13	.	.	.
cord-254852-qr5gdmbc	191	1	Pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	191	2	accounts	account	VBZ
cord-254852-qr5gdmbc	191	3	for	for	IN
cord-254852-qr5gdmbc	191	4	13	13	CD
cord-254852-qr5gdmbc	191	5	%	%	NN
cord-254852-qr5gdmbc	191	6	of	of	IN
cord-254852-qr5gdmbc	191	7	infectious	infectious	JJ
cord-254852-qr5gdmbc	191	8	illnesses	illness	NNS
cord-254852-qr5gdmbc	191	9	in	in	IN
cord-254852-qr5gdmbc	191	10	infants	infant	NNS
cord-254852-qr5gdmbc	191	11	and	and	CC
cord-254852-qr5gdmbc	191	12	toddlers	toddler	NNS
cord-254852-qr5gdmbc	191	13	younger	young	JJR
cord-254852-qr5gdmbc	191	14	than	than	IN
cord-254852-qr5gdmbc	191	15	2	2	CD
cord-254852-qr5gdmbc	191	16	years	year	NNS
cord-254852-qr5gdmbc	191	17	.	.	.
cord-254852-qr5gdmbc	192	1	50	50	CD
cord-254852-qr5gdmbc	192	2	Worldwide	Worldwide	NNP
cord-254852-qr5gdmbc	192	3	,	,	,
cord-254852-qr5gdmbc	192	4	approximately	approximately	RB
cord-254852-qr5gdmbc	192	5	150	150	CD
cord-254852-qr5gdmbc	192	6	million	million	CD
cord-254852-qr5gdmbc	192	7	new	new	JJ
cord-254852-qr5gdmbc	192	8	cases	case	NNS
cord-254852-qr5gdmbc	192	9	of	of	IN
cord-254852-qr5gdmbc	192	10	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	192	11	occur	occur	VBP
cord-254852-qr5gdmbc	192	12	annually	annually	RB
cord-254852-qr5gdmbc	192	13	among	among	IN
cord-254852-qr5gdmbc	192	14	children	child	NNS
cord-254852-qr5gdmbc	192	15	younger	young	JJR
cord-254852-qr5gdmbc	192	16	than	than	IN
cord-254852-qr5gdmbc	192	17	5	5	CD
cord-254852-qr5gdmbc	192	18	years	year	NNS
cord-254852-qr5gdmbc	192	19	.	.	.
cord-254852-qr5gdmbc	193	1	50	50	CD
cord-254852-qr5gdmbc	193	2	Pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	193	3	is	be	VBZ
cord-254852-qr5gdmbc	193	4	the	the	DT
cord-254852-qr5gdmbc	193	5	leading	leading	JJ
cord-254852-qr5gdmbc	193	6	cause	cause	NN
cord-254852-qr5gdmbc	193	7	of	of	IN
cord-254852-qr5gdmbc	193	8	death	death	NN
cord-254852-qr5gdmbc	193	9	in	in	IN
cord-254852-qr5gdmbc	193	10	children	child	NNS
cord-254852-qr5gdmbc	193	11	younger	young	JJR
cord-254852-qr5gdmbc	193	12	than	than	IN
cord-254852-qr5gdmbc	193	13	5	5	CD
cord-254852-qr5gdmbc	193	14	years	year	NNS
cord-254852-qr5gdmbc	193	15	in	in	IN
cord-254852-qr5gdmbc	193	16	developing	develop	VBG
cord-254852-qr5gdmbc	193	17	countries	country	NNS
cord-254852-qr5gdmbc	193	18	,	,	,
cord-254852-qr5gdmbc	193	19	accounting	account	VBG
cord-254852-qr5gdmbc	193	20	for	for	IN
cord-254852-qr5gdmbc	193	21	16	16	CD
cord-254852-qr5gdmbc	193	22	%	%	NN
cord-254852-qr5gdmbc	193	23	of	of	IN
cord-254852-qr5gdmbc	193	24	all	all	DT
cord-254852-qr5gdmbc	193	25	deaths	death	NNS
cord-254852-qr5gdmbc	193	26	of	of	IN
cord-254852-qr5gdmbc	193	27	children	child	NNS
cord-254852-qr5gdmbc	193	28	younger	young	JJR
cord-254852-qr5gdmbc	193	29	than	than	IN
cord-254852-qr5gdmbc	193	30	5	5	CD
cord-254852-qr5gdmbc	193	31	years	year	NNS
cord-254852-qr5gdmbc	193	32	and	and	CC
cord-254852-qr5gdmbc	193	33	killing	kill	VBG
cord-254852-qr5gdmbc	193	34	920,136	920,136	CD
cord-254852-qr5gdmbc	193	35	children	child	NNS
cord-254852-qr5gdmbc	193	36	in	in	IN
cord-254852-qr5gdmbc	193	37	2015	2015	CD
cord-254852-qr5gdmbc	193	38	.	.	.
cord-254852-qr5gdmbc	194	1	51	51	CD
cord-254852-qr5gdmbc	194	2	,	,	,
cord-254852-qr5gdmbc	194	3	52	52	CD
cord-254852-qr5gdmbc	194	4	Most	Most	JJS
cord-254852-qr5gdmbc	194	5	childhood	childhood	NN
cord-254852-qr5gdmbc	194	6	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	194	7	(	(	-LRB-
cord-254852-qr5gdmbc	194	8	CP	CP	NNP
cord-254852-qr5gdmbc	194	9	)	)	-RRB-
cord-254852-qr5gdmbc	194	10	can	can	MD
cord-254852-qr5gdmbc	194	11	be	be	VB
cord-254852-qr5gdmbc	194	12	treated	treat	VBN
cord-254852-qr5gdmbc	194	13	in	in	IN
cord-254852-qr5gdmbc	194	14	the	the	DT
cord-254852-qr5gdmbc	194	15	outpatient	outpatient	NN
cord-254852-qr5gdmbc	194	16	setting	setting	NN
cord-254852-qr5gdmbc	194	17	.	.	.
cord-254852-qr5gdmbc	195	1	The	the	DT
cord-254852-qr5gdmbc	195	2	rate	rate	NN
cord-254852-qr5gdmbc	195	3	of	of	IN
cord-254852-qr5gdmbc	195	4	hospitalization	hospitalization	NN
cord-254852-qr5gdmbc	195	5	for	for	IN
cord-254852-qr5gdmbc	195	6	CP	cp	NN
cord-254852-qr5gdmbc	195	7	through	through	IN
cord-254852-qr5gdmbc	195	8	age	age	NN
cord-254852-qr5gdmbc	195	9	18	18	CD
cord-254852-qr5gdmbc	195	10	years	year	NNS
cord-254852-qr5gdmbc	195	11	varies	vary	VBZ
cord-254852-qr5gdmbc	195	12	per	per	IN
cord-254852-qr5gdmbc	195	13	year	year	NN
cord-254852-qr5gdmbc	195	14	,	,	,
cord-254852-qr5gdmbc	195	15	but	but	CC
cord-254852-qr5gdmbc	195	16	in	in	IN
cord-254852-qr5gdmbc	195	17	2006	2006	CD
cord-254852-qr5gdmbc	195	18	it	-PRON-	PRP
cord-254852-qr5gdmbc	195	19	was	be	VBD
cord-254852-qr5gdmbc	195	20	201.1	201.1	CD
cord-254852-qr5gdmbc	195	21	per	per	IN
cord-254852-qr5gdmbc	195	22	100	100	CD
cord-254852-qr5gdmbc	195	23	000	000	CD
cord-254852-qr5gdmbc	195	24	.	.	.
cord-254852-qr5gdmbc	196	1	53	53	CD
cord-254852-qr5gdmbc	196	2	Infants	infant	NNS
cord-254852-qr5gdmbc	196	3	younger	young	JJR
cord-254852-qr5gdmbc	196	4	than	than	IN
cord-254852-qr5gdmbc	196	5	1	1	CD
cord-254852-qr5gdmbc	196	6	year	year	NN
cord-254852-qr5gdmbc	196	7	had	have	VBD
cord-254852-qr5gdmbc	196	8	the	the	DT
cord-254852-qr5gdmbc	196	9	highest	high	JJS
cord-254852-qr5gdmbc	196	10	rate	rate	NN
cord-254852-qr5gdmbc	196	11	of	of	IN
cord-254852-qr5gdmbc	196	12	hospitalization	hospitalization	NN
cord-254852-qr5gdmbc	196	13	(	(	-LRB-
cord-254852-qr5gdmbc	196	14	912.9	912.9	CD
cord-254852-qr5gdmbc	196	15	per	per	IN
cord-254852-qr5gdmbc	196	16	100	100	CD
cord-254852-qr5gdmbc	196	17	000	000	CD
cord-254852-qr5gdmbc	196	18	)	)	-RRB-
cord-254852-qr5gdmbc	196	19	,	,	,
cord-254852-qr5gdmbc	196	20	whereas	whereas	IN
cord-254852-qr5gdmbc	196	21	children	child	NNS
cord-254852-qr5gdmbc	196	22	aged	age	VBN
cord-254852-qr5gdmbc	196	23	13	13	CD
cord-254852-qr5gdmbc	196	24	to	to	TO
cord-254852-qr5gdmbc	196	25	18	18	CD
cord-254852-qr5gdmbc	196	26	years	year	NNS
cord-254852-qr5gdmbc	196	27	had	have	VBD
cord-254852-qr5gdmbc	196	28	the	the	DT
cord-254852-qr5gdmbc	196	29	lowest	low	JJS
cord-254852-qr5gdmbc	196	30	rate	rate	NN
cord-254852-qr5gdmbc	196	31	(	(	-LRB-
cord-254852-qr5gdmbc	196	32	62.8	62.8	CD
cord-254852-qr5gdmbc	196	33	per	per	IN
cord-254852-qr5gdmbc	196	34	100	100	CD
cord-254852-qr5gdmbc	196	35	000	000	CD
cord-254852-qr5gdmbc	196	36	)	)	-RRB-
cord-254852-qr5gdmbc	196	37	.	.	.
cord-254852-qr5gdmbc	197	1	53	53	CD
cord-254852-qr5gdmbc	197	2	 	 	_SP
cord-254852-qr5gdmbc	198	1	Signs	sign	NNS
cord-254852-qr5gdmbc	198	2	and	and	CC
cord-254852-qr5gdmbc	198	3	symptoms	symptom	NNS
cord-254852-qr5gdmbc	198	4	of	of	IN
cord-254852-qr5gdmbc	198	5	CP	CP	NNP
cord-254852-qr5gdmbc	198	6	are	be	VBP
cord-254852-qr5gdmbc	198	7	often	often	RB
cord-254852-qr5gdmbc	198	8	nonspecific	nonspecific	JJ
cord-254852-qr5gdmbc	198	9	and	and	CC
cord-254852-qr5gdmbc	198	10	depend	depend	VBP
cord-254852-qr5gdmbc	198	11	on	on	IN
cord-254852-qr5gdmbc	198	12	several	several	JJ
cord-254852-qr5gdmbc	198	13	factors	factor	NNS
cord-254852-qr5gdmbc	198	14	including	include	VBG
cord-254852-qr5gdmbc	198	15	age	age	NN
cord-254852-qr5gdmbc	198	16	,	,	,
cord-254852-qr5gdmbc	198	17	microbial	microbial	JJ
cord-254852-qr5gdmbc	198	18	organism	organism	NN
cord-254852-qr5gdmbc	198	19	,	,	,
cord-254852-qr5gdmbc	198	20	and	and	CC
cord-254852-qr5gdmbc	198	21	underlying	underlie	VBG
cord-254852-qr5gdmbc	198	22	health	health	NN
cord-254852-qr5gdmbc	198	23	of	of	IN
cord-254852-qr5gdmbc	198	24	the	the	DT
cord-254852-qr5gdmbc	198	25	patient	patient	NN
cord-254852-qr5gdmbc	198	26	.	.	.
cord-254852-qr5gdmbc	199	1	Clinical	clinical	JJ
cord-254852-qr5gdmbc	199	2	acumen	acumen	NN
cord-254852-qr5gdmbc	199	3	is	be	VBZ
cord-254852-qr5gdmbc	199	4	key	key	JJ
cord-254852-qr5gdmbc	199	5	to	to	TO
cord-254852-qr5gdmbc	199	6	successfully	successfully	RB
cord-254852-qr5gdmbc	199	7	diagnosing	diagnose	VBG
cord-254852-qr5gdmbc	199	8	CP	cp	NN
cord-254852-qr5gdmbc	199	9	.	.	.
cord-254852-qr5gdmbc	200	1	The	the	DT
cord-254852-qr5gdmbc	200	2	universal	universal	JJ
cord-254852-qr5gdmbc	200	3	symptom	symptom	NN
cord-254852-qr5gdmbc	200	4	of	of	IN
cord-254852-qr5gdmbc	200	5	CP	cp	NN
cord-254852-qr5gdmbc	200	6	is	be	VBZ
cord-254852-qr5gdmbc	200	7	cough	cough	NN
cord-254852-qr5gdmbc	200	8	.	.	.
cord-254852-qr5gdmbc	201	1	Other	other	JJ
cord-254852-qr5gdmbc	201	2	symptoms	symptom	NNS
cord-254852-qr5gdmbc	201	3	may	may	MD
cord-254852-qr5gdmbc	201	4	include	include	VB
cord-254852-qr5gdmbc	201	5	chest	chest	NN
cord-254852-qr5gdmbc	201	6	pain	pain	NN
cord-254852-qr5gdmbc	201	7	,	,	,
cord-254852-qr5gdmbc	201	8	headache	headache	NN
cord-254852-qr5gdmbc	201	9	,	,	,
cord-254852-qr5gdmbc	201	10	arthralgia	arthralgia	NNP
cord-254852-qr5gdmbc	201	11	,	,	,
cord-254852-qr5gdmbc	201	12	nausea	nausea	NN
cord-254852-qr5gdmbc	201	13	,	,	,
cord-254852-qr5gdmbc	201	14	and	and	CC
cord-254852-qr5gdmbc	201	15	abdominal	abdominal	JJ
cord-254852-qr5gdmbc	201	16	pain	pain	NN
cord-254852-qr5gdmbc	201	17	.	.	.
cord-254852-qr5gdmbc	202	1	54	54	CD
cord-254852-qr5gdmbc	203	1	Most	Most	JJS
cord-254852-qr5gdmbc	203	2	common	common	JJ
cord-254852-qr5gdmbc	203	3	signs	sign	NNS
cord-254852-qr5gdmbc	203	4	to	to	TO
cord-254852-qr5gdmbc	203	5	look	look	VB
cord-254852-qr5gdmbc	203	6	for	for	IN
cord-254852-qr5gdmbc	203	7	include	include	VBP
cord-254852-qr5gdmbc	203	8	fever	fever	NN
cord-254852-qr5gdmbc	203	9	,	,	,
cord-254852-qr5gdmbc	203	10	tachypnea	tachypnea	NNP
cord-254852-qr5gdmbc	203	11	,	,	,
cord-254852-qr5gdmbc	203	12	labored	labor	VBD
cord-254852-qr5gdmbc	203	13	breathing	breathing	NN
cord-254852-qr5gdmbc	203	14	,	,	,
cord-254852-qr5gdmbc	203	15	rhonchi	rhonchi	NNP
cord-254852-qr5gdmbc	203	16	,	,	,
cord-254852-qr5gdmbc	203	17	crackles	crackle	NNS
cord-254852-qr5gdmbc	203	18	,	,	,
cord-254852-qr5gdmbc	203	19	and	and	CC
cord-254852-qr5gdmbc	203	20	wheezing	wheezing	NN
cord-254852-qr5gdmbc	203	21	.	.	.
cord-254852-qr5gdmbc	204	1	54	54	CD
cord-254852-qr5gdmbc	205	1	Other	other	JJ
cord-254852-qr5gdmbc	205	2	physical	physical	JJ
cord-254852-qr5gdmbc	205	3	signs	sign	NNS
cord-254852-qr5gdmbc	205	4	to	to	TO
cord-254852-qr5gdmbc	205	5	identify	identify	VB
cord-254852-qr5gdmbc	205	6	include	include	VB
cord-254852-qr5gdmbc	205	7	grunting	grunt	VBG
cord-254852-qr5gdmbc	205	8	,	,	,
cord-254852-qr5gdmbc	205	9	nasal	nasal	NN
cord-254852-qr5gdmbc	205	10	flaring	flaring	NN
cord-254852-qr5gdmbc	205	11	,	,	,
cord-254852-qr5gdmbc	205	12	and	and	CC
cord-254852-qr5gdmbc	205	13	chest	chest	NN
cord-254852-qr5gdmbc	205	14	retractions	retraction	NNS
cord-254852-qr5gdmbc	205	15	because	because	IN
cord-254852-qr5gdmbc	205	16	these	these	DT
cord-254852-qr5gdmbc	205	17	increase	increase	VBP
cord-254852-qr5gdmbc	205	18	the	the	DT
cord-254852-qr5gdmbc	205	19	likelihood	likelihood	NN
cord-254852-qr5gdmbc	205	20	of	of	IN
cord-254852-qr5gdmbc	205	21	CP	cp	NN
cord-254852-qr5gdmbc	205	22	.	.	.
cord-254852-qr5gdmbc	206	1	55	55	CD
cord-254852-qr5gdmbc	206	2	Diagnostic	diagnostic	JJ
cord-254852-qr5gdmbc	206	3	testing	testing	NN
cord-254852-qr5gdmbc	206	4	is	be	VBZ
cord-254852-qr5gdmbc	206	5	usually	usually	RB
cord-254852-qr5gdmbc	206	6	performed	perform	VBN
cord-254852-qr5gdmbc	206	7	,	,	,
cord-254852-qr5gdmbc	206	8	when	when	WRB
cord-254852-qr5gdmbc	206	9	available	available	JJ
cord-254852-qr5gdmbc	206	10	,	,	,
cord-254852-qr5gdmbc	206	11	and	and	CC
cord-254852-qr5gdmbc	206	12	would	would	MD
cord-254852-qr5gdmbc	206	13	include	include	VB
cord-254852-qr5gdmbc	206	14	assessment	assessment	NN
cord-254852-qr5gdmbc	206	15	of	of	IN
cord-254852-qr5gdmbc	206	16	oxygen	oxygen	NN
cord-254852-qr5gdmbc	206	17	saturation	saturation	NN
cord-254852-qr5gdmbc	206	18	by	by	IN
cord-254852-qr5gdmbc	206	19	pulse	pulse	NN
cord-254852-qr5gdmbc	206	20	oximetry	oximetry	NN
cord-254852-qr5gdmbc	206	21	,	,	,
cord-254852-qr5gdmbc	206	22	chest	chest	NN
cord-254852-qr5gdmbc	206	23	radiograph	radiograph	NN
cord-254852-qr5gdmbc	206	24	,	,	,
cord-254852-qr5gdmbc	206	25	complete	complete	JJ
cord-254852-qr5gdmbc	206	26	blood	blood	NN
cord-254852-qr5gdmbc	206	27	cell	cell	NN
cord-254852-qr5gdmbc	206	28	count	count	NN
cord-254852-qr5gdmbc	206	29	,	,	,
cord-254852-qr5gdmbc	206	30	respiratory	respiratory	JJ
cord-254852-qr5gdmbc	206	31	microbial	microbial	JJ
cord-254852-qr5gdmbc	206	32	panel	panel	NN
cord-254852-qr5gdmbc	206	33	by	by	IN
cord-254852-qr5gdmbc	206	34	PCR	PCR	NNP
cord-254852-qr5gdmbc	206	35	,	,	,
cord-254852-qr5gdmbc	206	36	ultrasound	ultrasound	NN
cord-254852-qr5gdmbc	206	37	of	of	IN
cord-254852-qr5gdmbc	206	38	the	the	DT
cord-254852-qr5gdmbc	206	39	chest	chest	NN
cord-254852-qr5gdmbc	206	40	(	(	-LRB-
cord-254852-qr5gdmbc	206	41	when	when	WRB
cord-254852-qr5gdmbc	206	42	medically	medically	RB
cord-254852-qr5gdmbc	206	43	indicated	indicate	VBN
cord-254852-qr5gdmbc	206	44	)	)	-RRB-
cord-254852-qr5gdmbc	206	45	,	,	,
cord-254852-qr5gdmbc	206	46	and	and	CC
cord-254852-qr5gdmbc	206	47	cultures	culture	NNS
cord-254852-qr5gdmbc	206	48	.	.	.
cord-254852-qr5gdmbc	207	1	Disagreement	disagreement	NN
cord-254852-qr5gdmbc	207	2	about	about	IN
cord-254852-qr5gdmbc	207	3	whether	whether	IN
cord-254852-qr5gdmbc	207	4	blood	blood	NN
cord-254852-qr5gdmbc	207	5	cultures	culture	NNS
cord-254852-qr5gdmbc	207	6	are	be	VBP
cord-254852-qr5gdmbc	207	7	warranted	warrant	VBN
cord-254852-qr5gdmbc	207	8	exists	exist	VBZ
cord-254852-qr5gdmbc	207	9	in	in	IN
cord-254852-qr5gdmbc	207	10	the	the	DT
cord-254852-qr5gdmbc	207	11	literature	literature	NN
cord-254852-qr5gdmbc	207	12	.	.	.
cord-254852-qr5gdmbc	208	1	As	as	IN
cord-254852-qr5gdmbc	208	2	per	per	IN
cord-254852-qr5gdmbc	208	3	a	a	DT
cord-254852-qr5gdmbc	208	4	recent	recent	JJ
cord-254852-qr5gdmbc	208	5	study	study	NN
cord-254852-qr5gdmbc	208	6	,	,	,
cord-254852-qr5gdmbc	208	7	blood	blood	NN
cord-254852-qr5gdmbc	208	8	cultures	culture	NNS
cord-254852-qr5gdmbc	208	9	have	have	VBP
cord-254852-qr5gdmbc	208	10	not	not	RB
cord-254852-qr5gdmbc	208	11	been	be	VBN
cord-254852-qr5gdmbc	208	12	shown	show	VBN
cord-254852-qr5gdmbc	208	13	to	to	TO
cord-254852-qr5gdmbc	208	14	assist	assist	VB
cord-254852-qr5gdmbc	208	15	with	with	IN
cord-254852-qr5gdmbc	208	16	clinical	clinical	JJ
cord-254852-qr5gdmbc	208	17	management	management	NN
cord-254852-qr5gdmbc	208	18	in	in	IN
cord-254852-qr5gdmbc	208	19	children	child	NNS
cord-254852-qr5gdmbc	208	20	hospitalized	hospitalize	VBN
cord-254852-qr5gdmbc	208	21	with	with	IN
cord-254852-qr5gdmbc	208	22	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	208	23	.	.	.
cord-254852-qr5gdmbc	209	1	56	56	CD
cord-254852-qr5gdmbc	210	1	The	the	DT
cord-254852-qr5gdmbc	210	2	Infectious	Infectious	NNP
cord-254852-qr5gdmbc	210	3	Diseases	Diseases	NNPS
cord-254852-qr5gdmbc	210	4	Society	Society	NNP
cord-254852-qr5gdmbc	210	5	of	of	IN
cord-254852-qr5gdmbc	210	6	America	America	NNP
cord-254852-qr5gdmbc	210	7	,	,	,
cord-254852-qr5gdmbc	210	8	however	however	RB
cord-254852-qr5gdmbc	210	9	,	,	,
cord-254852-qr5gdmbc	210	10	recommends	recommend	VBZ
cord-254852-qr5gdmbc	210	11	blood	blood	NN
cord-254852-qr5gdmbc	210	12	cultures	culture	NNS
cord-254852-qr5gdmbc	210	13	for	for	IN
cord-254852-qr5gdmbc	210	14	all	all	DT
cord-254852-qr5gdmbc	210	15	hospitalized	hospitalize	VBN
cord-254852-qr5gdmbc	210	16	children	child	NNS
cord-254852-qr5gdmbc	210	17	with	with	IN
cord-254852-qr5gdmbc	210	18	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	210	19	.	.	.
cord-254852-qr5gdmbc	211	1	57	57	CD
cord-254852-qr5gdmbc	212	1	Etiologic	etiologic	JJ
cord-254852-qr5gdmbc	212	2	microbial	microbial	JJ
cord-254852-qr5gdmbc	212	3	organisms	organism	NNS
cord-254852-qr5gdmbc	212	4	differ	differ	VBP
cord-254852-qr5gdmbc	212	5	,	,	,
cord-254852-qr5gdmbc	212	6	depending	depend	VBG
cord-254852-qr5gdmbc	212	7	on	on	IN
cord-254852-qr5gdmbc	212	8	age	age	NN
cord-254852-qr5gdmbc	212	9	of	of	IN
cord-254852-qr5gdmbc	212	10	the	the	DT
cord-254852-qr5gdmbc	212	11	child	child	NN
cord-254852-qr5gdmbc	212	12	.	.	.
cord-254852-qr5gdmbc	213	1	In	in	IN
cord-254852-qr5gdmbc	213	2	infants	infant	NNS
cord-254852-qr5gdmbc	213	3	,	,	,
cord-254852-qr5gdmbc	213	4	toddlers	toddler	NNS
cord-254852-qr5gdmbc	213	5	,	,	,
cord-254852-qr5gdmbc	213	6	and	and	CC
cord-254852-qr5gdmbc	213	7	preschoolers	preschooler	NNS
cord-254852-qr5gdmbc	213	8	,	,	,
cord-254852-qr5gdmbc	213	9	viruses	virus	NNS
cord-254852-qr5gdmbc	213	10	predominate	predominate	VBP
cord-254852-qr5gdmbc	213	11	(	(	-LRB-
cord-254852-qr5gdmbc	213	12	Table	table	NN
cord-254852-qr5gdmbc	213	13	8)	8)	NN
cord-254852-qr5gdmbc	213	14	.	.	.
cord-254852-qr5gdmbc	214	1	Less	less	RBR
cord-254852-qr5gdmbc	214	2	common	common	JJ
cord-254852-qr5gdmbc	214	3	bacterial	bacterial	JJ
cord-254852-qr5gdmbc	214	4	organisms	organism	NNS
cord-254852-qr5gdmbc	214	5	may	may	MD
cord-254852-qr5gdmbc	214	6	infect	infect	VB
cord-254852-qr5gdmbc	214	7	newborns	newborn	NNS
cord-254852-qr5gdmbc	214	8	(	(	-LRB-
cord-254852-qr5gdmbc	214	9	see	see	VB
cord-254852-qr5gdmbc	214	10	Table	Table	NNP
cord-254852-qr5gdmbc	214	11	8	8	CD
cord-254852-qr5gdmbc	214	12	)	)	-RRB-
cord-254852-qr5gdmbc	214	13	.	.	.
cord-254852-qr5gdmbc	215	1	In	in	IN
cord-254852-qr5gdmbc	215	2	older	old	JJR
cord-254852-qr5gdmbc	215	3	children	child	NNS
cord-254852-qr5gdmbc	215	4	,	,	,
cord-254852-qr5gdmbc	215	5	bacteria	bacteria	NNS
cord-254852-qr5gdmbc	215	6	are	be	VBP
cord-254852-qr5gdmbc	215	7	the	the	DT
cord-254852-qr5gdmbc	215	8	more	more	RBR
cord-254852-qr5gdmbc	215	9	common	common	JJ
cord-254852-qr5gdmbc	215	10	culprit	culprit	NN
cord-254852-qr5gdmbc	215	11	(	(	-LRB-
cord-254852-qr5gdmbc	215	12	Table	table	NN
cord-254852-qr5gdmbc	215	13	9	9	CD
cord-254852-qr5gdmbc	215	14	)	)	-RRB-
cord-254852-qr5gdmbc	215	15	.	.	.
cord-254852-qr5gdmbc	216	1	Atypical	atypical	JJ
cord-254852-qr5gdmbc	216	2	organisms	organism	NNS
cord-254852-qr5gdmbc	216	3	may	may	MD
cord-254852-qr5gdmbc	216	4	be	be	VB
cord-254852-qr5gdmbc	216	5	involved	involve	VBN
cord-254852-qr5gdmbc	216	6	when	when	WRB
cord-254852-qr5gdmbc	216	7	children	child	NNS
cord-254852-qr5gdmbc	216	8	are	be	VBP
cord-254852-qr5gdmbc	216	9	immunocompromised	immunocompromised	JJ
cord-254852-qr5gdmbc	216	10	or	or	CC
cord-254852-qr5gdmbc	216	11	have	have	VBP
cord-254852-qr5gdmbc	216	12	other	other	JJ
cord-254852-qr5gdmbc	216	13	underlying	underlie	VBG
cord-254852-qr5gdmbc	216	14	comorbidities	comorbiditie	NNS
cord-254852-qr5gdmbc	216	15	(	(	-LRB-
cord-254852-qr5gdmbc	216	16	see	see	VB
cord-254852-qr5gdmbc	216	17	Table	Table	NNP
cord-254852-qr5gdmbc	216	18	9	9	CD
cord-254852-qr5gdmbc	216	19	)	)	-RRB-
cord-254852-qr5gdmbc	216	20	.	.	.
cord-254852-qr5gdmbc	217	1	In	in	IN
cord-254852-qr5gdmbc	217	2	order	order	NN
cord-254852-qr5gdmbc	217	3	to	to	TO
cord-254852-qr5gdmbc	217	4	provide	provide	VB
cord-254852-qr5gdmbc	217	5	optimal	optimal	JJ
cord-254852-qr5gdmbc	217	6	care	care	NN
cord-254852-qr5gdmbc	217	7	to	to	IN
cord-254852-qr5gdmbc	217	8	a	a	DT
cord-254852-qr5gdmbc	217	9	child	child	NN
cord-254852-qr5gdmbc	217	10	with	with	IN
cord-254852-qr5gdmbc	217	11	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	217	12	,	,	,
cord-254852-qr5gdmbc	217	13	it	-PRON-	PRP
cord-254852-qr5gdmbc	217	14	is	be	VBZ
cord-254852-qr5gdmbc	217	15	important	important	JJ
cord-254852-qr5gdmbc	217	16	to	to	TO
cord-254852-qr5gdmbc	217	17	determine	determine	VB
cord-254852-qr5gdmbc	217	18	the	the	DT
cord-254852-qr5gdmbc	217	19	severity	severity	NN
cord-254852-qr5gdmbc	217	20	of	of	IN
cord-254852-qr5gdmbc	217	21	the	the	DT
cord-254852-qr5gdmbc	217	22	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	217	23	and	and	CC
cord-254852-qr5gdmbc	217	24	the	the	DT
cord-254852-qr5gdmbc	217	25	child	child	NN
cord-254852-qr5gdmbc	217	26	's	's	POS
cord-254852-qr5gdmbc	217	27	clinical	clinical	JJ
cord-254852-qr5gdmbc	217	28	status	status	NN
cord-254852-qr5gdmbc	217	29	.	.	.
cord-254852-qr5gdmbc	218	1	Most	Most	JJS
cord-254852-qr5gdmbc	218	2	children	child	NNS
cord-254852-qr5gdmbc	218	3	will	will	MD
cord-254852-qr5gdmbc	218	4	not	not	RB
cord-254852-qr5gdmbc	218	5	require	require	VB
cord-254852-qr5gdmbc	218	6	inpatient	inpatient	JJ
cord-254852-qr5gdmbc	218	7	admission	admission	NN
cord-254852-qr5gdmbc	218	8	;	;	:
cord-254852-qr5gdmbc	218	9	criteria	criterion	NNS
cord-254852-qr5gdmbc	218	10	exist	exist	VBP
cord-254852-qr5gdmbc	218	11	to	to	TO
cord-254852-qr5gdmbc	218	12	help	help	VB
cord-254852-qr5gdmbc	218	13	stratify	stratify	VB
cord-254852-qr5gdmbc	218	14	severity	severity	NN
cord-254852-qr5gdmbc	218	15	of	of	IN
cord-254852-qr5gdmbc	218	16	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	218	17	and	and	CC
cord-254852-qr5gdmbc	218	18	necessity	necessity	NN
cord-254852-qr5gdmbc	218	19	of	of	IN
cord-254852-qr5gdmbc	218	20	hospitalization	hospitalization	NN
cord-254852-qr5gdmbc	219	1	(	(	-LRB-
cord-254852-qr5gdmbc	219	2	Box	Box	NNP
cord-254852-qr5gdmbc	219	3	1	1	CD
cord-254852-qr5gdmbc	219	4	and	and	CC
cord-254852-qr5gdmbc	219	5	2	2	CD
cord-254852-qr5gdmbc	219	6	)	)	-RRB-
cord-254852-qr5gdmbc	219	7	.	.	.
cord-254852-qr5gdmbc	220	1	Choosing	choose	VBG
cord-254852-qr5gdmbc	220	2	an	an	DT
cord-254852-qr5gdmbc	220	3	antibiotic	antibiotic	NN
cord-254852-qr5gdmbc	220	4	for	for	IN
cord-254852-qr5gdmbc	220	5	CP	CP	NNP
cord-254852-qr5gdmbc	220	6	is	be	VBZ
cord-254852-qr5gdmbc	220	7	initially	initially	RB
cord-254852-qr5gdmbc	220	8	always	always	RB
cord-254852-qr5gdmbc	220	9	an	an	DT
cord-254852-qr5gdmbc	220	10	empirical	empirical	JJ
cord-254852-qr5gdmbc	220	11	process	process	NN
cord-254852-qr5gdmbc	220	12	and	and	CC
cord-254852-qr5gdmbc	220	13	based	base	VBN
cord-254852-qr5gdmbc	220	14	on	on	IN
cord-254852-qr5gdmbc	220	15	local	local	JJ
cord-254852-qr5gdmbc	220	16	and	and	CC
cord-254852-qr5gdmbc	220	17	regional	regional	JJ
cord-254852-qr5gdmbc	220	18	microbial	microbial	JJ
cord-254852-qr5gdmbc	220	19	susceptibility	susceptibility	NN
cord-254852-qr5gdmbc	220	20	and	and	CC
cord-254852-qr5gdmbc	220	21	resistance	resistance	NN
cord-254852-qr5gdmbc	220	22	patterns	pattern	NNS
cord-254852-qr5gdmbc	220	23	,	,	,
cord-254852-qr5gdmbc	220	24	along	along	IN
cord-254852-qr5gdmbc	220	25	with	with	IN
cord-254852-qr5gdmbc	220	26	the	the	DT
cord-254852-qr5gdmbc	220	27	child	child	NN
cord-254852-qr5gdmbc	220	28	's	's	POS
cord-254852-qr5gdmbc	220	29	age	age	NN
cord-254852-qr5gdmbc	220	30	,	,	,
cord-254852-qr5gdmbc	220	31	immunization	immunization	NN
cord-254852-qr5gdmbc	220	32	status	status	NN
cord-254852-qr5gdmbc	220	33	,	,	,
cord-254852-qr5gdmbc	220	34	and	and	CC
cord-254852-qr5gdmbc	220	35	any	any	DT
cord-254852-qr5gdmbc	220	36	underlying	underlying	JJ
cord-254852-qr5gdmbc	220	37	,	,	,
cord-254852-qr5gdmbc	220	38	preexisting	preexist	VBG
cord-254852-qr5gdmbc	220	39	health	health	NN
cord-254852-qr5gdmbc	220	40	conditions	condition	NNS
cord-254852-qr5gdmbc	220	41	.	.	.
cord-254852-qr5gdmbc	221	1	50	50	CD
cord-254852-qr5gdmbc	221	2	,	,	,
cord-254852-qr5gdmbc	221	3	54	54	CD
cord-254852-qr5gdmbc	221	4	,	,	,
cord-254852-qr5gdmbc	221	5	58	58	CD
cord-254852-qr5gdmbc	221	6	,	,	,
cord-254852-qr5gdmbc	221	7	59	59	CD
cord-254852-qr5gdmbc	222	1	Most	Most	JJS
cord-254852-qr5gdmbc	222	2	children	child	NNS
cord-254852-qr5gdmbc	222	3	can	can	MD
cord-254852-qr5gdmbc	222	4	be	be	VB
cord-254852-qr5gdmbc	222	5	treated	treat	VBN
cord-254852-qr5gdmbc	222	6	with	with	IN
cord-254852-qr5gdmbc	222	7	oral	oral	JJ
cord-254852-qr5gdmbc	222	8	antibiotics	antibiotic	NNS
cord-254852-qr5gdmbc	222	9	in	in	IN
cord-254852-qr5gdmbc	222	10	the	the	DT
cord-254852-qr5gdmbc	222	11	outpatient	outpatient	NN
cord-254852-qr5gdmbc	222	12	setting	setting	NN
cord-254852-qr5gdmbc	222	13	.	.	.
cord-254852-qr5gdmbc	223	1	First	first	JJ
cord-254852-qr5gdmbc	223	2	-	-	HYPH
cord-254852-qr5gdmbc	223	3	line	line	NN
cord-254852-qr5gdmbc	223	4	and	and	CC
cord-254852-qr5gdmbc	223	5	preferred	preferred	JJ
cord-254852-qr5gdmbc	223	6	agent	agent	NN
cord-254852-qr5gdmbc	223	7	is	be	VBZ
cord-254852-qr5gdmbc	223	8	still	still	RB
cord-254852-qr5gdmbc	223	9	amoxicillin	amoxicillin	JJ
cord-254852-qr5gdmbc	223	10	.	.	.
cord-254852-qr5gdmbc	224	1	50	50	CD
cord-254852-qr5gdmbc	224	2	,	,	,
cord-254852-qr5gdmbc	224	3	54	54	CD
cord-254852-qr5gdmbc	224	4	,	,	,
cord-254852-qr5gdmbc	224	5	57	57	CD
cord-254852-qr5gdmbc	224	6	,	,	,
cord-254852-qr5gdmbc	224	7	59	59	CD
cord-254852-qr5gdmbc	224	8	Alternative	alternative	JJ
cord-254852-qr5gdmbc	224	9	agents	agent	NNS
cord-254852-qr5gdmbc	224	10	are	be	VBP
cord-254852-qr5gdmbc	224	11	cephalosporins	cephalosporin	NNS
cord-254852-qr5gdmbc	224	12	and	and	CC
cord-254852-qr5gdmbc	224	13	macrolide	macrolide	JJ
cord-254852-qr5gdmbc	224	14	antibiotics	antibiotic	NNS
cord-254852-qr5gdmbc	224	15	;	;	:
cord-254852-qr5gdmbc	224	16	however	however	RB
cord-254852-qr5gdmbc	224	17	,	,	,
cord-254852-qr5gdmbc	224	18	increasing	increase	VBG
cord-254852-qr5gdmbc	224	19	resistance	resistance	NN
cord-254852-qr5gdmbc	224	20	to	to	IN
cord-254852-qr5gdmbc	224	21	penicillin	penicillin	NN
cord-254852-qr5gdmbc	224	22	derivatives	derivative	NNS
cord-254852-qr5gdmbc	224	23	and	and	CC
cord-254852-qr5gdmbc	224	24	macrolides	macrolide	NNS
cord-254852-qr5gdmbc	224	25	should	should	MD
cord-254852-qr5gdmbc	224	26	be	be	VB
cord-254852-qr5gdmbc	224	27	noted	note	VBN
cord-254852-qr5gdmbc	224	28	60	60	CD
cord-254852-qr5gdmbc	225	1	(	(	-LRB-
cord-254852-qr5gdmbc	225	2	Children	child	NNS
cord-254852-qr5gdmbc	225	3	and	and	CC
cord-254852-qr5gdmbc	225	4	infants	infant	NNS
cord-254852-qr5gdmbc	225	5	for	for	IN
cord-254852-qr5gdmbc	225	6	whom	whom	WP
cord-254852-qr5gdmbc	225	7	there	there	EX
cord-254852-qr5gdmbc	225	8	is	be	VBZ
cord-254852-qr5gdmbc	225	9	concern	concern	NN
cord-254852-qr5gdmbc	225	10	about	about	IN
cord-254852-qr5gdmbc	225	11	careful	careful	JJ
cord-254852-qr5gdmbc	225	12	observation	observation	NN
cord-254852-qr5gdmbc	225	13	at	at	IN
cord-254852-qr5gdmbc	225	14	home	home	NN
cord-254852-qr5gdmbc	225	15	or	or	CC
cord-254852-qr5gdmbc	225	16	who	who	WP
cord-254852-qr5gdmbc	225	17	are	be	VBP
cord-254852-qr5gdmbc	225	18	unable	unable	JJ
cord-254852-qr5gdmbc	225	19	to	to	TO
cord-254852-qr5gdmbc	225	20	comply	comply	VB
cord-254852-qr5gdmbc	225	21	with	with	IN
cord-254852-qr5gdmbc	225	22	therapy	therapy	NN
cord-254852-qr5gdmbc	225	23	or	or	CC
cord-254852-qr5gdmbc	225	24	unable	unable	JJ
cord-254852-qr5gdmbc	225	25	to	to	TO
cord-254852-qr5gdmbc	225	26	be	be	VB
cord-254852-qr5gdmbc	225	27	followed	follow	VBN
cord-254852-qr5gdmbc	225	28	-	-	HYPH
cord-254852-qr5gdmbc	225	29	up	up	RP
cord-254852-qr5gdmbc	225	30	Children	child	NNS
cord-254852-qr5gdmbc	225	31	and	and	CC
cord-254852-qr5gdmbc	225	32	infants	infant	NNS
cord-254852-qr5gdmbc	225	33	who	who	WP
cord-254852-qr5gdmbc	225	34	have	have	VBP
cord-254852-qr5gdmbc	225	35	respiratory	respiratory	JJ
cord-254852-qr5gdmbc	225	36	distress	distress	NN
cord-254852-qr5gdmbc	225	37	and	and	CC
cord-254852-qr5gdmbc	225	38	hypoxemia	hypoxemia	NN
cord-254852-qr5gdmbc	225	39	(	(	-LRB-
cord-254852-qr5gdmbc	225	40	oxygen	oxygen	NN
cord-254852-qr5gdmbc	225	41	saturation	saturation	NN
cord-254852-qr5gdmbc	225	42	<	<	XX
cord-254852-qr5gdmbc	225	43	92	92	CD
cord-254852-qr5gdmbc	225	44	%	%	NN
cord-254852-qr5gdmbc	225	45	)	)	-RRB-
cord-254852-qr5gdmbc	226	1	(	(	-LRB-
cord-254852-qr5gdmbc	226	2	see	see	VB
cord-254852-qr5gdmbc	226	3	Table	Table	NNP
cord-254852-qr5gdmbc	226	4	2	2	CD
cord-254852-qr5gdmbc	226	5	)	)	-RRB-
cord-254852-qr5gdmbc	226	6	Children	child	NNS
cord-254852-qr5gdmbc	226	7	and	and	CC
cord-254852-qr5gdmbc	226	8	infants	infant	NNS
cord-254852-qr5gdmbc	226	9	with	with	IN
cord-254852-qr5gdmbc	226	10	comorbidities	comorbiditie	NNS
cord-254852-qr5gdmbc	226	11	(	(	-LRB-
cord-254852-qr5gdmbc	226	12	eg	eg	IN
cord-254852-qr5gdmbc	226	13	,	,	,
cord-254852-qr5gdmbc	226	14	asthma	asthma	NN
cord-254852-qr5gdmbc	226	15	,	,	,
cord-254852-qr5gdmbc	226	16	cystic	cystic	JJ
cord-254852-qr5gdmbc	226	17	fibrosis	fibrosis	NN
cord-254852-qr5gdmbc	226	18	,	,	,
cord-254852-qr5gdmbc	226	19	congenital	congenital	JJ
cord-254852-qr5gdmbc	226	20	heart	heart	NN
cord-254852-qr5gdmbc	226	21	disease	disease	NN
cord-254852-qr5gdmbc	226	22	,	,	,
cord-254852-qr5gdmbc	226	23	diabetes	diabetes	NN
cord-254852-qr5gdmbc	226	24	mellitus	mellitus	NN
cord-254852-qr5gdmbc	226	25	,	,	,
cord-254852-qr5gdmbc	226	26	neuromuscular	neuromuscular	JJ
cord-254852-qr5gdmbc	226	27	disease	disease	NN
cord-254852-qr5gdmbc	226	28	)	)	-RRB-
cord-254852-qr5gdmbc	227	1	Poor	poor	JJ
cord-254852-qr5gdmbc	227	2	feeding	feeding	NN
cord-254852-qr5gdmbc	227	3	and/or	and/or	CC
cord-254852-qr5gdmbc	228	1	signs	sign	NNS
cord-254852-qr5gdmbc	228	2	of	of	IN
cord-254852-qr5gdmbc	228	3	dehydration	dehydration	NN
cord-254852-qr5gdmbc	228	4	have	have	VBP
cord-254852-qr5gdmbc	228	5	been	be	VBN
cord-254852-qr5gdmbc	228	6	linked	link	VBN
cord-254852-qr5gdmbc	228	7	to	to	IN
cord-254852-qr5gdmbc	228	8	development	development	NN
cord-254852-qr5gdmbc	228	9	of	of	IN
cord-254852-qr5gdmbc	228	10	childhood	childhood	NN
cord-254852-qr5gdmbc	228	11	tendonitis	tendonitis	NN
cord-254852-qr5gdmbc	228	12	/	/	,
cord-254852-qr5gdmbc	228	13	tendinopathy	tendinopathy	NN
cord-254852-qr5gdmbc	228	14	,	,	,
cord-254852-qr5gdmbc	228	15	yet	yet	RB
cord-254852-qr5gdmbc	229	1	recent	recent	JJ
cord-254852-qr5gdmbc	229	2	literature	literature	NN
cord-254852-qr5gdmbc	229	3	indicates	indicate	VBZ
cord-254852-qr5gdmbc	229	4	these	these	DT
cord-254852-qr5gdmbc	229	5	disabling	disable	VBG
cord-254852-qr5gdmbc	229	6	side	side	NN
cord-254852-qr5gdmbc	229	7	effects	effect	NNS
cord-254852-qr5gdmbc	229	8	are	be	VBP
cord-254852-qr5gdmbc	229	9	rare	rare	JJ
cord-254852-qr5gdmbc	229	10	.	.	.
cord-254852-qr5gdmbc	230	1	61,62	61,62	CD
cord-254852-qr5gdmbc	230	2	Inpatient	Inpatient	NNP
cord-254852-qr5gdmbc	230	3	treatment	treatment	NN
cord-254852-qr5gdmbc	230	4	guidelines	guideline	NNS
cord-254852-qr5gdmbc	230	5	have	have	VBP
cord-254852-qr5gdmbc	230	6	also	also	RB
cord-254852-qr5gdmbc	230	7	been	be	VBN
cord-254852-qr5gdmbc	230	8	established	establish	VBN
cord-254852-qr5gdmbc	230	9	(	(	-LRB-
cord-254852-qr5gdmbc	230	10	Table	table	NN
cord-254852-qr5gdmbc	230	11	11	11	CD
cord-254852-qr5gdmbc	230	12	)	)	-RRB-
cord-254852-qr5gdmbc	230	13	.	.	.
cord-254852-qr5gdmbc	231	1	Isolation	isolation	NN
cord-254852-qr5gdmbc	231	2	of	of	IN
cord-254852-qr5gdmbc	231	3	the	the	DT
cord-254852-qr5gdmbc	231	4	particular	particular	JJ
cord-254852-qr5gdmbc	231	5	microbial	microbial	JJ
cord-254852-qr5gdmbc	231	6	organism	organism	NN
cord-254852-qr5gdmbc	231	7	is	be	VBZ
cord-254852-qr5gdmbc	231	8	ideal	ideal	JJ
cord-254852-qr5gdmbc	231	9	,	,	,
cord-254852-qr5gdmbc	231	10	but	but	CC
cord-254852-qr5gdmbc	231	11	not	not	RB
cord-254852-qr5gdmbc	231	12	required	require	VBN
cord-254852-qr5gdmbc	231	13	,	,	,
cord-254852-qr5gdmbc	231	14	in	in	IN
cord-254852-qr5gdmbc	231	15	order	order	NN
cord-254852-qr5gdmbc	231	16	to	to	TO
cord-254852-qr5gdmbc	231	17	determine	determine	VB
cord-254852-qr5gdmbc	231	18	duration	duration	NN
cord-254852-qr5gdmbc	231	19	of	of	IN
cord-254852-qr5gdmbc	231	20	therapy	therapy	NN
cord-254852-qr5gdmbc	231	21	.	.	.
cord-254852-qr5gdmbc	232	1	Uncomplicated	uncomplicated	JJ
cord-254852-qr5gdmbc	232	2	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	232	3	treatment	treatment	NN
cord-254852-qr5gdmbc	232	4	in	in	IN
cord-254852-qr5gdmbc	232	5	the	the	DT
cord-254852-qr5gdmbc	232	6	outpatient	outpatient	NN
cord-254852-qr5gdmbc	232	7	setting	setting	NN
cord-254852-qr5gdmbc	232	8	usually	usually	RB
cord-254852-qr5gdmbc	232	9	should	should	MD
cord-254852-qr5gdmbc	232	10	last	last	VB
cord-254852-qr5gdmbc	232	11	5	5	CD
cord-254852-qr5gdmbc	232	12	to	to	TO
cord-254852-qr5gdmbc	232	13	10	10	CD
cord-254852-qr5gdmbc	232	14	days	day	NNS
cord-254852-qr5gdmbc	232	15	.	.	.
cord-254852-qr5gdmbc	233	1	54	54	CD
cord-254852-qr5gdmbc	234	1	Inpatient	inpatient	JJ
cord-254852-qr5gdmbc	234	2	admission	admission	NN
cord-254852-qr5gdmbc	234	3	for	for	IN
cord-254852-qr5gdmbc	234	4	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	234	5	warrants	warrant	NNS
cord-254852-qr5gdmbc	234	6	longer	long	JJR
cord-254852-qr5gdmbc	234	7	duration	duration	NN
cord-254852-qr5gdmbc	234	8	of	of	IN
cord-254852-qr5gdmbc	234	9	antibiotic	antibiotic	JJ
cord-254852-qr5gdmbc	234	10	therapy	therapy	NN
cord-254852-qr5gdmbc	234	11	,	,	,
cord-254852-qr5gdmbc	234	12	typically	typically	RB
cord-254852-qr5gdmbc	234	13	7	7	CD
cord-254852-qr5gdmbc	234	14	to	to	TO
cord-254852-qr5gdmbc	234	15	10	10	CD
cord-254852-qr5gdmbc	234	16	days	day	NNS
cord-254852-qr5gdmbc	234	17	of	of	IN
cord-254852-qr5gdmbc	234	18	combined	combine	VBN
cord-254852-qr5gdmbc	234	19	parenteral	parenteral	JJ
cord-254852-qr5gdmbc	234	20	and	and	CC
cord-254852-qr5gdmbc	234	21	oral	oral	JJ
cord-254852-qr5gdmbc	234	22	therapy	therapy	NN
cord-254852-qr5gdmbc	234	23	or	or	CC
cord-254852-qr5gdmbc	234	24	at	at	IN
cord-254852-qr5gdmbc	234	25	least	least	JJS
cord-254852-qr5gdmbc	234	26	1	1	CD
cord-254852-qr5gdmbc	234	27	week	week	NN
cord-254852-qr5gdmbc	234	28	after	after	IN
cord-254852-qr5gdmbc	234	29	becoming	become	VBG
cord-254852-qr5gdmbc	234	30	afebrile	afebrile	NNP
cord-254852-qr5gdmbc	234	31	.	.	.
cord-254852-qr5gdmbc	235	1	58	58	CD
cord-254852-qr5gdmbc	235	2	Complicated	complicated	JJ
cord-254852-qr5gdmbc	235	3	cases	case	NNS
cord-254852-qr5gdmbc	235	4	of	of	IN
cord-254852-qr5gdmbc	235	5	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	235	6	will	will	MD
cord-254852-qr5gdmbc	235	7	require	require	VB
cord-254852-qr5gdmbc	235	8	a	a	DT
cord-254852-qr5gdmbc	235	9	minimum	minimum	NN
cord-254852-qr5gdmbc	235	10	of	of	IN
cord-254852-qr5gdmbc	235	11	2	2	CD
cord-254852-qr5gdmbc	235	12	weeks	week	NNS
cord-254852-qr5gdmbc	235	13	of	of	IN
cord-254852-qr5gdmbc	235	14	therapy	therapy	NN
cord-254852-qr5gdmbc	235	15	once	once	IN
cord-254852-qr5gdmbc	235	16	lack	lack	NN
cord-254852-qr5gdmbc	235	17	of	of	IN
cord-254852-qr5gdmbc	235	18	fever	fever	NN
cord-254852-qr5gdmbc	235	19	is	be	VBZ
cord-254852-qr5gdmbc	235	20	confirmed	confirm	VBN
cord-254852-qr5gdmbc	235	21	and	and	CC
cord-254852-qr5gdmbc	235	22	may	may	MD
cord-254852-qr5gdmbc	235	23	be	be	VB
cord-254852-qr5gdmbc	235	24	extended	extend	VBN
cord-254852-qr5gdmbc	235	25	for	for	IN
cord-254852-qr5gdmbc	235	26	up	up	IN
cord-254852-qr5gdmbc	235	27	to	to	TO
cord-254852-qr5gdmbc	235	28	4	4	CD
cord-254852-qr5gdmbc	235	29	weeks	week	NNS
cord-254852-qr5gdmbc	235	30	.	.	.
cord-254852-qr5gdmbc	236	1	58	58	CD
cord-254852-qr5gdmbc	237	1	The	the	DT
cord-254852-qr5gdmbc	237	2	switch	switch	NN
cord-254852-qr5gdmbc	237	3	from	from	IN
cord-254852-qr5gdmbc	237	4	parenteral	parenteral	JJ
cord-254852-qr5gdmbc	237	5	to	to	IN
cord-254852-qr5gdmbc	237	6	oral	oral	JJ
cord-254852-qr5gdmbc	237	7	therapy	therapy	NN
cord-254852-qr5gdmbc	237	8	may	may	MD
cord-254852-qr5gdmbc	237	9	occur	occur	VB
cord-254852-qr5gdmbc	237	10	after	after	IN
cord-254852-qr5gdmbc	237	11	24	24	CD
cord-254852-qr5gdmbc	237	12	to	to	TO
cord-254852-qr5gdmbc	237	13	48	48	CD
cord-254852-qr5gdmbc	237	14	hours	hour	NNS
cord-254852-qr5gdmbc	237	15	of	of	IN
cord-254852-qr5gdmbc	237	16	documented	documented	JJ
cord-254852-qr5gdmbc	237	17	lack	lack	NN
cord-254852-qr5gdmbc	237	18	of	of	IN
cord-254852-qr5gdmbc	237	19	fever	fever	NN
cord-254852-qr5gdmbc	237	20	but	but	CC
cord-254852-qr5gdmbc	237	21	is	be	VBZ
cord-254852-qr5gdmbc	237	22	not	not	RB
cord-254852-qr5gdmbc	237	23	always	always	RB
cord-254852-qr5gdmbc	237	24	practical	practical	JJ
cord-254852-qr5gdmbc	237	25	in	in	IN
cord-254852-qr5gdmbc	237	26	complicated	complicated	JJ
cord-254852-qr5gdmbc	238	1	and/	and/	NNP
cord-254852-qr5gdmbc	238	2	or	or	CC
cord-254852-qr5gdmbc	238	3	ICU	ICU	NNP
cord-254852-qr5gdmbc	238	4	-	-	HYPH
cord-254852-qr5gdmbc	238	5	admitted	admit	VBN
cord-254852-qr5gdmbc	238	6	patients	patient	NNS
cord-254852-qr5gdmbc	238	7	.	.	.
cord-254852-qr5gdmbc	239	1	63	63	CD
cord-254852-qr5gdmbc	239	2	 	 	_SP
cord-254852-qr5gdmbc	240	1	Pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	240	2	is	be	VBZ
cord-254852-qr5gdmbc	240	3	a	a	DT
cord-254852-qr5gdmbc	240	4	common	common	JJ
cord-254852-qr5gdmbc	240	5	,	,	,
cord-254852-qr5gdmbc	240	6	well	well	RB
cord-254852-qr5gdmbc	240	7	-	-	HYPH
cord-254852-qr5gdmbc	240	8	recognized	recognize	VBN
cord-254852-qr5gdmbc	240	9	respiratory	respiratory	JJ
cord-254852-qr5gdmbc	240	10	infection	infection	NN
cord-254852-qr5gdmbc	240	11	seen	see	VBN
cord-254852-qr5gdmbc	240	12	in	in	IN
cord-254852-qr5gdmbc	240	13	primary	primary	JJ
cord-254852-qr5gdmbc	240	14	care	care	NN
cord-254852-qr5gdmbc	240	15	settings	setting	NNS
cord-254852-qr5gdmbc	240	16	.	.	.
cord-254852-qr5gdmbc	241	1	Triage	triage	NN
cord-254852-qr5gdmbc	241	2	of	of	IN
cord-254852-qr5gdmbc	241	3	the	the	DT
cord-254852-qr5gdmbc	241	4	usual	usual	JJ
cord-254852-qr5gdmbc	241	5	presenting	present	VBG
cord-254852-qr5gdmbc	241	6	symptoms	symptom	NNS
cord-254852-qr5gdmbc	241	7	will	will	MD
cord-254852-qr5gdmbc	241	8	generally	generally	RB
cord-254852-qr5gdmbc	241	9	set	set	VB
cord-254852-qr5gdmbc	241	10	into	into	IN
cord-254852-qr5gdmbc	241	11	motion	motion	NN
cord-254852-qr5gdmbc	241	12	a	a	DT
cord-254852-qr5gdmbc	241	13	typical	typical	JJ
cord-254852-qr5gdmbc	241	14	course	course	NN
cord-254852-qr5gdmbc	241	15	of	of	IN
cord-254852-qr5gdmbc	241	16	action	action	NN
cord-254852-qr5gdmbc	241	17	,	,	,
cord-254852-qr5gdmbc	241	18	including	include	VBG
cord-254852-qr5gdmbc	241	19	physical	physical	JJ
cord-254852-qr5gdmbc	241	20	examination	examination	NN
cord-254852-qr5gdmbc	241	21	and	and	CC
cord-254852-qr5gdmbc	241	22	possibly	possibly	RB
cord-254852-qr5gdmbc	241	23	imaging	image	VBG
cord-254852-qr5gdmbc	241	24	to	to	TO
cord-254852-qr5gdmbc	241	25	confirm	confirm	VB
cord-254852-qr5gdmbc	241	26	clinical	clinical	JJ
cord-254852-qr5gdmbc	241	27	suspicion	suspicion	NN
cord-254852-qr5gdmbc	241	28	.	.	.
cord-254852-qr5gdmbc	242	1	Further	further	JJ
cord-254852-qr5gdmbc	242	2	testing	testing	NN
cord-254852-qr5gdmbc	242	3	depends	depend	VBZ
cord-254852-qr5gdmbc	242	4	on	on	IN
cord-254852-qr5gdmbc	242	5	treatment	treatment	NN
cord-254852-qr5gdmbc	242	6	venue	venue	NN
cord-254852-qr5gdmbc	242	7	(	(	-LRB-
cord-254852-qr5gdmbc	242	8	outpatient	outpatient	NN
cord-254852-qr5gdmbc	242	9	vs	vs	IN
cord-254852-qr5gdmbc	242	10	inpatient	inpatient	NN
cord-254852-qr5gdmbc	242	11	)	)	-RRB-
cord-254852-qr5gdmbc	242	12	and	and	CC
cord-254852-qr5gdmbc	242	13	other	other	JJ
cord-254852-qr5gdmbc	242	14	specific	specific	JJ
cord-254852-qr5gdmbc	242	15	criteria	criterion	NNS
cord-254852-qr5gdmbc	242	16	(	(	-LRB-
cord-254852-qr5gdmbc	242	17	see	see	VB
cord-254852-qr5gdmbc	242	18	Table	Table	NNP
cord-254852-qr5gdmbc	242	19	3	3	CD
cord-254852-qr5gdmbc	242	20	)	)	-RRB-
cord-254852-qr5gdmbc	242	21	.	.	.
cord-254852-qr5gdmbc	243	1	Empirical	empirical	JJ
cord-254852-qr5gdmbc	243	2	antibiotic	antibiotic	JJ
cord-254852-qr5gdmbc	243	3	therapy	therapy	NN
cord-254852-qr5gdmbc	243	4	is	be	VBZ
cord-254852-qr5gdmbc	243	5	the	the	DT
cord-254852-qr5gdmbc	243	6	cornerstone	cornerstone	NN
cord-254852-qr5gdmbc	243	7	of	of	IN
cord-254852-qr5gdmbc	243	8	treatment	treatment	NN
cord-254852-qr5gdmbc	243	9	,	,	,
cord-254852-qr5gdmbc	243	10	and	and	CC
cord-254852-qr5gdmbc	243	11	knowledge	knowledge	NN
cord-254852-qr5gdmbc	243	12	of	of	IN
cord-254852-qr5gdmbc	243	13	local	local	JJ
cord-254852-qr5gdmbc	243	14	and	and	CC
cord-254852-qr5gdmbc	243	15	regional	regional	JJ
cord-254852-qr5gdmbc	243	16	microbial	microbial	JJ
cord-254852-qr5gdmbc	243	17	susceptibility	susceptibility	NN
cord-254852-qr5gdmbc	243	18	and	and	CC
cord-254852-qr5gdmbc	243	19	resistance	resistance	NN
cord-254852-qr5gdmbc	243	20	will	will	MD
cord-254852-qr5gdmbc	243	21	bolster	bolster	VB
cord-254852-qr5gdmbc	243	22	the	the	DT
cord-254852-qr5gdmbc	243	23	success	success	NN
cord-254852-qr5gdmbc	243	24	rate	rate	NN
cord-254852-qr5gdmbc	243	25	of	of	IN
cord-254852-qr5gdmbc	243	26	outpatient	outpatient	NN
cord-254852-qr5gdmbc	243	27	management	management	NN
cord-254852-qr5gdmbc	243	28	of	of	IN
cord-254852-qr5gdmbc	243	29	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	243	30	,	,	,
cord-254852-qr5gdmbc	243	31	regardless	regardless	RB
cord-254852-qr5gdmbc	243	32	of	of	IN
cord-254852-qr5gdmbc	243	33	demographic	demographic	JJ
cord-254852-qr5gdmbc	243	34	and/or	and/or	CC
cord-254852-qr5gdmbc	243	35	accompanying	accompany	VBG
cord-254852-qr5gdmbc	243	36	morbidities	morbidity	NNS
cord-254852-qr5gdmbc	243	37	.	.	.
cord-254852-qr5gdmbc	244	1	Special	special	JJ
cord-254852-qr5gdmbc	244	2	circumstances	circumstance	NNS
cord-254852-qr5gdmbc	244	3	and	and	CC
cord-254852-qr5gdmbc	244	4	scenarios	scenario	NNS
cord-254852-qr5gdmbc	244	5	that	that	WDT
cord-254852-qr5gdmbc	244	6	may	may	MD
cord-254852-qr5gdmbc	244	7	occur	occur	VB
cord-254852-qr5gdmbc	244	8	,	,	,
cord-254852-qr5gdmbc	244	9	including	include	VBG
cord-254852-qr5gdmbc	244	10	nonresolving	nonresolve	VBG
cord-254852-qr5gdmbc	244	11	pneumonias	pneumonia	NNS
cord-254852-qr5gdmbc	244	12	,	,	,
cord-254852-qr5gdmbc	244	13	pediatric	pediatric	JJ
cord-254852-qr5gdmbc	244	14	or	or	CC
cord-254852-qr5gdmbc	244	15	geriatric	geriatric	JJ
cord-254852-qr5gdmbc	244	16	populations	population	NNS
cord-254852-qr5gdmbc	244	17	,	,	,
cord-254852-qr5gdmbc	244	18	travel	travel	NN
cord-254852-qr5gdmbc	244	19	-	-	HYPH
cord-254852-qr5gdmbc	244	20	related	relate	VBN
cord-254852-qr5gdmbc	244	21	infections	infection	NNS
cord-254852-qr5gdmbc	244	22	,	,	,
cord-254852-qr5gdmbc	244	23	among	among	IN
cord-254852-qr5gdmbc	244	24	others	other	NNS
cord-254852-qr5gdmbc	244	25	,	,	,
cord-254852-qr5gdmbc	244	26	will	will	MD
cord-254852-qr5gdmbc	244	27	necessitate	necessitate	VB
cord-254852-qr5gdmbc	244	28	a	a	DT
cord-254852-qr5gdmbc	244	29	more	more	RBR
cord-254852-qr5gdmbc	244	30	careful	careful	JJ
cord-254852-qr5gdmbc	244	31	attention	attention	NN
cord-254852-qr5gdmbc	244	32	to	to	IN
cord-254852-qr5gdmbc	244	33	history	history	NN
cord-254852-qr5gdmbc	244	34	,	,	,
cord-254852-qr5gdmbc	244	35	physical	physical	JJ
cord-254852-qr5gdmbc	244	36	examination	examination	NN
cord-254852-qr5gdmbc	244	37	,	,	,
cord-254852-qr5gdmbc	244	38	and	and	CC
cord-254852-qr5gdmbc	244	39	antibiotic	antibiotic	JJ
cord-254852-qr5gdmbc	244	40	selection	selection	NN
cord-254852-qr5gdmbc	244	41	.	.	.
cord-254852-qr5gdmbc	244	42	 	 	_SP
cord-254852-qr5gdmbc	245	1	Trends	trend	NNS
cord-254852-qr5gdmbc	245	2	in	in	IN
cord-254852-qr5gdmbc	245	3	hospital	hospital	NN
cord-254852-qr5gdmbc	245	4	inpatient	inpatient	NN
cord-254852-qr5gdmbc	245	5	stays	stay	VBZ
cord-254852-qr5gdmbc	245	6	in	in	IN
cord-254852-qr5gdmbc	245	7	the	the	DT
cord-254852-qr5gdmbc	245	8	United	United	NNP
cord-254852-qr5gdmbc	245	9	States	States	NNP
cord-254852-qr5gdmbc	245	10	National	National	NNP
cord-254852-qr5gdmbc	245	11	Hospital	Hospital	NNP
cord-254852-qr5gdmbc	245	12	Ambulatory	Ambulatory	NNP
cord-254852-qr5gdmbc	245	13	Medical	Medical	NNP
cord-254852-qr5gdmbc	245	14	Care	Care	NNP
cord-254852-qr5gdmbc	245	15	Survey	Survey	NNP
cord-254852-qr5gdmbc	245	16	:	:	:
cord-254852-qr5gdmbc	245	17	2014	2014	CD
cord-254852-qr5gdmbc	245	18	emergency	emergency	NN
cord-254852-qr5gdmbc	245	19	department	department	NN
cord-254852-qr5gdmbc	245	20	summary	summary	NN
cord-254852-qr5gdmbc	245	21	tables	table	NNS
cord-254852-qr5gdmbc	245	22	National	National	NNP
cord-254852-qr5gdmbc	245	23	inpatient	inpatient	JJ
cord-254852-qr5gdmbc	245	24	hospital	hospital	NN
cord-254852-qr5gdmbc	245	25	costs	cost	NNS
cord-254852-qr5gdmbc	245	26	:	:	:
cord-254852-qr5gdmbc	246	1	the	the	DT
cord-254852-qr5gdmbc	246	2	most	most	RBS
cord-254852-qr5gdmbc	246	3	expensive	expensive	JJ
cord-254852-qr5gdmbc	246	4	conditions	condition	NNS
cord-254852-qr5gdmbc	246	5	by	by	IN
cord-254852-qr5gdmbc	246	6	payer	payer	NN
cord-254852-qr5gdmbc	246	7	Community	community	NN
cord-254852-qr5gdmbc	246	8	-	-	HYPH
cord-254852-qr5gdmbc	246	9	acquired	acquire	VBN
cord-254852-qr5gdmbc	246	10	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	246	11	requiring	require	VBG
cord-254852-qr5gdmbc	246	12	hospitalization	hospitalization	NN
cord-254852-qr5gdmbc	246	13	among	among	IN
cord-254852-qr5gdmbc	246	14	U.S.	U.S.	NNP
cord-254852-qr5gdmbc	246	15	adults	adult	NNS
cord-254852-qr5gdmbc	247	1	The	the	DT
cord-254852-qr5gdmbc	247	2	Washington	Washington	NNP
cord-254852-qr5gdmbc	247	3	manual	manual	NN
cord-254852-qr5gdmbc	247	4	of	of	IN
cord-254852-qr5gdmbc	247	5	outpatient	outpatient	JJ
cord-254852-qr5gdmbc	247	6	internal	internal	JJ
cord-254852-qr5gdmbc	247	7	medicine	medicine	NN
cord-254852-qr5gdmbc	247	8	.	.	.
cord-254852-qr5gdmbc	248	1	Philadelphia	Philadelphia	NNP
cord-254852-qr5gdmbc	248	2	:	:	:
cord-254852-qr5gdmbc	249	1	Lippincott	Lippincott	NNP
cord-254852-qr5gdmbc	249	2	Williams	Williams	NNP
cord-254852-qr5gdmbc	249	3	&	&	CC
cord-254852-qr5gdmbc	249	4	Wilkins	Wilkins	NNP
cord-254852-qr5gdmbc	249	5	Community	Community	NNP
cord-254852-qr5gdmbc	249	6	-	-	HYPH
cord-254852-qr5gdmbc	249	7	acquired	acquire	VBN
cord-254852-qr5gdmbc	249	8	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	249	9	in	in	IN
cord-254852-qr5gdmbc	249	10	adults	adult	NNS
cord-254852-qr5gdmbc	249	11	:	:	:
cord-254852-qr5gdmbc	249	12	diagnosis	diagnosis	NN
cord-254852-qr5gdmbc	249	13	and	and	CC
cord-254852-qr5gdmbc	249	14	management	management	NN
cord-254852-qr5gdmbc	249	15	Prediction	Prediction	NNP
cord-254852-qr5gdmbc	249	16	of	of	IN
cord-254852-qr5gdmbc	249	17	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	249	18	in	in	IN
cord-254852-qr5gdmbc	249	19	outpatients	outpatient	NNS
cord-254852-qr5gdmbc	249	20	with	with	IN
cord-254852-qr5gdmbc	249	21	acute	acute	JJ
cord-254852-qr5gdmbc	249	22	cough	cough	NN
cord-254852-qr5gdmbc	249	23	:	:	:
cord-254852-qr5gdmbc	249	24	a	a	DT
cord-254852-qr5gdmbc	249	25	statistical	statistical	JJ
cord-254852-qr5gdmbc	249	26	approach	approach	NN
cord-254852-qr5gdmbc	249	27	The	the	DT
cord-254852-qr5gdmbc	249	28	rational	rational	JJ
cord-254852-qr5gdmbc	249	29	clinical	clinical	JJ
cord-254852-qr5gdmbc	249	30	examination	examination	NN
cord-254852-qr5gdmbc	249	31	:	:	:
cord-254852-qr5gdmbc	249	32	evidence	evidence	NN
cord-254852-qr5gdmbc	249	33	-	-	HYPH
cord-254852-qr5gdmbc	249	34	based	base	VBN
cord-254852-qr5gdmbc	249	35	clinical	clinical	JJ
cord-254852-qr5gdmbc	249	36	diagnosis	diagnosis	NN
cord-254852-qr5gdmbc	250	1	Common	common	JJ
cord-254852-qr5gdmbc	250	2	questions	question	NNS
cord-254852-qr5gdmbc	250	3	about	about	IN
cord-254852-qr5gdmbc	250	4	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	250	5	in	in	IN
cord-254852-qr5gdmbc	250	6	nursing	nursing	NN
cord-254852-qr5gdmbc	250	7	home	home	NN
cord-254852-qr5gdmbc	250	8	residents	resident	NNS
cord-254852-qr5gdmbc	250	9	Predicting	predict	VBG
cord-254852-qr5gdmbc	250	10	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	250	11	in	in	IN
cord-254852-qr5gdmbc	250	12	adults	adult	NNS
cord-254852-qr5gdmbc	250	13	with	with	IN
cord-254852-qr5gdmbc	250	14	respiratory	respiratory	JJ
cord-254852-qr5gdmbc	250	15	illness	illness	NN
cord-254852-qr5gdmbc	250	16	Infectious	Infectious	NNP
cord-254852-qr5gdmbc	250	17	Diseases	Diseases	NNPS
cord-254852-qr5gdmbc	250	18	Society	Society	NNP
cord-254852-qr5gdmbc	250	19	of	of	IN
cord-254852-qr5gdmbc	250	20	America/	america/	JJ
cord-254852-qr5gdmbc	250	21	American	American	NNP
cord-254852-qr5gdmbc	250	22	Thoracic	Thoracic	NNP
cord-254852-qr5gdmbc	250	23	Society	Society	NNP
cord-254852-qr5gdmbc	250	24	consensus	consensus	NN
cord-254852-qr5gdmbc	250	25	guidelines	guideline	NNS
cord-254852-qr5gdmbc	250	26	on	on	IN
cord-254852-qr5gdmbc	250	27	the	the	DT
cord-254852-qr5gdmbc	250	28	management	management	NN
cord-254852-qr5gdmbc	250	29	of	of	IN
cord-254852-qr5gdmbc	250	30	community	community	NN
cord-254852-qr5gdmbc	250	31	-	-	HYPH
cord-254852-qr5gdmbc	250	32	acquired	acquire	VBN
cord-254852-qr5gdmbc	250	33	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	250	34	in	in	IN
cord-254852-qr5gdmbc	250	35	adults	adult	NNS
cord-254852-qr5gdmbc	250	36	BTS	BTS	NNP
cord-254852-qr5gdmbc	250	37	guidelines	guideline	NNS
cord-254852-qr5gdmbc	250	38	for	for	IN
cord-254852-qr5gdmbc	250	39	the	the	DT
cord-254852-qr5gdmbc	250	40	management	management	NN
cord-254852-qr5gdmbc	250	41	of	of	IN
cord-254852-qr5gdmbc	250	42	community	community	NN
cord-254852-qr5gdmbc	250	43	acquired	acquire	VBD
cord-254852-qr5gdmbc	250	44	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	250	45	in	in	IN
cord-254852-qr5gdmbc	250	46	adults	adult	NNS
cord-254852-qr5gdmbc	250	47	:	:	:
cord-254852-qr5gdmbc	250	48	update	update	VB
cord-254852-qr5gdmbc	250	49	Guidelines	guideline	NNS
cord-254852-qr5gdmbc	250	50	for	for	IN
cord-254852-qr5gdmbc	250	51	diagnosis	diagnosis	NN
cord-254852-qr5gdmbc	250	52	and	and	CC
cord-254852-qr5gdmbc	250	53	management	management	NN
cord-254852-qr5gdmbc	250	54	of	of	IN
cord-254852-qr5gdmbc	250	55	community	community	NN
cord-254852-qr5gdmbc	250	56	-	-	HYPH
cord-254852-qr5gdmbc	250	57	and	and	CC
cord-254852-qr5gdmbc	250	58	hospital	hospital	NN
cord-254852-qr5gdmbc	250	59	-	-	HYPH
cord-254852-qr5gdmbc	250	60	acquired	acquire	VBN
cord-254852-qr5gdmbc	250	61	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	250	62	in	in	IN
cord-254852-qr5gdmbc	250	63	adults	adult	NNS
cord-254852-qr5gdmbc	250	64	:	:	:
cord-254852-qr5gdmbc	251	1	joint	joint	JJ
cord-254852-qr5gdmbc	251	2	ICS/	ICS/	NNP
cord-254852-qr5gdmbc	251	3	NCCP(I	NCCP(I	NNP
cord-254852-qr5gdmbc	251	4	)	)	-RRB-
cord-254852-qr5gdmbc	251	5	recommendations	recommendation	VBZ
cord-254852-qr5gdmbc	251	6	Severity	severity	NN
cord-254852-qr5gdmbc	251	7	assessment	assessment	NN
cord-254852-qr5gdmbc	251	8	tools	tool	NNS
cord-254852-qr5gdmbc	251	9	for	for	IN
cord-254852-qr5gdmbc	251	10	predicting	predict	VBG
cord-254852-qr5gdmbc	251	11	mortality	mortality	NN
cord-254852-qr5gdmbc	251	12	in	in	IN
cord-254852-qr5gdmbc	251	13	hospitalised	hospitalise	VBN
cord-254852-qr5gdmbc	251	14	patients	patient	NNS
cord-254852-qr5gdmbc	251	15	with	with	IN
cord-254852-qr5gdmbc	251	16	community	community	NN
cord-254852-qr5gdmbc	251	17	-	-	HYPH
cord-254852-qr5gdmbc	251	18	acquired	acquire	VBN
cord-254852-qr5gdmbc	251	19	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	251	20	.	.	.
cord-254852-qr5gdmbc	252	1	Systematic	systematic	JJ
cord-254852-qr5gdmbc	252	2	review	review	NN
cord-254852-qr5gdmbc	252	3	and	and	CC
cord-254852-qr5gdmbc	252	4	meta	meta	NN
cord-254852-qr5gdmbc	252	5	-	-	HYPH
cord-254852-qr5gdmbc	252	6	analysis	analysis	NN
cord-254852-qr5gdmbc	252	7	Defining	define	VBG
cord-254852-qr5gdmbc	252	8	community	community	NN
cord-254852-qr5gdmbc	252	9	acquired	acquire	VBD
cord-254852-qr5gdmbc	252	10	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	252	11	severity	severity	NN
cord-254852-qr5gdmbc	252	12	on	on	IN
cord-254852-qr5gdmbc	252	13	presentation	presentation	NN
cord-254852-qr5gdmbc	252	14	to	to	IN
cord-254852-qr5gdmbc	252	15	hospital	hospital	NN
cord-254852-qr5gdmbc	252	16	:	:	:
cord-254852-qr5gdmbc	253	1	an	an	DT
cord-254852-qr5gdmbc	253	2	international	international	JJ
cord-254852-qr5gdmbc	253	3	derivation	derivation	NN
cord-254852-qr5gdmbc	253	4	and	and	CC
cord-254852-qr5gdmbc	253	5	validation	validation	NN
cord-254852-qr5gdmbc	253	6	study	study	NN
cord-254852-qr5gdmbc	253	7	Antibiotics	antibiotic	NNS
cord-254852-qr5gdmbc	253	8	for	for	IN
cord-254852-qr5gdmbc	253	9	community	community	NN
cord-254852-qr5gdmbc	253	10	-	-	HYPH
cord-254852-qr5gdmbc	253	11	acquired	acquire	VBN
cord-254852-qr5gdmbc	253	12	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	253	13	in	in	IN
cord-254852-qr5gdmbc	253	14	adult	adult	NN
cord-254852-qr5gdmbc	253	15	outpatients	outpatient	NNS
cord-254852-qr5gdmbc	253	16	Duration	duration	NN
cord-254852-qr5gdmbc	253	17	of	of	IN
cord-254852-qr5gdmbc	253	18	antibiotic	antibiotic	JJ
cord-254852-qr5gdmbc	253	19	treatment	treatment	NN
cord-254852-qr5gdmbc	253	20	in	in	IN
cord-254852-qr5gdmbc	253	21	community	community	NN
cord-254852-qr5gdmbc	253	22	-	-	HYPH
cord-254852-qr5gdmbc	253	23	acquired	acquire	VBN
cord-254852-qr5gdmbc	253	24	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	253	25	Corticosteroids	Corticosteroids	NNPS
cord-254852-qr5gdmbc	253	26	for	for	IN
cord-254852-qr5gdmbc	253	27	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	253	28	Corticosteroid	Corticosteroid	NNP
cord-254852-qr5gdmbc	253	29	therapy	therapy	NN
cord-254852-qr5gdmbc	253	30	for	for	IN
cord-254852-qr5gdmbc	253	31	patients	patient	NNS
cord-254852-qr5gdmbc	253	32	hospitalized	hospitalize	VBN
cord-254852-qr5gdmbc	253	33	with	with	IN
cord-254852-qr5gdmbc	253	34	community	community	NN
cord-254852-qr5gdmbc	253	35	-	-	HYPH
cord-254852-qr5gdmbc	253	36	acquired	acquire	VBN
cord-254852-qr5gdmbc	253	37	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	253	38	Corticosteroids	Corticosteroids	NNPS
cord-254852-qr5gdmbc	253	39	in	in	IN
cord-254852-qr5gdmbc	253	40	the	the	DT
cord-254852-qr5gdmbc	253	41	adjunctive	adjunctive	JJ
cord-254852-qr5gdmbc	253	42	therapy	therapy	NN
cord-254852-qr5gdmbc	253	43	of	of	IN
cord-254852-qr5gdmbc	253	44	communityacquired	communityacquired	JJ
cord-254852-qr5gdmbc	253	45	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	253	46	:	:	:
cord-254852-qr5gdmbc	253	47	an	an	DT
cord-254852-qr5gdmbc	253	48	appraisal	appraisal	NN
cord-254852-qr5gdmbc	253	49	of	of	IN
cord-254852-qr5gdmbc	253	50	recent	recent	JJ
cord-254852-qr5gdmbc	253	51	meta	meta	JJ
cord-254852-qr5gdmbc	253	52	-	-	HYPH
cord-254852-qr5gdmbc	253	53	analyses	analysis	NNS
cord-254852-qr5gdmbc	253	54	of	of	IN
cord-254852-qr5gdmbc	253	55	clinical	clinical	JJ
cord-254852-qr5gdmbc	253	56	trials	trial	NNS
cord-254852-qr5gdmbc	253	57	Procalcitonin	Procalcitonin	NNP
cord-254852-qr5gdmbc	253	58	-	-	HYPH
cord-254852-qr5gdmbc	253	59	guided	guide	VBN
cord-254852-qr5gdmbc	253	60	diagnosis	diagnosis	NN
cord-254852-qr5gdmbc	253	61	and	and	CC
cord-254852-qr5gdmbc	253	62	antibiotic	antibiotic	JJ
cord-254852-qr5gdmbc	253	63	stewardship	stewardship	NN
cord-254852-qr5gdmbc	253	64	revisited	revisit	VBN
cord-254852-qr5gdmbc	253	65	Procalcitonin	Procalcitonin	NNP
cord-254852-qr5gdmbc	253	66	to	to	TO
cord-254852-qr5gdmbc	253	67	initiate	initiate	VB
cord-254852-qr5gdmbc	253	68	or	or	CC
cord-254852-qr5gdmbc	253	69	discontinue	discontinue	VB
cord-254852-qr5gdmbc	253	70	antibiotics	antibiotic	NNS
cord-254852-qr5gdmbc	253	71	in	in	IN
cord-254852-qr5gdmbc	253	72	acute	acute	JJ
cord-254852-qr5gdmbc	253	73	respiratory	respiratory	JJ
cord-254852-qr5gdmbc	253	74	tract	tract	NN
cord-254852-qr5gdmbc	253	75	infections	infection	NNS
cord-254852-qr5gdmbc	254	1	Unresolved	unresolved	JJ
cord-254852-qr5gdmbc	254	2	Acute	acute	JJ
cord-254852-qr5gdmbc	254	3	Pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	254	4	:	:	:
cord-254852-qr5gdmbc	255	1	a	a	DT
cord-254852-qr5gdmbc	255	2	"	"	``
cord-254852-qr5gdmbc	255	3	BAD	bad	JJ
cord-254852-qr5gdmbc	255	4	OMEN	OMEN	NNP
cord-254852-qr5gdmbc	255	5	Pneumococcal	Pneumococcal	NNP
cord-254852-qr5gdmbc	255	6	vaccination	vaccination	NN
cord-254852-qr5gdmbc	255	7	j	j	NN
cord-254852-qr5gdmbc	256	1	what	what	WP
cord-254852-qr5gdmbc	256	2	you	-PRON-	PRP
cord-254852-qr5gdmbc	256	3	should	should	MD
cord-254852-qr5gdmbc	256	4	know	know	VB
cord-254852-qr5gdmbc	256	5	j	j	NNP
cord-254852-qr5gdmbc	256	6	CDC	CDC	NNP
cord-254852-qr5gdmbc	256	7	Polysaccharide	Polysaccharide	NNP
cord-254852-qr5gdmbc	256	8	conjugate	conjugate	JJ
cord-254852-qr5gdmbc	256	9	vaccine	vaccine	NN
cord-254852-qr5gdmbc	256	10	against	against	IN
cord-254852-qr5gdmbc	256	11	pneumococcal	pneumococcal	JJ
cord-254852-qr5gdmbc	256	12	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	256	13	in	in	IN
cord-254852-qr5gdmbc	256	14	adults	adult	NNS
cord-254852-qr5gdmbc	257	1	Updated	update	VBN
cord-254852-qr5gdmbc	257	2	recommendations	recommendation	NNS
cord-254852-qr5gdmbc	257	3	for	for	IN
cord-254852-qr5gdmbc	257	4	prevention	prevention	NN
cord-254852-qr5gdmbc	257	5	of	of	IN
cord-254852-qr5gdmbc	257	6	invasive	invasive	JJ
cord-254852-qr5gdmbc	257	7	pneumococcal	pneumococcal	JJ
cord-254852-qr5gdmbc	257	8	disease	disease	NN
cord-254852-qr5gdmbc	257	9	among	among	IN
cord-254852-qr5gdmbc	257	10	adults	adult	NNS
cord-254852-qr5gdmbc	257	11	using	use	VBG
cord-254852-qr5gdmbc	257	12	the	the	DT
cord-254852-qr5gdmbc	257	13	23-valent	23-valent	CD
cord-254852-qr5gdmbc	257	14	pneumococcal	pneumococcal	JJ
cord-254852-qr5gdmbc	257	15	polysaccharide	polysaccharide	NN
cord-254852-qr5gdmbc	257	16	vaccine	vaccine	NN
cord-254852-qr5gdmbc	257	17	(	(	-LRB-
cord-254852-qr5gdmbc	257	18	PPSV23	ppsv23	NN
cord-254852-qr5gdmbc	257	19	)	)	-RRB-
cord-254852-qr5gdmbc	257	20	Vaccines	vaccine	NNS
cord-254852-qr5gdmbc	257	21	for	for	IN
cord-254852-qr5gdmbc	257	22	preventing	prevent	VBG
cord-254852-qr5gdmbc	257	23	pneumococcal	pneumococcal	JJ
cord-254852-qr5gdmbc	257	24	infection	infection	NN
cord-254852-qr5gdmbc	257	25	in	in	IN
cord-254852-qr5gdmbc	257	26	adults	adult	NNS
cord-254852-qr5gdmbc	257	27	What	what	WP
cord-254852-qr5gdmbc	257	28	is	be	VBZ
cord-254852-qr5gdmbc	257	29	the	the	DT
cord-254852-qr5gdmbc	257	30	best	good	JJS
cord-254852-qr5gdmbc	257	31	approach	approach	NN
cord-254852-qr5gdmbc	257	32	to	to	IN
cord-254852-qr5gdmbc	257	33	the	the	DT
cord-254852-qr5gdmbc	257	34	nonresponding	nonresponde	VBG
cord-254852-qr5gdmbc	257	35	patient	patient	NN
cord-254852-qr5gdmbc	257	36	with	with	IN
cord-254852-qr5gdmbc	257	37	community	community	NN
cord-254852-qr5gdmbc	257	38	-	-	HYPH
cord-254852-qr5gdmbc	257	39	acquired	acquire	VBN
cord-254852-qr5gdmbc	257	40	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	257	41	?	?	.
cord-254852-qr5gdmbc	258	1	Pulmonary	pulmonary	JJ
cord-254852-qr5gdmbc	258	2	infections	infection	NNS
cord-254852-qr5gdmbc	258	3	in	in	IN
cord-254852-qr5gdmbc	258	4	the	the	DT
cord-254852-qr5gdmbc	258	5	returned	return	VBN
cord-254852-qr5gdmbc	258	6	traveler	traveler	NN
cord-254852-qr5gdmbc	258	7	Non	non	JJ
cord-254852-qr5gdmbc	258	8	-	-	JJ
cord-254852-qr5gdmbc	258	9	infectious	infectious	JJ
cord-254852-qr5gdmbc	258	10	mimics	mimic	NNS
cord-254852-qr5gdmbc	258	11	of	of	IN
cord-254852-qr5gdmbc	258	12	community	community	NN
cord-254852-qr5gdmbc	258	13	-	-	HYPH
cord-254852-qr5gdmbc	258	14	acquired	acquire	VBN
cord-254852-qr5gdmbc	258	15	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	259	1	The	the	DT
cord-254852-qr5gdmbc	259	2	management	management	NN
cord-254852-qr5gdmbc	259	3	of	of	IN
cord-254852-qr5gdmbc	259	4	community	community	NN
cord-254852-qr5gdmbc	259	5	-	-	HYPH
cord-254852-qr5gdmbc	259	6	acquired	acquire	VBN
cord-254852-qr5gdmbc	259	7	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	259	8	in	in	IN
cord-254852-qr5gdmbc	259	9	the	the	DT
cord-254852-qr5gdmbc	259	10	elderly	elderly	JJ
cord-254852-qr5gdmbc	259	11	CDC	CDC	NNP
cord-254852-qr5gdmbc	259	12	yellow	yellow	JJ
cord-254852-qr5gdmbc	259	13	book	book	NN
cord-254852-qr5gdmbc	259	14	2018	2018	CD
cord-254852-qr5gdmbc	259	15	:	:	:
cord-254852-qr5gdmbc	259	16	health	health	NN
cord-254852-qr5gdmbc	259	17	information	information	NN
cord-254852-qr5gdmbc	259	18	for	for	IN
cord-254852-qr5gdmbc	259	19	international	international	JJ
cord-254852-qr5gdmbc	259	20	travel	travel	NN
cord-254852-qr5gdmbc	259	21	Travel	travel	NN
cord-254852-qr5gdmbc	259	22	-	-	HYPH
cord-254852-qr5gdmbc	259	23	related	relate	VBN
cord-254852-qr5gdmbc	259	24	respiratory	respiratory	JJ
cord-254852-qr5gdmbc	259	25	infections	infection	NNS
cord-254852-qr5gdmbc	259	26	General	general	JJ
cord-254852-qr5gdmbc	259	27	approach	approach	NN
cord-254852-qr5gdmbc	259	28	to	to	IN
cord-254852-qr5gdmbc	259	29	the	the	DT
cord-254852-qr5gdmbc	259	30	returned	return	VBN
cord-254852-qr5gdmbc	259	31	traveler	traveler	NN
cord-254852-qr5gdmbc	259	32	Histoplasmosis	Histoplasmosis	NNP
cord-254852-qr5gdmbc	259	33	and	and	CC
cord-254852-qr5gdmbc	259	34	other	other	JJ
cord-254852-qr5gdmbc	259	35	endemic	endemic	JJ
cord-254852-qr5gdmbc	259	36	fungal	fungal	JJ
cord-254852-qr5gdmbc	259	37	infections	infection	NNS
cord-254852-qr5gdmbc	259	38	Ventilator	ventilator	NN
cord-254852-qr5gdmbc	259	39	-	-	HYPH
cord-254852-qr5gdmbc	259	40	associated	associate	VBN
cord-254852-qr5gdmbc	259	41	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	259	42	overview	overview	NN
cord-254852-qr5gdmbc	259	43	of	of	IN
cord-254852-qr5gdmbc	259	44	nosocomial	nosocomial	JJ
cord-254852-qr5gdmbc	259	45	pneumonias	pneumonia	NNS
cord-254852-qr5gdmbc	259	46	Treatment	Treatment	NNP
cord-254852-qr5gdmbc	259	47	of	of	IN
cord-254852-qr5gdmbc	259	48	hospital	hospital	NN
cord-254852-qr5gdmbc	259	49	-	-	HYPH
cord-254852-qr5gdmbc	259	50	acquired	acquire	VBN
cord-254852-qr5gdmbc	259	51	and	and	CC
cord-254852-qr5gdmbc	259	52	ventilator	ventilator	NN
cord-254852-qr5gdmbc	259	53	-	-	HYPH
cord-254852-qr5gdmbc	259	54	associated	associate	VBN
cord-254852-qr5gdmbc	259	55	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	259	56	in	in	IN
cord-254852-qr5gdmbc	259	57	adults	adult	NNS
cord-254852-qr5gdmbc	260	1	Incidence	incidence	NN
cord-254852-qr5gdmbc	260	2	of	of	IN
cord-254852-qr5gdmbc	260	3	and	and	CC
cord-254852-qr5gdmbc	260	4	risk	risk	NN
cord-254852-qr5gdmbc	260	5	factors	factor	NNS
cord-254852-qr5gdmbc	260	6	for	for	IN
cord-254852-qr5gdmbc	260	7	ventilatorassociated	ventilatorassociated	JJ
cord-254852-qr5gdmbc	260	8	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	260	9	in	in	IN
cord-254852-qr5gdmbc	260	10	critically	critically	RB
cord-254852-qr5gdmbc	260	11	ill	ill	JJ
cord-254852-qr5gdmbc	260	12	patients	patient	NNS
cord-254852-qr5gdmbc	260	13	Clinical	clinical	JJ
cord-254852-qr5gdmbc	260	14	diagnosis	diagnosis	NN
cord-254852-qr5gdmbc	260	15	of	of	IN
cord-254852-qr5gdmbc	260	16	ventilator	ventilator	NN
cord-254852-qr5gdmbc	260	17	-	-	HYPH
cord-254852-qr5gdmbc	260	18	associated	associate	VBN
cord-254852-qr5gdmbc	260	19	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	260	20	revisited	revisit	VBD
cord-254852-qr5gdmbc	260	21	:	:	:
cord-254852-qr5gdmbc	260	22	comparative	comparative	JJ
cord-254852-qr5gdmbc	260	23	validation	validation	NN
cord-254852-qr5gdmbc	260	24	using	use	VBG
cord-254852-qr5gdmbc	260	25	immediate	immediate	JJ
cord-254852-qr5gdmbc	260	26	post	post	JJ
cord-254852-qr5gdmbc	260	27	-	-	JJ
cord-254852-qr5gdmbc	260	28	mortem	mortem	JJ
cord-254852-qr5gdmbc	260	29	lung	lung	NN
cord-254852-qr5gdmbc	260	30	biopsies	biopsy	NNS
cord-254852-qr5gdmbc	260	31	Philadelphia	Philadelphia	NNP
cord-254852-qr5gdmbc	260	32	:	:	:
cord-254852-qr5gdmbc	260	33	Lippincott	Lippincott	NNP
cord-254852-qr5gdmbc	260	34	Williams	Williams	NNP
cord-254852-qr5gdmbc	260	35	and	and	CC
cord-254852-qr5gdmbc	260	36	Wilkins	Wilkins	NNP
cord-254852-qr5gdmbc	260	37	Impact	Impact	NNP
cord-254852-qr5gdmbc	260	38	of	of	IN
cord-254852-qr5gdmbc	260	39	inappropriate	inappropriate	JJ
cord-254852-qr5gdmbc	260	40	antibiotic	antibiotic	JJ
cord-254852-qr5gdmbc	260	41	therapy	therapy	NN
cord-254852-qr5gdmbc	260	42	on	on	IN
cord-254852-qr5gdmbc	260	43	mortality	mortality	NN
cord-254852-qr5gdmbc	260	44	in	in	IN
cord-254852-qr5gdmbc	260	45	patients	patient	NNS
cord-254852-qr5gdmbc	260	46	with	with	IN
cord-254852-qr5gdmbc	260	47	ventilator	ventilator	NN
cord-254852-qr5gdmbc	260	48	-	-	HYPH
cord-254852-qr5gdmbc	260	49	associate	associate	JJ
cord-254852-qr5gdmbc	260	50	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	260	51	and	and	CC
cord-254852-qr5gdmbc	260	52	blood	blood	NN
cord-254852-qr5gdmbc	260	53	stream	stream	NN
cord-254852-qr5gdmbc	260	54	infection	infection	NN
cord-254852-qr5gdmbc	260	55	:	:	:
cord-254852-qr5gdmbc	260	56	a	a	DT
cord-254852-qr5gdmbc	260	57	meta	meta	JJ
cord-254852-qr5gdmbc	260	58	-	-	HYPH
cord-254852-qr5gdmbc	260	59	analysis	analysis	NN
cord-254852-qr5gdmbc	261	1	The	the	DT
cord-254852-qr5gdmbc	261	2	adequacy	adequacy	NN
cord-254852-qr5gdmbc	261	3	of	of	IN
cord-254852-qr5gdmbc	261	4	timely	timely	RB
cord-254852-qr5gdmbc	261	5	empiric	empiric	JJ
cord-254852-qr5gdmbc	261	6	antibiotic	antibiotic	JJ
cord-254852-qr5gdmbc	261	7	therapy	therapy	NN
cord-254852-qr5gdmbc	261	8	for	for	IN
cord-254852-qr5gdmbc	261	9	ventilator	ventilator	NN
cord-254852-qr5gdmbc	261	10	-	-	HYPH
cord-254852-qr5gdmbc	261	11	associate	associate	JJ
cord-254852-qr5gdmbc	261	12	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	261	13	:	:	:
cord-254852-qr5gdmbc	261	14	an	an	DT
cord-254852-qr5gdmbc	261	15	important	important	JJ
cord-254852-qr5gdmbc	261	16	determinant	determinant	NN
cord-254852-qr5gdmbc	261	17	of	of	IN
cord-254852-qr5gdmbc	261	18	outcome	outcome	NN
cord-254852-qr5gdmbc	261	19	Systematic	systematic	JJ
cord-254852-qr5gdmbc	261	20	review	review	NN
cord-254852-qr5gdmbc	261	21	and	and	CC
cord-254852-qr5gdmbc	261	22	meta	meta	NN
cord-254852-qr5gdmbc	261	23	-	-	HYPH
cord-254852-qr5gdmbc	261	24	analysis	analysis	NN
cord-254852-qr5gdmbc	261	25	of	of	IN
cord-254852-qr5gdmbc	261	26	the	the	DT
cord-254852-qr5gdmbc	261	27	efficacy	efficacy	NN
cord-254852-qr5gdmbc	261	28	of	of	IN
cord-254852-qr5gdmbc	261	29	appropriate	appropriate	JJ
cord-254852-qr5gdmbc	261	30	empiric	empiric	JJ
cord-254852-qr5gdmbc	261	31	antibiotic	antibiotic	JJ
cord-254852-qr5gdmbc	261	32	therapy	therapy	NN
cord-254852-qr5gdmbc	261	33	for	for	IN
cord-254852-qr5gdmbc	261	34	sepsis	sepsis	NN
cord-254852-qr5gdmbc	262	1	Empirical	empirical	JJ
cord-254852-qr5gdmbc	262	2	antibiotic	antibiotic	JJ
cord-254852-qr5gdmbc	262	3	therapy	therapy	NN
cord-254852-qr5gdmbc	262	4	for	for	IN
cord-254852-qr5gdmbc	262	5	ventilator	ventilator	NN
cord-254852-qr5gdmbc	262	6	-	-	HYPH
cord-254852-qr5gdmbc	262	7	associated	associate	VBN
cord-254852-qr5gdmbc	262	8	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	262	9	Profile	Profile	NNP
cord-254852-qr5gdmbc	262	10	of	of	IN
cord-254852-qr5gdmbc	262	11	infective	infective	JJ
cord-254852-qr5gdmbc	262	12	microorganisms	microorganism	NNS
cord-254852-qr5gdmbc	262	13	causing	cause	VBG
cord-254852-qr5gdmbc	262	14	ventilator	ventilator	NN
cord-254852-qr5gdmbc	262	15	-	-	HYPH
cord-254852-qr5gdmbc	262	16	associated	associate	VBN
cord-254852-qr5gdmbc	262	17	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	262	18	:	:	:
cord-254852-qr5gdmbc	263	1	A	a	DT
cord-254852-qr5gdmbc	263	2	clinical	clinical	JJ
cord-254852-qr5gdmbc	263	3	study	study	NN
cord-254852-qr5gdmbc	263	4	from	from	IN
cord-254852-qr5gdmbc	263	5	resource	resource	NN
cord-254852-qr5gdmbc	263	6	limited	limited	JJ
cord-254852-qr5gdmbc	263	7	intensive	intensive	JJ
cord-254852-qr5gdmbc	263	8	care	care	NN
cord-254852-qr5gdmbc	263	9	unit	unit	NN
cord-254852-qr5gdmbc	263	10	Microbial	microbial	JJ
cord-254852-qr5gdmbc	263	11	causes	cause	NNS
cord-254852-qr5gdmbc	263	12	of	of	IN
cord-254852-qr5gdmbc	263	13	ventilator	ventilator	NN
cord-254852-qr5gdmbc	263	14	-	-	HYPH
cord-254852-qr5gdmbc	263	15	associated	associate	VBN
cord-254852-qr5gdmbc	263	16	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	263	17	Management	Management	NNP
cord-254852-qr5gdmbc	263	18	of	of	IN
cord-254852-qr5gdmbc	263	19	adults	adult	NNS
cord-254852-qr5gdmbc	263	20	with	with	IN
cord-254852-qr5gdmbc	263	21	hospitalacquired	hospitalacquired	NNP
cord-254852-qr5gdmbc	263	22	and	and	CC
cord-254852-qr5gdmbc	263	23	ventilator	ventilator	NN
cord-254852-qr5gdmbc	263	24	-	-	HYPH
cord-254852-qr5gdmbc	263	25	associated	associate	VBN
cord-254852-qr5gdmbc	263	26	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	263	27	:	:	:
cord-254852-qr5gdmbc	263	28	2016	2016	CD
cord-254852-qr5gdmbc	263	29	clinical	clinical	JJ
cord-254852-qr5gdmbc	263	30	practice	practice	NN
cord-254852-qr5gdmbc	263	31	guidelines	guideline	NNS
cord-254852-qr5gdmbc	263	32	by	by	IN
cord-254852-qr5gdmbc	263	33	the	the	DT
cord-254852-qr5gdmbc	263	34	Infectious	Infectious	NNP
cord-254852-qr5gdmbc	263	35	Diseases	Diseases	NNPS
cord-254852-qr5gdmbc	263	36	Society	Society	NNP
cord-254852-qr5gdmbc	263	37	of	of	IN
cord-254852-qr5gdmbc	263	38	America	America	NNP
cord-254852-qr5gdmbc	263	39	and	and	CC
cord-254852-qr5gdmbc	263	40	the	the	DT
cord-254852-qr5gdmbc	263	41	American	American	NNP
cord-254852-qr5gdmbc	263	42	Thoracic	Thoracic	NNP
cord-254852-qr5gdmbc	263	43	Society	Society	NNP
cord-254852-qr5gdmbc	263	44	Using	use	VBG
cord-254852-qr5gdmbc	263	45	local	local	JJ
cord-254852-qr5gdmbc	263	46	microbiologic	microbiologic	JJ
cord-254852-qr5gdmbc	263	47	data	datum	NNS
cord-254852-qr5gdmbc	263	48	to	to	TO
cord-254852-qr5gdmbc	263	49	develop	develop	VB
cord-254852-qr5gdmbc	263	50	institution	institution	NN
cord-254852-qr5gdmbc	263	51	-	-	HYPH
cord-254852-qr5gdmbc	263	52	specific	specific	JJ
cord-254852-qr5gdmbc	263	53	guidelines	guideline	NNS
cord-254852-qr5gdmbc	263	54	for	for	IN
cord-254852-qr5gdmbc	263	55	the	the	DT
cord-254852-qr5gdmbc	263	56	treatment	treatment	NN
cord-254852-qr5gdmbc	263	57	of	of	IN
cord-254852-qr5gdmbc	263	58	hospital	hospital	NN
cord-254852-qr5gdmbc	263	59	-	-	HYPH
cord-254852-qr5gdmbc	263	60	acquired	acquire	VBN
cord-254852-qr5gdmbc	263	61	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	263	62	Pediatric	Pediatric	NNP
cord-254852-qr5gdmbc	263	63	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	263	64	Child	Child	NNP
cord-254852-qr5gdmbc	263	65	Health	Health	NNP
cord-254852-qr5gdmbc	263	66	Epidemiology	Epidemiology	NNP
cord-254852-qr5gdmbc	263	67	Reference	Reference	NNP
cord-254852-qr5gdmbc	263	68	Group	Group	NNP
cord-254852-qr5gdmbc	263	69	of	of	IN
cord-254852-qr5gdmbc	263	70	WHO	WHO	NNP
cord-254852-qr5gdmbc	263	71	and	and	CC
cord-254852-qr5gdmbc	263	72	UNICEF	UNICEF	NNP
cord-254852-qr5gdmbc	263	73	.	.	.
cord-254852-qr5gdmbc	264	1	Global	global	JJ
cord-254852-qr5gdmbc	264	2	,	,	,
cord-254852-qr5gdmbc	264	3	regional	regional	JJ
cord-254852-qr5gdmbc	264	4	,	,	,
cord-254852-qr5gdmbc	264	5	and	and	CC
cord-254852-qr5gdmbc	264	6	national	national	JJ
cord-254852-qr5gdmbc	264	7	causes	cause	NNS
cord-254852-qr5gdmbc	264	8	of	of	IN
cord-254852-qr5gdmbc	264	9	child	child	NN
cord-254852-qr5gdmbc	264	10	mortality	mortality	NN
cord-254852-qr5gdmbc	264	11	in	in	IN
cord-254852-qr5gdmbc	264	12	2008	2008	CD
cord-254852-qr5gdmbc	264	13	:	:	:
cord-254852-qr5gdmbc	264	14	a	a	DT
cord-254852-qr5gdmbc	264	15	systematic	systematic	JJ
cord-254852-qr5gdmbc	264	16	analysis	analysis	NN
cord-254852-qr5gdmbc	264	17	World	World	NNP
cord-254852-qr5gdmbc	264	18	Health	Health	NNP
cord-254852-qr5gdmbc	264	19	Organization	Organization	NNP
cord-254852-qr5gdmbc	265	1	Pneumonia	Pneumonia	NNP
cord-254852-qr5gdmbc	265	2	National	National	NNP
cord-254852-qr5gdmbc	265	3	hospitalization	hospitalization	NN
cord-254852-qr5gdmbc	265	4	trends	trend	NNS
cord-254852-qr5gdmbc	265	5	for	for	IN
cord-254852-qr5gdmbc	265	6	pediatric	pediatric	JJ
cord-254852-qr5gdmbc	265	7	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	265	8	and	and	CC
cord-254852-qr5gdmbc	265	9	associated	associate	VBD
cord-254852-qr5gdmbc	265	10	complications	complication	NNS
cord-254852-qr5gdmbc	265	11	Community	Community	NNP
cord-254852-qr5gdmbc	265	12	-	-	HYPH
cord-254852-qr5gdmbc	265	13	acquired	acquire	VBN
cord-254852-qr5gdmbc	265	14	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	265	15	in	in	IN
cord-254852-qr5gdmbc	265	16	children	child	NNS
cord-254852-qr5gdmbc	266	1	The	the	DT
cord-254852-qr5gdmbc	266	2	rational	rational	JJ
cord-254852-qr5gdmbc	266	3	clinical	clinical	JJ
cord-254852-qr5gdmbc	266	4	examination	examination	NN
cord-254852-qr5gdmbc	266	5	.	.	.
cord-254852-qr5gdmbc	267	1	Does	do	VBZ
cord-254852-qr5gdmbc	267	2	this	this	DT
cord-254852-qr5gdmbc	267	3	infant	infant	NN
cord-254852-qr5gdmbc	267	4	have	have	VB
cord-254852-qr5gdmbc	267	5	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	267	6	?	?	.
cord-254852-qr5gdmbc	268	1	Utility	utility	NN
cord-254852-qr5gdmbc	268	2	of	of	IN
cord-254852-qr5gdmbc	268	3	blood	blood	NN
cord-254852-qr5gdmbc	268	4	culture	culture	NN
cord-254852-qr5gdmbc	268	5	among	among	IN
cord-254852-qr5gdmbc	268	6	children	child	NNS
cord-254852-qr5gdmbc	268	7	hospitalized	hospitalize	VBN
cord-254852-qr5gdmbc	268	8	with	with	IN
cord-254852-qr5gdmbc	268	9	community	community	NN
cord-254852-qr5gdmbc	268	10	-	-	HYPH
cord-254852-qr5gdmbc	268	11	acquired	acquire	VBN
cord-254852-qr5gdmbc	268	12	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	269	1	The	the	DT
cord-254852-qr5gdmbc	269	2	management	management	NN
cord-254852-qr5gdmbc	269	3	of	of	IN
cord-254852-qr5gdmbc	269	4	communityacquired	communityacquired	JJ
cord-254852-qr5gdmbc	269	5	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	269	6	in	in	IN
cord-254852-qr5gdmbc	269	7	infants	infant	NNS
cord-254852-qr5gdmbc	269	8	and	and	CC
cord-254852-qr5gdmbc	269	9	children	child	NNS
cord-254852-qr5gdmbc	269	10	older	old	JJR
cord-254852-qr5gdmbc	269	11	than	than	IN
cord-254852-qr5gdmbc	269	12	3	3	CD
cord-254852-qr5gdmbc	269	13	months	month	NNS
cord-254852-qr5gdmbc	269	14	of	of	IN
cord-254852-qr5gdmbc	269	15	age	age	NN
cord-254852-qr5gdmbc	269	16	:	:	:
cord-254852-qr5gdmbc	269	17	clinical	clinical	JJ
cord-254852-qr5gdmbc	269	18	practice	practice	NN
cord-254852-qr5gdmbc	269	19	guidelines	guideline	NNS
cord-254852-qr5gdmbc	269	20	by	by	IN
cord-254852-qr5gdmbc	269	21	the	the	DT
cord-254852-qr5gdmbc	269	22	Pediatric	Pediatric	NNP
cord-254852-qr5gdmbc	269	23	Infectious	Infectious	NNP
cord-254852-qr5gdmbc	269	24	Diseases	Diseases	NNPS
cord-254852-qr5gdmbc	269	25	Society	Society	NNP
cord-254852-qr5gdmbc	269	26	and	and	CC
cord-254852-qr5gdmbc	269	27	the	the	DT
cord-254852-qr5gdmbc	269	28	Infectious	Infectious	NNP
cord-254852-qr5gdmbc	269	29	Diseases	Diseases	NNPS
cord-254852-qr5gdmbc	269	30	Society	Society	NNP
cord-254852-qr5gdmbc	269	31	of	of	IN
cord-254852-qr5gdmbc	269	32	America	America	NNP
cord-254852-qr5gdmbc	269	33	Pneumonia	Pneumonia	NNP
cord-254852-qr5gdmbc	269	34	in	in	IN
cord-254852-qr5gdmbc	269	35	children	child	NNS
cord-254852-qr5gdmbc	269	36	:	:	:
cord-254852-qr5gdmbc	269	37	inpatient	inpatient	JJ
cord-254852-qr5gdmbc	269	38	treatment	treatment	NN
cord-254852-qr5gdmbc	269	39	Evidence	evidence	NN
cord-254852-qr5gdmbc	269	40	-	-	HYPH
cord-254852-qr5gdmbc	269	41	based	base	VBN
cord-254852-qr5gdmbc	269	42	care	care	NN
cord-254852-qr5gdmbc	269	43	guideline	guideline	NN
cord-254852-qr5gdmbc	269	44	.	.	.
cord-254852-qr5gdmbc	270	1	Community	community	NN
cord-254852-qr5gdmbc	270	2	acquired	acquire	VBD
cord-254852-qr5gdmbc	270	3	pneumonia	pneumonia	NN
cord-254852-qr5gdmbc	270	4	in	in	IN
cord-254852-qr5gdmbc	270	5	children	child	NNS
cord-254852-qr5gdmbc	270	6	60	60	CD
cord-254852-qr5gdmbc	270	7	days	day	NNS
cord-254852-qr5gdmbc	270	8	through	through	IN
cord-254852-qr5gdmbc	270	9	17years	17years	CD
cord-254852-qr5gdmbc	270	10	of	of	IN
cord-254852-qr5gdmbc	270	11	age	age	NN
cord-254852-qr5gdmbc	270	12	Factors	factor	NNS
cord-254852-qr5gdmbc	270	13	associated	associate	VBN
cord-254852-qr5gdmbc	270	14	with	with	IN
cord-254852-qr5gdmbc	270	15	antimicrobial	antimicrobial	JJ
cord-254852-qr5gdmbc	270	16	resistance	resistance	NN
cord-254852-qr5gdmbc	270	17	and	and	CC
cord-254852-qr5gdmbc	270	18	mortality	mortality	NN
cord-254852-qr5gdmbc	270	19	in	in	IN
cord-254852-qr5gdmbc	270	20	pneumococcal	pneumococcal	JJ
cord-254852-qr5gdmbc	270	21	bacteremia	bacteremia	NN
cord-254852-qr5gdmbc	270	22	Parenteral	parenteral	NN
cord-254852-qr5gdmbc	270	23	-	-	HYPH
cord-254852-qr5gdmbc	270	24	oral	oral	JJ
cord-254852-qr5gdmbc	270	25	switch	switch	NN
cord-254852-qr5gdmbc	270	26	in	in	IN
cord-254852-qr5gdmbc	270	27	the	the	DT
cord-254852-qr5gdmbc	270	28	management	management	NN
cord-254852-qr5gdmbc	270	29	of	of	IN
cord-254852-qr5gdmbc	270	30	pediatric	pediatric	JJ
cord-254852-qr5gdmbc	270	31	pneumonia	pneumonia	NN